text
stringlengths 10
159k
| url
stringlengths 19
865
| crawl_date
timestamp[s]date 2022-02-01 01:02:23
2024-12-02 05:16:38
| lang
stringclasses 1
value | lang_conf
float64 0.65
1
|
|---|---|---|---|---|
NASHVILLE, Tenn., July 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the three months period ended June 30, 2022 (second quarter 2022) on Thursday, August 4, 2022 after U.S. markets close.
In addition to the earnings release, a document titled "Cryoport Second Quarter 2022 in Review", providing a review of Cryoport's recent financial and operational performance and a general business update, will be issued at 4:05 pm ET on Thursday, August 4, 2022. The document is designed to be read in advance of the questions and answers conference call and will be accessible at http://ir.cryoport.com/events-and-presentations.
Cryoport management will host a conference call the same day at 5:00 pm ET. The conference call will be in the format of a questions and answers session and will address questions members of the investment community have regarding the Company's reported results. A slide deck will accompany the call.
Conference Call Information
The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoport.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until August 11, 2022. To access the replay, dial 1-877-344-7529 (United States) or 1-412-317-0088 (International) and enter replay pin number: 1018766
Cryoport, Inc. (Nasdaq: CYRX), headquartered in Nashville, TN, is a global leader in temperature-controlled supply chain solutions for the life sciences industry supporting life-saving cell and gene therapies across the clinical and commercial spectrum. With 38 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical solutions, services, and products to Biopharma, Animal Health, and Reproductive Medicine customers worldwide. In addition to its standard setting supply chain solutions, Cryoport is the world's largest manufacturer of cryogenic systems and one of the largest life science focused specialty couriers.
For more information, visit www.cryoport.com or follow @cryoport on Twitter at www.twitter.com/cryoport for live updates.
Statements in this press release which are not purely historical, including statements regarding the Company's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to the Company's industry, business, plans, strategy, acquisitions, financial results, and financial condition. It is important to note that the Company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the Company's cash flow, market acceptance risks, and technical development risks. The Company's business could be affected by a number of other factors, including the risk factors discussed in the Company's Securities and Exchange Commission ("SEC") reports including, but not limited to, the Company's Annual Report on Form 10-K for the twelve months ended December 31, 2021 and any subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and the Company cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, the Company disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
View original content to download multimedia:
SOURCE Cryoport, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/cryoport-report-second-quarter-2022-financial-results-august-4-2022/
| 2022-07-28T13:33:23
|
en
| 0.914315
|
Board increases quarterly common dividend by 16 percent to $0.87
SAN ANTONIO, July 28, 2022 /PRNewswire/ -- Cullen/Frost Bankers, Inc. (NYSE: CFR) today reported second quarter 2022 results. Net income available to common shareholders for the second quarter of 2022 was $117.4 million compared to $116.4 million in the second quarter of 2021. On a per-share basis, net income available to common shareholders for the second quarter of 2022 was $1.81 per diluted common share, compared to $1.80 per diluted common share reported a year earlier. Returns on average assets and average common equity were 0.92 percent and 13.88 percent, respectively, for the second quarter of 2022 compared to 1.02 percent and 11.18 percent, respectively, for the same period a year earlier.
For the second quarter of 2022, net interest income on a taxable-equivalent basis was $311.4 million, up 11.2 percent, compared to the same quarter in 2021. Average loans for the second quarter of 2022 decreased $572 million, or 3.3 percent, to $16.7 billion, from the $17.2 billion reported for the second quarter a year earlier. Excluding PPP loans, second quarter average loans of $16.5 billion represented a 13.2 percent increase compared to the second quarter of 2021 and a 2.8 percent increase compared to the first quarter of 2022. Average deposits for the quarter were $44.7 billion, up $6.5 billion, or 16.9 percent, compared to the $38.3 billion reported for last year's second quarter.
"I'm proud of the success we achieved in the second quarter as we continued to execute our organic growth strategy, and I thank our staff for their performance in generating double digit growth for both loans and deposits," said Phil Green, Cullen/Frost Chairman and CEO.
Noted financial data for the second quarter of 2022 follows:
- The Common Equity Tier 1, Tier 1 and Total Risk-Based Capital Ratios at the end of the second quarter of 2022 were 12.64 percent, 13.17 percent and 14.75 percent, respectively, and continue to be in excess of well-capitalized levels and exceed Basel III minimum requirements.
- Net interest income on a taxable-equivalent basis was $311.4 million, an increase of 11.2 percent, compared to the prior year period. Net interest margin was 2.56 percent for the second quarter of 2022 compared to 2.33 percent for the first quarter of 2022 and 2.65 percent for the second quarter of 2021.
- Non-interest income for the second quarter of 2022 totaled $97.9 million, an increase of $6.7 million, or 7.3 percent, from the $91.2 million reported for the second quarter of 2021. Service charges on deposit accounts increased $4.0 million, or 20.3 percent, compared to the second quarter of 2021. The increase was mainly driven by increases in overdraft charges (up $2.7 million) and commercial service charges (up $1.1 million). Other charges, commissions and fees increased $1.2 million, or 14.4 percent, compared to the second quarter of 2021. The increase was primarily related to increases in income from the placement of money market accounts (up $1.1 million) and merchant services rebates/bonuses (up $472,000), among other things, partly offset by a decrease in income from the sale of mutual funds (down $448,000). Insurance commissions and fees increased $1.0 million, or 9.3 percent, compared to the second quarter of 2021. The increase was the result of increases in commission income (up $774,000) and contingent income (up $229,000).
- Non-interest expense was $246.3 million for the quarter, up $31.1 million, or 14.4 percent, compared to the $215.3 million reported for the second quarter a year earlier. Salaries and wages expense increased $19.8 million, or 20.5 percent, compared to the second quarter of 2021. The increase in salaries and wages was primarily related to increases in salaries due to annual merit and market increases as well as the implementation of a $20 per hour minimum wage in December, 2021. Salaries and wages was also impacted by increases in the number of employees and increases in incentive compensation. We are experiencing an increasingly competitive labor market which has resulted in and could continue to result in an increase in our staffing costs. Employee benefits expense of $20.7 million represented an increase of $2.0 million, or 10.7 percent, compared to the second quarter of 2021. The increase was primarily related to increases in payroll taxes, 401(k) plan expense, and medical benefits plan expense. Other non-interest expense increased $4.8 million, or 11.5 percent, compared to the second quarter of 2021. The increase included increases in travel, meals and entertainment (up $1.7 million); professional services expense (up $1.2 million); sundry and other miscellaneous expenses (up $1.1 million); and advertising/promotions expense (up $661,000). Technology, furniture and equipment expense increased $1.9 million, or 6.9 percent, compared to the second quarter of 2021. The increase was primarily related to increases in cloud services expense (up $1.1 million) and service contracts expense (up $466,000), among other things, partly offset by a decrease in software maintenance (down $199,000). Net occupancy expense increased $1.7 million, or 6.5 percent, compared to the second quarter of 2021. The increase was primarily related to an increase in repairs and maintenance/service contracts expense (up $1.0 million) and was also impacted by our expansion activities in the Houston and Dallas regions, among other things.
- For the second quarter of 2022, the company did not report a credit loss expense, and reported net charge-offs of $2.8 million. This compares to no credit loss expense and net charge-offs of $6.3 million for the first quarter of 2022 and no credit loss expense and net charge-offs of $1.6 million for the second quarter of 2021. The allowance for credit losses on loans as a percentage of total loans was 1.43 percent at June 30, 2022, compared to 1.49 percent at the end of the first quarter of 2022 and 1.54 percent at the end of the second quarter of 2021. Excluding PPP loans, which carry a guarantee from the SBA, the allowance for credit losses on loans as a percentage of total loans was 1.44 percent at the end of the second quarter of 2022, compared to 1.51 percent at the end of the first quarter of 2022 and 1.74 percent at the end of the second quarter of 2021. Non-accrual loans were $35.1 million at the end of the second quarter of 2022, compared to $49.0 million at the end of the first quarter of 2022 and $57.3 million at the end of the second quarter of 2021.
The Cullen/Frost board declared a third-quarter cash dividend of $0.87 per common share, representing an increase of $0.12, or 16 percent. The dividend on common stock is payable September 15, 2022 to shareholders of record on August 31 of this year. The board of directors also declared a cash dividend of $11.125 per share of Series B Preferred Stock (or $0.278125 per depositary share). The depositary shares representing the Series B Preferred Stock are traded on the NYSE under the symbol "CFR PrB." The Series B Preferred Stock dividend is payable on September 15, 2022, to shareholders of record on August 31 of this year.
Cullen/Frost Bankers, Inc. will host a conference call on Thursday, July 28, 2022, at 1 p.m. Central Time (CT) to discuss the results for the quarter. The media and other interested parties are invited to access the call in a "listen only" mode at 1-877-709-8150 or via webcast on our investor relations website linked below. Playback of the conference call will be available after 5 p.m. CT on the day of the call until midnight Sunday, July 31, 2022 at 1-877-660-6853 with Conference ID # of 13731744. A replay of the call will also be available by webcast at the URL listed below after 5 p.m. CT on the day of the call.
Cullen/Frost investor relations website: https://investor.frostbank.com/
Cullen/Frost Bankers, Inc. (NYSE: CFR) is a financial holding company, headquartered in San Antonio, with $51.8 billion in assets at June 30, 2022. Frost provides a wide range of banking, investments and insurance services to businesses and individuals across Texas in the Austin, Corpus Christi, Dallas, Fort Worth, Houston, Permian Basin, Rio Grande Valley and San Antonio regions. Founded in 1868, Frost has helped clients with their financial needs during three centuries. Additional information is available at www.frostbank.com.
Certain statements contained in this Earnings Release that are not statements of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"), including statements regarding the potential effects of the COVID-19 pandemic on our business, financial condition, liquidity and results of operations, notwithstanding that such statements are not specifically identified as such. In addition, certain statements may be contained in our future filings with the SEC, in press releases, and in oral and written statements made by us or with our approval that are not statements of historical fact and constitute forward-looking statements within the meaning of the Act. Examples of forward-looking statements include, but are not limited to: (i) projections of revenues, expenses, income or loss, earnings or loss per share, the payment or nonpayment of dividends, capital structure and other financial items; (ii) statements of plans, objectives and expectations of Cullen/Frost or its management or Board of Directors, including those relating to products, services or operations; (iii) statements of future economic performance; and (iv) statements of assumptions underlying such statements. Words such as "believes", "anticipates", "expects", "intends", "targeted", "continue", "remain", "will", "should", "may" and other similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.
Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those in such statements. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:
- Local, regional, national and international economic conditions and the impact they may have on us and our customers and our assessment of that impact.
- Volatility and disruption in national and international financial and commodity markets.
- Government intervention in the U.S. financial system.
- Changes in the mix of loan geographies, sectors and types or the level of non-performing assets and charge-offs.
- Changes in estimates of future reserve requirements based upon the periodic review thereof under relevant regulatory and accounting requirements.
- The effects of and changes in trade and monetary and fiscal policies and laws, including the interest rate policies of the Federal Reserve Board.
- Inflation, interest rate, securities market and monetary fluctuations.
- The effect of changes in laws and regulations (including laws and regulations concerning taxes, banking, securities and insurance) and their application with which we and our subsidiaries must comply.
- The soundness of other financial institutions.
- Political instability.
- Impairment of our goodwill or other intangible assets.
- Acts of God or of war or terrorism.
- The potential impact of climate change.
- The timely development and acceptance of new products and services and perceived overall value of these products and services by users.
- Changes in consumer spending, borrowing and saving habits.
- Changes in the financial performance and/or condition of our borrowers.
- Technological changes.
- The cost and effects of cyber incidents or other failures, interruptions, or security breaches of our systems or those of our customers or third-party providers.
- Acquisitions and integration of acquired businesses.
- Our ability to increase market share and control expenses.
- Our ability to attract and retain qualified employees.
- Changes in the competitive environment in our markets and among banking organizations and other financial service providers.
- The effect of changes in accounting policies and practices, as may be adopted by the regulatory agencies, as well as the Public Company Accounting Oversight Board, the Financial Accounting Standards Board and other accounting standard setters.
- Changes in the reliability of our vendors, internal control systems or information systems.
- Changes in our liquidity position.
- Changes in our organization, compensation and benefit plans.
- The impact of the ongoing COVID-19 pandemic and any other pandemic, epidemic or health-related crisis.
- The costs and effects of legal and regulatory developments, the resolution of legal proceedings or regulatory or other governmental inquiries, the results of regulatory examinations or reviews and the ability to obtain required regulatory approvals.
- Greater than expected costs or difficulties related to the integration of new products and lines of business.
- Our success at managing the risks involved in the foregoing items.
In addition, financial markets and global supply chains may be adversely affected by the current or anticipated impact of military conflict, including the current Russian invasion of Ukraine, terrorism or other geopolitical events.
Further, statements about the potential effects of the ongoing COVID-19 pandemic on our business, financial condition, liquidity and results of operations may constitute forward-looking statements and are subject to the risk that the actual effects may differ, possibly materially, from what is reflected in those forward-looking statements due to factors and future developments that are uncertain, unpredictable and in many cases beyond our control, including the scope and duration of the pandemic, actions taken by governmental authorities in response to the pandemic, and the direct and indirect impact of the pandemic on our customers, clients, third parties and us.
Forward-looking statements speak only as of the date on which such statements are made. We do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events.
A.B. Mendez
Investor Relations
210.220.5234
or
Bill Day
Media Relations
210.220.5427
View original content to download multimedia:
SOURCE Cullen/Frost Bankers, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/cullenfrost-reports-second-quarter-results/
| 2022-07-28T13:33:29
|
en
| 0.947857
|
Around 50,000 children from Delhi government schools will come together seeking to create a world record of making the largest layout of the tricolour on August 4, Chief Minister Arvind Kejriwal announced on Thursday.
In an online briefing, Kejriwal lamented that several nations have witnessed rapid growth and surpassed India in the last 75 years.
The programme will be held at Burari Grounds here.
READ | World Hepatitis Day 2022: Some habits you must avoid to prevent from getting liver disease
"The Lord has blessed India with abundance of rivers, mineral ores, mountains, herbs, crops, oceans and seas. Indians are the smartest and most hardworking in the world, yet why do we lag behind?" he said.
"If we leave the country at the mercy of these leaders and their parties, then we'll stay behind the world for another 75 years," he added.
Kejriwal urged "130 crore Indians" to come together and take a pledge to make the country the greatest and the strongest in the world.
"Seventy five years ago, when the whole country came together, we drove the British out. Today, we all have to come together again to make India the greatest country in the world," he said.
He emphasised that it has to be a collective effort and expressed confidence that the days of India becoming the "best country" in the world are not far.
"Can India lead the world, some people ask me? Why not, is how I respond. I need to ask everyone, what do you think? why can't India rise to become the world's greatest country?
"But to accomplish this, we must all work together," he stressed.
He said the participation of entrepreneurs, farmers, industrialists, labourers, members of service class, doctors, engineers, and lawyers is needed to realise the dream.
|
https://www.dnaindia.com/india/report-world-s-largest-tricolour-to-be-formed-by-delhi-children-on-august-4-says-cm-arvind-kejriwal-2972267
| 2022-07-28T13:33:32
|
en
| 0.953656
|
BELLEVUE, Wash., July 28, 2022 /PRNewswire/ -- Icertis, the contract intelligence company that pushes the boundaries of what's possible with contract lifecycle management (CLM), announced today that former SAP President and VMware COO, Sanjay Poonen, has joined the Icertis Advisory Board as a Strategic Advisor. Mr. Poonen, a proven enterprise SaaS leader with experience scaling multi-billion-dollar businesses and spearheading product innovation, will help guide Icertis in shaping and optimizing its growth trajectory.
The data within contracts has emerged as a critical asset for true digital transformation. Icertis' Contract Intelligence (ICI) platform structures and connects the business data in a company's contracts and delivers artificial intelligence (AI), automation, and insights that ensure the intent of every contract in the enterprise is correctly memorialized and fully realized.
"Icertis has seized the opportunity to lead the booming CLM category with AI-powered contract intelligence technology that unearths the data within contracts and integrates that data with other systems of record, such as ERP, CRM, SRM, and HCM," said Icertis Strategic Advisor Sanjay Poonen. "Myriad use cases of the cloud-based Icertis platform, combined with the company's expanded SAP partnership, among others, signal both vast business value and market opportunity. I'm looking forward to helping Icertis solidify its place in SaaS history as the world's Contract Intelligence platform."
Mr. Poonen joins the distinguished Icertis Advisory Board with decades of experience driving growth for market-leading SaaS companies. From 2006-2013 he served as President at SAP, where he ran analytics, big data, and industry solutions, contributing to the company's ascent from $10 billion in revenue to $20 billion. Following SAP, he was COO of VMware, a top provider of multi-cloud services for apps, where he oversaw all business functions, led efforts to grow revenue from $7 billion to $12 billion, and ran VMware's End-User Computing and Security businesses. Mr. Poonen also has extensive board and advisory experience with companies such as Zoom, Infor, Royal Philips NV, and Snyk.
"Sanjay's track record is unique in the world of enterprise software—he has led the strategy and doubling of revenues for two of the most celebrated companies in the technology space," said Samir Bodas, CEO and Co-founder of Icertis. "As important, his business values and approach to company culture align perfectly with Icertis' FORTE values and culture. I am honored to have Sanjay join us and contribute his technology and operational expertise as Icertis transforms enterprise contracting—the foundation of all commerce."
Icertis has been consistently recognized for its record growth, market leadership, employer practices, and contract management software innovations. The company has earned top-tier analyst, partner, and industry accolades and awards in recent years, such as inclusion on the Forbes Cloud 100, Deloitte's Technology 500 List, and Inc.'s Best-Led Companies in America.
About Icertis
With unmatched technology and category-defining innovation, Icertis pushes the boundaries of what's possible with contract lifecycle management (CLM). The AI-powered, analyst-validated Icertis Contract Intelligence (ICI) platform turns contracts from static documents into strategic advantage by structuring and connecting the critical contract information that defines how an organization runs. Today, the world's most iconic brands and disruptive innovators trust Icertis to govern the rights and commitments in their 10 million+ contracts worth more than $1 trillion in 40+ languages and 90+ countries.
Contact
Liza Colburn
Director of Corporate Communications
Liza.colburn@icertis.com
+1 (781) 562-0111
View original content to download multimedia:
SOURCE Icertis
|
https://www.wlbt.com/prnewswire/2022/07/28/distinguished-tech-executive-sanjay-poonen-joins-icertis-advisory-board/
| 2022-07-28T13:33:36
|
en
| 0.94556
|
- Three independent battery systems totaling 12 megawatts were installed at Scott Solar facility in Powhatan County
- Energy storage is key to grid reliability, continued solar and wind expansion, and achieving net zero emissions
- More battery energy storage projects are under development by Dominion Energy
RICHMOND, Va., July 28, 2022 /PRNewswire/ -- Dominion Energy Virginia today celebrated its largest operational battery energy storage pilot project, which was recently energized at the Scott Solar facility in Powhatan County, paving the way for the development of additional energy storage technology needed to support the company's commitment to achieve net zero carbon and methane emissions by 2050, increase renewable generation and improve grid reliability.
The company has two other battery storage pilot projects in its portfolio – a 2-megawatt battery in New Kent County that was commissioned in late February and a 2-megawatt battery in Hanover County that is scheduled to become operational later this year. All three projects were approved by the Virginia State Corporation Commission (SCC) in February 2020.
The three utility-scale battery storage pilot projects totaling 16 megawatts are the first of their kind in Virginia. Dominion Energy is using lithium-ion batteries, like those found in electric vehicles, to better understand how this emerging technology can be integrated into various applications to benefit our customers.
"Battery storage is an integral component to the clean energy transition in Virginia, supporting grid reliability for our customers during periods of high demand and by helping to fill gaps due to the inherent intermittency of solar and wind power," said Ed Baine, president of Dominion Energy Virginia. "These battery systems will help us better understand how best to deploy utility scale batteries across our service territory to support our goal of net zero emissions by 2050."
The three Central Virginia-based projects provide key information on distinct use cases for batteries on the energy grid. Annual updates on the pilots' performance will be reported to the SCC.
- Three independent 4-hour battery systems totaling 12 megawatts at the Scott Solar facility in Powhatan County will provide valuable information on the proficiency of battery technology to store energy generated from solar panels during periods of high production and release energy during periods when load is high or solar generation is low. It would also reveal how well a battery can optimize power production of the solar facility.
- A 2-megawatt, 2-hour battery at a substation in the Town of Ashland, Hanover County will bolster the existing grid capacity to serve customers during times of high energy demand without the need to engage in wholesale equipment upgrades.
- A 2-megawatt, 2-hour battery at a substation in New Kent County serving a 20-megawatt solar facility will demonstrate how batteries can help manage voltage and loading issues caused by reverse energy flow, to maintain stable power delivery to our customers.
In addition to these three pilot projects, Dominion Energy has received regulatory approval from the Virginia SCC for the 20-megawatt Dry Bridge storage in Chesterfield County and 50 megawatts of storage at Dulles International Airport in Loudoun County.
As the company continues to increase its solar fleet – currently the second largest solar portfolio in the country – and build out its offshore wind development off the coast of Virginia Beach, the company is exploring ways to store energy for use during periods of high demand to maintain reliable service to customers.
About Dominion Energy
About 7 million customers in 14 states energize their homes and businesses with electricity or natural gas from Dominion Energy (NYSE: D), headquartered in Richmond, Va. The company is committed to sustainable, reliable, affordable and safe energy and to achieving net zero carbon dioxide and methane emissions from its power generation and gas infrastructure operations by 2050. Please visit DominionEnergy.com to learn more.
View original content to download multimedia:
SOURCE Dominion Energy
|
https://www.wlbt.com/prnewswire/2022/07/28/dominion-energys-largest-battery-storage-pilot-project-now-operational/
| 2022-07-28T13:33:43
|
en
| 0.950418
|
Like many voters in Ohio, you may find the repeated failed attempts at drawing new state and federal election maps confusing.
We break down your questions and in an attempt to give you a straight forward explanation.
» MOST RECENTLY: Ohio Supreme Court throws out map of U.S. House districts
How did we get here?
In an effort to end gerrymandering, Ohio voted in 2015 to redraw state legislative maps to make them more fair. In 2018, Ohio voted to also change the way congressional districts are drawn as well in state constitutional amendments.
What’s the problem?
There is an impasse between the Republican-dominated Ohio Redistricting Commission, which draws the maps, and the Ohio Supreme Court, which approves the maps. After multiple attempts at creating new maps, the court has ruled that the maps are unconstitutional in multiple 4-3 decisions.
Why does the Ohio Supreme Court keep rejecting the maps?
The court believes that Republicans have maintained an unfair advantage in each of the maps drawn by the Ohio Redistricting Commission. This was done by gerrymandering districts to provide “safe” Republican seats while creating many Democratic seats with narrow partisan margins, and that the Supreme Court has held out for maps that generally reflect the 54%-46% partisan breakdown seen in recent statewide elections.
Who is on the Ohio Redistricting Commission?
The Commission consists of seven state officials, five Republicans and two Democrats. The commission is tasked with the drawing of the maps.
What maps are being used in the next election?
The maps being used for state House and Senate races this year were ruled unconstitutional by the Ohio Supreme Court. But a federal court ruled that they had to be used — for this year’s elections only — to break an impasse between the state court and Republican-dominated Ohio Redistricting Commission.
The federal ruling was the result of a Republican-backed lawsuit, alleging that voters’ civil rights were being violated by not having maps in place. Ohio Secretary of State Frank LaRose has asserted only those maps (the third set the commission approved) were feasible to use because most county boards of elections were already programming them into their systems before they were ruled unconstitutional, meaning they could be reinstated with less time and effort.
What is going on with the Ohio Congressional map?
In accordance with 2020 census results, Ohio must reduce its U.S. House seats from 16 to 15. The Ohio Supreme Court on Tuesday, July 19, threw out the district map for the state’s 15 congressional seats, but that now-invalid map will still be used for the Nov. 8 election.
What is the current makeup of Ohio’s U.S. House of Representatives seats?
Currently Ohio is represented by 12 Republicans and four Democrats.
What is going on with the state legislative map?
The Ohio Redistricting Commission has passed five sets of House and Senate maps since September and all have been rejected by the Ohio Supreme Court.
Although legislative district maps are now in place for a state House and Senate primary election Aug. 2, those district lines (using the third proposed map) are likely to change again before the next primary season.
What happens with the maps long-term?
The Ohio Supreme Court has ordered the commission to make a sixth try, though that is not expected until at least after the November election and probably next year.
New maps will not be put in place until 2024.
A map passed with single-party support, even if upheld by the court, must be redrawn in four years. A map supported by both parties would be valid until the election after the next U.S. census in 2030.
How do I know what district I’m voting in?
The Secretary of State’s Office released an online tool at findmydistrict.ohiosos.gov allowing people to type in their address and find out which districts they will be voting in this year.
About the Author
|
https://www.journal-news.com/local/your-questions-answered-understanding-rejected-maps-and-the-redistricting-problem-in-ohio/M6PUSZC2VBC5FJ3KC4YT34SFFI/
| 2022-07-28T13:33:46
|
en
| 0.97717
|
BEIJING (AP) — Beijing grumbled but swallowed its irritation in 1997 when then-Speaker Newt Gingrich of the U.S. House of Representatives visited Taiwan, the island democracy claimed by the mainland’s ruling Communist Party as its own territory.
China had other priorities. President Jiang Zemin’s government was preparing to celebrate Hong Kong’s return and wanted to lock in Beijing’s emergence from diplomatic isolation after its 1989 crackdown on pro-democracy demonstrations in Tiananmen Square. Gingrich, a booster of closer U.S.-Chinese ties, had just helped that campaign by meeting Jiang in Beijing. China avoided a disruptive clash with Washington.
A quarter-century later, conditions have changed drastically. Chinese President Xi Jinping's government is richer, more heavily armed and less willing to compromise over Taiwan following news reports the current speaker, Nancy Pelosi, might become the most senior U.S. official since Gingrich to visit the island.
Beijing sees any official contact with Taiwan as recognition of its democratically elected government, which the mainland says has no right to conduct foreign relations.
The timing adds to political pressure. Xi is widely expected to try to award himself a third five-year term as party leader at a meeting in the autumn. That could be undercut if rivals can accuse Xi of failing to be tough enough in the face of what they consider American provocation.
Pelosi has yet to confirm whether she might visit, but Beijing is warning of “forceful measures” including military action if she does.
The United States “must not arrange for Pelosi to visit Taiwan,” a Chinese Ministry of Defense spokesman, Tan Kefei, said Tuesday.
“If the United States goes ahead with this, the Chinese military will never watch and do nothing,” Tan said. “It will take strong measures to thwart any external interference and separatist plans for ‘Taiwan independence’ and resolutely defend national sovereignty and territorial integrity.”
Tan referred to Pelosi as “No. 3 in the U.S. government,” after her place in the line of succession to become president. That suggests Beijing sees her as President Joe Biden's subordinate, instead of his equal as head of one of three independent branches of the government.
Biden told reporters the American military thinks a visit is "not a good idea right now." But, possibly in deference to her position, the president hasn't said Pelosi shouldn't go. U.S. officials told The Associated Press that if Pelosi goes, the American military would likely use fighter jets, ships and other forces to provide protection for her flight.
Chinese rhetoric about that is "quite disturbing,” the chairman of the Joint Chiefs of Staff, Gen. Mark Milley, told the Australian Broadcasting Corp. “If we’re asked, we’ll do what is necessary in order to ensure a safe visit.”
U.S. officials have said the administration doubts China would take direct action against Pelosi herself or try to sabotage the visit. But they don’t rule out the possibility that China could escalate provocative flights of military aircraft in or near Taiwanese airspace and naval patrols in the Taiwan Strait should the trip take place. And they don’t preclude Chinese actions elsewhere in the region as a show of strength.
Taiwan and China split in 1949 after a civil war that ended with a communist victory on the mainland. Both governments say they are one country but disagree about which is the national leader. The two sides have no official relations but are connected by billions of dollars of trade and investment.
The United States switched diplomatic recognition from Taipei to Beijing in 1979 but has extensive commercial and unofficial ties with the island. U.S. law obligates Washington to make sure Taiwan has the means to defend itself.
Beijing hasn’t hesitated to try to intimidate Taiwan with shows of force.
The ruling party’s military, the People’s Liberation Army, fired missiles into the sea near Taiwan to drive voters away from then-President Lee Teng-hui in the island’s first direct presidential election in early 1996. That backfired by allowing Lee to talk tough about standing up to Beijing in front of cheering supporters. He was elected with 54% of the vote in a four-way race.
The U.S. responded by dispatching two aircraft carrier battle groups to the area, a move that forced China to acknowledge it couldn’t stop Washington from coming to Taiwan’s aid, which helped propel Beijing’s massive military upgrading in the years since.
The following year, Gingrich led a delegation of American lawmakers to Taiwan following a three-day visit to the mainland. That followed a visit to Beijing the previous week by Vice President Al Gore.
Previously one of Beijing’s fiercest critics in Washington on human rights and Taiwan, Gingrich praised China’s economic development. He talked sympathetically about the challenges Beijing would face running Hong Kong after 150 years of British rule. He said Congress supported China’s claim to Taiwan so long as unification was peaceful. He expressed hope the two sides might evolve to become one state.
Gingrich said he told Chinese leaders that “we will defend Taiwan” but said they responded that Beijing had no intention of attacking.
After Gingrich's comments, China’s foreign ministry said it was confused about U.S. policy. “What the U.S. government and the leaders of some government branches say and what they promised are not the same,” a ministry spokesman, Shen Guofang, said at the time.
In the quarter-century since then, Beijing's stance toward Taiwan has hardened and its military resources have grown. And the mainland has warned it will invade if talks on uniting the two sides fail to make progress.
China passed Germany and Japan to become the second-largest economy behind the United States. Its military spending also is No. 2 after Washington at $293 billion in 2021 following a 27-year string of increases, according to the Stockholm International Peace Research Institute.
The political landscape also has been changed by the rise of Xi, who has amassed more power over the past decade than any Chinese leader since at least the 1980s and wants to be seen as restoring the country to its historic greatness. That includes being more assertive abroad and stepping up pressure on Taiwan.
The ruling party has spent hundreds of billions of dollars to develop fighter planes, submarines, an aircraft carrier and other high-tech weapons. It is working on “carrier killer” missiles that are believed to be meant to block the U.S. Navy from defending Taiwan in the event of an attack. The PLA sends growing numbers of fighters and bombers to fly near Taiwan.
Beijing's bigger economy and global role also give it more diplomatic tools to show its anger to Washington. The Biden administration wants Chinese cooperation on climate, fighting the coronavirus and other global challenges, all of which Beijing could disrupt.
Washington and Beijing already are mired in conflicts over trade, Hong Kong, Beijing's treatment of Muslim minorities and Chinese claims to large sections of the South China and East China Seas.
Pelosi is hardly new to irking Beijing. As a rookie member of Congress in 1991, she unfurled a black-and-white banner on Tiananmen Square that said, “To those who died for democracy.” This came two years after the bloody crackdown in which hundreds, perhaps thousands were killed. Diplomatic protocol prevented Chinese police from detaining Pelosi.
A visit to Taiwan could cause long-term harm to U.S.-Chinese relations, said Liu Jiangyong, an international relations specialist at Tsinghua University.
Allowing a visit to go ahead “will affect the credibility of recent promises the Biden administration has made,” Liu said. Dialogue between Biden and Xi about other issues “may all be seriously affected.”
___
AP researcher Yu Bing in Beijing and AP Writers David Rising in Bangkok and Lolita C. Baldor in Sydney contributed.
Credit: J. Scott Applewhite
Credit: J. Scott Applewhite
Credit: Huizhong Wu
Credit: Huizhong Wu
|
https://www.journal-news.com/nation-world/a-richer-stronger-china-warns-pelosi-not-to-visit-taiwan/PEI725WHHFAADGU22TB6MRZXVI/
| 2022-07-28T13:33:48
|
en
| 0.9635
|
Dr. Taha Merghoub Appointed Deputy Director
NEW YORK, July 28, 2022 /PRNewswire/ -- Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.
In his new role, Dr. Wolchok will lead an expansive, multidisciplinary research and clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes. Dr. Wolchok will also expand the exemplary care delivered at the institution's flagship Upper East Side Manhattan location and further enhance care for patients in Brooklyn and Queens.
Dr. Wolchok currently serves as chief of the Immuno-Oncology Service and the Lloyd J. Old /Virginia and Daniel K. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK), and he is a professor of medicine at Weill Cornell Medicine. He succeeds Dr. Massimo Loda, chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine, who has served as interim director since last year's departure of Dr. Lewis Cantley, the center's founding Meyer Director.
"Dr. Wolchok is a distinguished physician-scientist and an esteemed leader in oncology, whose innovative research in immunotherapy has transformed the prognosis for countless melanoma patients and will undoubtedly have lasting implications for other types of cancer. We are thrilled he will be heading the Meyer Cancer Center," said Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine. "His expertise and vision will be crucial as the institution enhances cancer research and treatment efforts throughout the city, providing critical care and hope to cancer patients, and building on the center's outstanding reputation as a leader in this field.
"We would also like to thank Dr. Loda for his dedicated service as interim director of the Meyer Cancer Center over the past year," Dr. Choi added. "His strong leadership and vast experience in this area of medicine have allowed the center to continue its vital, groundbreaking work in cancer research and care."
Created in 2014 with a $75 million gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation, the Weill Cornell Medicine Meyer Cancer Center, in partnership with NewYork-Presbyterian, unifies cancer research throughout Weill Cornell Medicine and has more than 140 core members, including basic scientists, surgeons, oncologists, radiologists, pathologists and other clinicians. The Meyer Cancer Center focuses on multidisciplinary, high-impact science, harnessing cutting-edge technology and new biomedical approaches to illuminate the biological conditions that allow cancer to develop and proliferate. Collaborations between basic scientists and physicians are accelerating the application of these findings into clinical care, while partnerships with community stakeholders help to rapidly translate cancer prevention and detection discoveries into new outreach programs for the communities that need it most.
"Dr. Wolchok is a renowned physician-scientist and exceptional leader whose pioneering research in immunotherapy has fundamentally changed the way we approach cancer care and improved the lives of countless patients. We are delighted to welcome him as the new director of the Meyer Cancer Center," said Dr. Steven J. Corwin, president and CEO of NewYork-Presbyterian. "His leadership and experience will be instrumental in elevating the groundbreaking work of the Meyer Cancer Center and further enhancing the innovative, personalized and compassionate cancer care we provide to patients in all the communities we serve. We would like to express our gratitude to Dr. Loda for his dedication and leadership in helming the center as interim director for the past year."
Dr. Wolchok is a pioneer in a cancer treatment approach that harnesses immune cells to fight the disease, with a specific focus on melanoma. A clinician-scientist, he investigates innovative immunotherapy strategies in laboratory models of melanoma and has served as principal investigator of multiple clinical trials. Immunotherapy has now emerged as a fourth pillar of standard cancer therapy, alongside surgery, radiation therapy and chemotherapy. Dr. Wolchok played a pivotal role in the clinical development of the U.S. Food and Drug Administration-approved immunotherapy ipilimumab for advanced melanoma and more recently designed and led a global phase 3 trial of the first combination of immunotherapies, known as immune checkpoint blocking antibodies, aimed at reactivating the immune response to melanoma. These approaches have resulted in therapeutic success in multiple cancer types after initial studies in melanoma.
The institution has also appointed Dr. Taha Merghoub, a highly accomplished and innovative research scientist who has been Dr. Wolchok's scientific partner at Memorial Sloan Kettering for over 15 years as well as a professor of immunology research in medicine at Weill Cornell Medicine, as deputy director of the Meyer Cancer Center. Dr. Merghoub, who was also recruited as the Margaret and Herman Sokol Professor of Oncology Research as well as a professor of pharmacology, will lead a laboratory at Weill Cornell Medicine, which investigates the development of immune-based therapies to treat cancer. Dr. Merghoub strives to understand why immunotherapy is effective in some patients but not others and aims to develop new mechanism-based combination therapies that can overcome treatment resistance.
"Through the generosity and vision of Sandra and Edward Meyer, the Meyer Cancer Center serves as the backbone of Weill Cornell Medicine's cancer ecosystem, as we advance our mission to provide the best care for our patients and find cures for these devastating diseases," said Jessica M. Bibliowicz, chairman of the Weill Cornell Medicine Board of Fellows. "Dr. Wolchok is a proven leader and innovator in this field and the ideal choice for this position, harnessing the incredible, collaborative achievements in cancer research and treatment and elevating it to the next level of excellence."
"Bringing the standard of care and the research portfolio that exists at the Meyer Cancer Center to patients in Brooklyn and Queens is a key priority for me to ensure that all New Yorkers receive 'A-team' cancer treatment that is based upon the latest research," Dr. Wolchok said. "I'm honored to lead our physicians and scientists across all of oncology to continue driving discoveries that change medicine."
"This is an opportunity for me to enhance the impact of my efforts so far in my career," he said. "I've been proud to be a Weill Cornell Medicine faculty member throughout my time at Memorial Sloan Kettering, and this new role will allow me to learn more about the institution from the inside, build a bigger cancer team and share what I've learned."
"Jedd Wolchok's contributions to Memorial Sloan Kettering Cancer Center have benefitted the MSK community, patients and trainees worldwide," said Dr. Craig B. Thompson, president and chief executive officer of MSK. "We are grateful to Dr. Wolchok for his dedication and compassionate care and know that he will continue to accelerate progress and make a difference in the lives of people with cancer in his new endeavor."
In his new role, Dr. Wolchok will elevate the Meyer Cancer Center's activities, recruiting leading cancer researchers and clinicians, with a focus on enhancing both faculty diversity and broadening the reach of health care to diverse patient populations. He will strive to bolster the center's educational programs to train generations of physicians and scientists. He will also prioritize expanding the center's clinical trial enterprise, seeking to create a balanced portfolio "that has high impact across the populations that we serve," he said, including investigator-initiated trials, National Cancer Institute cooperative group trials, as well as trials sponsored by industry. These trials will extend to NewYork-Presbyterian Brooklyn Methodist Hospital and NewYork-Presbyterian Queens, to better reach patients who live in traditionally underserved communities and increase access to the most advanced treatments where it's convenient for them.
"I am a proud physician-scientist, and neither one of those descriptors is more important than the other," said Dr. Wolchok, who noted that he will continue to see patients. "At the Meyer Cancer Center, I hope to achieve a true balance, and with real-time communication between our clinicians and researchers, we will be able to achieve the highest degree of success."
About Dr. Jedd Wolchok
Dr. Wolchok is a board-certified oncologist and investigator who specializes in exploring innovative immunotherapeutic strategies, with a focus on melanoma research and clinical expertise in the care of people with advanced stages of the disease. He has published more than 275 scholarly papers in leading peer-reviewed journals including The New England Journal of Medicine, Nature, Cell, Journal of Clinical Oncology, Cancer Discovery and The Journal of Experimental Medicine, where he serves as an academic editor. His work has been consistently funded by the National Cancer Institute, the Ludwig Institute for Cancer Research, the Parker Institute for Cancer Immunotherapy, Swim Across America, Stand Up to Cancer, the Mark Foundation, and the Melanoma Research Alliance, among other organizations.
He is a member of American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the American Association of Physicians and the American Society for Clinical Investigation. Dr. Wolchok has received numerous awards and honors including the Damon Runyon-Lilly Clinical Investigator Award, the Melanoma Research Foundation Humanitarian Award, the AACR's Richard and Hinda Rosenthal Memorial Award and Joseph H. Burchenal Award, and, most recently, ASCO's David Karnofsky Award.
Dr. Wolchok received his undergraduate degree from Princeton University, his doctorate in microbiology from NYU Graduate School of Arts and Sciences and medical degree from NYU Grossman School of Medicine, where he also completed his residency program in internal medicine. After completing a fellowship in medical oncology-hematology at Memorial Sloan Kettering Cancer Center, he joined its faculty—as well as Weill Cornell Medicine's—and has served there for more than 25 years, ultimately rising to the position of chief of the Immuno-Oncology Service.
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine — faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization — are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side's scientific corridor, Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide exemplary patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Westchester Behavioral Health Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.
NewYork-Presbyterian
NewYork-Presbyterian is one of the nation's most comprehensive, integrated academic healthcare systems, encompassing 10 hospitals across the Greater New York area, nearly 200 primary and specialty care clinics and medical groups, and an array of telemedicine services.
A leader in medical education, NewYork-Presbyterian Hospital is the only academic medical center in the nation affiliated with two world-class medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. This collaboration means patients have access to the country's leading physicians, the full range of medical specialties, latest innovations in care, and research that is developing cures and saving lives.
Founded 250 years ago, NewYork-Presbyterian Hospital has a long legacy of medical breakthroughs and innovation, from the invention of the Pap test to pioneering the groundbreaking heart valve replacement procedure called TAVR.
NewYork-Presbyterian's 48,000 employees and affiliated physicians are dedicated to providing the highest quality, most compassionate care to New Yorkers and patients from across the country and around the world.
For more information, visit www.nyp.org and find us on Facebook, Twitter, Instagram, and YouTube.
Contact:
Jen Gundersen
jeg2034@med.cornell.edu
917) 242-2389
View original content to download multimedia:
SOURCE Weill Cornell Medicine
|
https://www.wlbt.com/prnewswire/2022/07/28/dr-jedd-wolchok-appointed-meyer-director-sandra-edward-meyer-cancer-center-weill-cornell-medicine/
| 2022-07-28T13:33:49
|
en
| 0.940846
|
WASHINGTON (AP) — President Joe Biden was speaking Thursday morning with China's Xi Jinping, the fifth conversation of their presidencies, as the two leaders chart the future of their complicated relationship at a time of simmering economic and geopolitical tensions.
The call, which began at 8:33 a.m. EDT, comes as Biden aims to find new ways to work with the rising global power as well as strategies to contain China's influence around the world. Differing perspectives on global health, economic policy and human rights have long tested the relationship — with China's refusal to condemn Russia's invasion of Ukraine adding further strain.
The latest pressure point has been House Speaker Nancy Pelosi's potential visit to Taiwan, the island that governs itself democratically and receives informal defensive support from the U.S., but which China considers part of its territory. Beijing has said it would view such a trip as a provocation, a threat U.S. officials are taking with heightened seriousness in light of Russia's incursion into Ukraine.
“If the U.S. insists on going its own way and challenging China’s bottom line, it will surely be met with forceful responses,” Zhao Lijian, a spokesperson for China's Foreign Ministry, told reporters earlier this week. “All ensuing consequences shall be borne by the U.S.”
Pelosi would be the highest-ranking U.S. elected official to travel to Taiwan since Republican Newt Gingrich visited the island in 1997 when he was House speaker. Biden last week told reporters that U.S. military officials believed it was “not a good idea” for the speaker to visit the island at the moment.
John Kirby, a U.S. national security spokesman, said Wednesday that it was important for Biden and Xi to regularly touch base.
“The president wants to make sure that the lines of communication with President Xi remain open because they need to,” Kirby told reporters at a White House briefing. “There are issues where we can cooperate with China on, and there are issues where obviously there are friction and tension.”
Biden and Xi last spoke in March, shortly after the Russian invasion of Ukraine.
“This is one of the most consequential bilateral relationships in the world today, with ramifications well beyond both individual countries,” Kirby said.
The conversation comes as Biden has moved to shift U.S. reliance off Chinese manufacturing, including Senate passage Wednesday of legislation to encourage semiconductor companies to build more high-tech plants in the U.S. Biden wants to marshal global democracies to support infrastructure investments in low- and middle-income nations as an alternative to China's "Belt and Road Initiative," which aims to boost China trade with other global markets.
Kirby listed a number of areas of U.S,-China friction that he said would be part of the conversation, including “tensions over Taiwan, tensions over ... China’s aggressive course of behavior in the Indo-Pacific outside of Taiwan, tensions in the economic relationship” and over China’s reaction to Russia’s war in Ukraine.
Biden, who has kept in place Trump-era tariffs on many Chinese-manufactured goods in order to maintain leverage over Beijing, is weighing whether to ease at least some of them in a move to lessen the impact of soaring inflation on American households.
U.S. officials have also criticized China's “zero-COVID” policy of mass testing and lockdowns in an effort to contain the spread of COVID-19 in its territory, labeling it misguided and fretting that it will further slow global economic growth.
Other points of strain include China’s treatment of Uyghur Muslims, which the U.S. has declared a genocide, its militarization in the South China Sea, and global campaign of economic and political espionage.
Credit: Susan Walsh
Credit: Susan Walsh
|
https://www.journal-news.com/nation-world/biden-xi-holding-fifth-talk-of-their-presidencies-thursday/YXE5CR5FPRAD5KOKW2TC6YBOMI/
| 2022-07-28T13:33:51
|
en
| 0.96488
|
BERLIN (AP) — Germany's annual inflation rate has declined slightly for the second consecutive month, official data showed Thursday, but July's pace of 7.5% was still within sight of the nearly half-century high it reached in May.
Inflation in Europe's biggest economy rose 7.9% in May from a year earlier, the highest level since the early 1970s, before slipping to 7.6% last month. The preliminary monthly figure for July, reported Thursday by the Federal Statistical Office, is usually confirmed in a final report about two weeks later.
Energy prices spiked 35.7% this month from a year earlier and food prices rose 14.8%.
Germany temporarily lowered taxes on diesel fuel and gasoline at the start of June and introduced an ultra-cheap ticket that allows people to use all local and regional public transportation for 9 euros ($9.15) a month. The measures are due to last for three months. The statistics office said it wasn't yet clear to what extent they dampened inflation.
As in other countries around the world, inflation in Germany has been stoked by Russia's war in Ukraine, which has led to a rise in energy costs and food prices.
Chancellor Olaf Scholz wants to work with unions and employers to find ways to address the impact of rising prices while preventing an inflationary spiral.
The July inflation rate for all 19 countries that use the euro will be released by the European Union's statistics office Friday after consecutive months of record highs. It reached 8.6% in June.
|
https://www.journal-news.com/nation-world/german-inflation-rate-slips-again-in-july-from-month-before/NRI4TNXLEZCNHPDOCRQCRTLBFY/
| 2022-07-28T13:33:52
|
en
| 0.970739
|
Lauren Pearl is giving new meaning to the term high-flying soprano.
Sure, her latest venture calls for her to sing up to a high C, but plenty of operatic heroines have to do that. What’s different in Pearl’s case is that she will be singing while scaling a 60-foot brick wall.
Pearl is performing the role of Louise in “Gould’s Wall,” a work that is receiving its world premiere at Toronto’s adventuresome Tapestry Opera beginning Aug. 4.
The opera is the brainchild of composer Brian Current, who regularly passes the wall on his way to work with students at the Glenn Gould School, which is housed in Toronto’s Royal Conservatory of Music. The brick facade is a remnant of a building that dates back to 1881, and it was preserved when the conservatory got a new, modern facility.
“That vertical space was just crying out for something to happen,” Current said. “With singers climbing on the walls, and the audience in the atrium looking up.”
He enlisted Liza Balkan, a performer, director and writer, who created a libretto that, as she said, tells “the story of a young artist, a woman, climbing the wall as a journey toward finding her own voice, the readiness to fly and soar.”
Along the way she encounters numerous characters who are harnessed to windows on the wall. Singing from below is Gould himself — the legendary pianist known for perfectionism who remains one of Canada’s most revered classical music figures nearly 40 years after his death.
“He is a presence in the building always,” Balkan said, and in the opera “he is there to support and also interrogate” the artist on her journey.
To play Louise, the company engaged Pearl, who was not a climber but had been training as an aerialist after, as she explained, “I fell in love with a circus performer.”
“I felt the story was very resonant and uplifting and inspiring,” Pearl said. “I thought immediately, I want to do that. But yeah, it’s daunting. It’s a high space.”
She has been practicing on the wall with the help of DangerBoy, a company whose website says it specializes in “stunts, rigging and special effects.” For the performances, Pearl will be securely fastened to a harness with a carabiner for extra protection.
Pearl said she found that singing while suspended from ropes and scaling a wall requires some adjustment in her vocal technique. ”There needs to be a line of energy through my entire body,” she said. “A greater awareness of tension and support.”
Current’s score, which runs about an hour, will be played by an orchestra consisting of five pianos along with an ensemble of brass, winds, strings and percussion.
The audience of just over 100 will be divided into sections, with prime seating on the atrium floor in reclining chairs angled to provide an easy view of the ascent.
“We thought at first of having people lie on mats,” Current said. “But our audience is largely people who aren’t 20.”
Other spectators will be on a balcony of the new building across from the wall. “Then you’re almost at the same level of the singers and also looking down and you can see the orchestra down below,” Current said.
Tom Comet, head rigger for DangerBoy, said the technical aspect of supporting Pearl’s climb is “pretty simple stuff. We’re pulling on a rope, we’re pulling some ropes through some pulleys, we’re redirecting that line.
“That said,” Comet added, “anytime we have human life in our hands … we need to be 100,000% sure that everything’s going to work as we anticipate.
“For me,” Comet said, “the coolest thing is that Lauren is actually belting out opera fearlessly while she’s suspended in the air, 40-50 feet up. It’s gonna be pretty incredible to experience.”
—-
Mike Silverman writes frequently about opera for The AP. He can be reached at mkslvrmn@gmail.com.
Credit: Dahlia Katz
Credit: Dahlia Katz
Credit: Dahlia Katz
Credit: Dahlia Katz
|
https://www.journal-news.com/nation-world/new-opera-has-soprano-scaling-the-heights-literally/BHKT3HV64VCQJCV4W7KAVDLG2I/
| 2022-07-28T13:33:52
|
en
| 0.96998
|
BOULDER, Colo., July 28, 2022 /PRNewswire/ -- Registration is open for the Working Together for an Equitable Energy Future Virtual National Workshop 2022, hosted by E Source and DEFG's Equity in a Clean Energy (ECEE) Collaborative. The workshop is open to the public.
The ECEE Collaborative is assembling stakeholders to discuss new approaches and tools to ensure affordability and equity in the US transition to clean energy.
This national workshop will feature keynote presentations by equity leaders, a variety of panel sessions, breakout sessions, new research, and customer survey findings with an emphasis on bringing voices of disadvantaged communities into the deliberations. The workshop is designed to be interactive to help build relationships between stakeholders. The online nature will ensure maximum participation nationwide.
The collaborative has invited musicians, videographers, and other artists to provide clips of their work and perspectives on equity and clean energy in their communities. And the event will premiere a voices-of-the-community documentary in partnership with NiSource, a dual-fuel utility serving nearly 4 million customers across six midwestern states.
"With the July 2022 acquisition of DEFG, E Source has gained important capabilities that help utilities with their transformation to a Sustainable Utility, in particular the component that focuses on customer equity. We can now help utilities improve their customer experience and manage affordability for customers as a whole, especially those who are most vulnerable," says Jamie Wimberly, senior vice president of Customer Strategy Solutions at E Source. "The ECEE collaborative and this national workshop play an essential role in helping utilities and communities come together to equitably serve all customers."
To learn more about the workshop, visit www.eceecollaborative.com and register today. Or email info@defgllc.com to connect with the collaborative directly.
E Source, the data authority for the utility industry, blends industry-leading research, predictive data science, and solution services to help utilities make better decisions to support their customers, their bottom line, and our planet. With a commitment to practical innovation, we use more than three decades of utility-focused experience and our unique solution set to help clients achieve their goal of becoming a Sustainable Utility. E Source is headquartered in Boulder, Colorado, with offices across the US. For more information, see www.esource.com.
Contacts:
Media inquiries:
Sannie Sieper
sannie_sieper@esource.com
303-817-1996
View original content to download multimedia:
SOURCE E Source Companies LLC
|
https://www.wlbt.com/prnewswire/2022/07/28/e-source-defgs-equity-clean-energy-economy-collaborative-host-public-workshop-address-an-equitable-energy-future/
| 2022-07-28T13:33:56
|
en
| 0.932428
|
While Housing Inventory Remains Low, eLEND's Chattel Financing Allows Consumers to Enter the Factory-Built Home Market
PARSIPPANY, N.J., July 28, 2022 /PRNewswire/ -- eLEND, a consumer-facing division of American Financial Resources, Inc. (AFR) and a leading provider of home mortgage loans, is pleased to announce an expansion of its Manufactured Home Financing and Chattel Home-Only Financing program. Now available in 45 states nationwide*, the program aims to provide a financing opportunity for securing manufactured housing to traditional and first-time homebuyers searching for their dream homes. This program will still be offered under ManufacturedHome.loan, a secondary consumer-facing division of AFR specializing in manufactured home lending, and will now be able to reach so many more families.
Whether it's on private land or in a park, both eLEND and ManufacturedHome.loan can help prospective buyers obtain chattel financing for manufactured or mobile homes that are not permanently affixed to the land. Available programs may provide eligible borrowers an option for a 5% down payment and the opportunity to finance closing costs, with terms of up to 25 years for new construction and 23 years for existing homes.
"As housing inventory remains low, entering the factory-built home market is a great option to close on a brand new home," said Christopher Guerin, Executive Vice President of Origination and Business Development at eLEND's parent company, American Financial Resources. "Our mission remains to help the underserved, whether it be first-time homebuyers, veterans, or families without the budget for a hefty down payment. Without many new, budget-friendly houses on the market and with rates continuously increasing, our loan officers at eLEND and ManufacturedHome.loan are excited to offer Chattel Home-Only financing as another avenue for families to secure their dream home."
Buyers who enter the world of factory-built housing benefit from lower construction costs and accelerated timelines versus site-built homes as there are no weather-related delays or damages throughout the construction process. Factory-built homes also require multiple inspections throughout construction to ensure structural stability. With floorplan variations and amenities that look and feel like site-built homes, buyers are even able to personalize these properties the same way as any on-site new build.
The program adds to eLEND's existing land & home, or real property, financing options, which include a suite of FHA loans, VA loans, USDA loans and Conventional Loans. With an always-expanding list of products introduced based on market demand including Non-QM, VA Renovation, Down Payment-Assistance Program, One-Time Close Construction and more, eLEND has a program for everyone, cementing the company's commitment to always find the best option to serve their customers.
For additional information about eLEND's latest Chattel Home-Only Financing expansion, schedule a call with a trusted eLEND loan officer today. For more information about eLEND and its current product offerings overall, please visit www.eLEND.com.
*For available states, please contact an eLEND representative.
eLEND is one of American Financial Resources, Inc.'s Consumer Direct Divisions, offering first-time homebuyers and existing homeowners affordable mortgage options. From 30 year fixed rate mortgage programs to adjustable rate mortgages and from zero down payment options to loans for refinancing an investment property, eLEND offers mortgages for many types of property and financial situations. eLEND utilizes the latest technology to deliver educational resources to customers to simplify the mortgage process and provide consistent and dedicated service with a personal touch. Lender NMLS 2826 at www.nmlsconsumeraccess.org. For more information, visit www.eLEND.com.
View original content:
SOURCE eLEND
|
https://www.wlbt.com/prnewswire/2022/07/28/elend-expands-manufactured-home-only-financing-program/
| 2022-07-28T13:34:02
|
en
| 0.929101
|
Labor organizers at a Trader Joe's store in Massachusetts will find out Thursday if there is enough support among employees to form the chain's first union.
About 80 workers at the store in Hadley were expected to cast ballots over two days, said Maeg Yosef, a union organizer who has worked at Trader Joe's for 18 years.
The workers are organizing under the name Trader Joe’s United, which if successful, would be an independent union, and not affiliated with a larger existing union.
Workers from at least two other Trader Joe’s locations have initiated unionization efforts. Employees at a Minneapolis location have a union vote scheduled for Aug. 11 and 12, while the United Food and Commercial Workers Local 7 on Tuesday filed a union election petition with the National Labor Relations Board on behalf of crew members at a Boulder, Colorado store.
The Trader Joe's workers are part of a nationwide wave of employees at major companies who have or are attempting to unionize in an effort to secure a bigger say in their work conditions and compensation.
Workers at multiple Starbucks coffee shop locations across the country, as well as employees at Amazon, Apple and REI are among those who have joined unions in the past year.
Trader Joe’s management has engaged in what Yosef called “classic union-busting” tactics, including hiring a law firm specializing in fighting unionization to try and talk employees out of approving a union.
California-based Trader Joe’s, which has about 550 stores nationwide, also just announced an enhanced benefits package that includes more paid time off and better pay for some employees, which she said was an effort to head off unionization.
Trader Joe's has generous pay and benefits by retail industry standards, a company spokesperson said this week.
“Trader Joe’s is a great place to work and our compensation, benefits, flexibility, and working conditions are among the best when compared to any retailer,” Nakia Rohde said in an email. “We welcome a fair vote by our crew members.”
|
https://www.journal-news.com/nation-world/union-vote-to-wrap-up-at-trader-joes-store-in-massachusetts/LCOMCBTJYNCXPAGHVIHFVJWLXQ/
| 2022-07-28T13:34:06
|
en
| 0.974753
|
- Obtains exclusive worldwide rights (outside Greater China) to develop and commercialize EO-3021 (SYSA1801)
- Expands pipeline to now include two clinical stage precision oncology candidates for patients with genomically defined solid tumors, including those with Claudin18.2 overexpression
- Company expects to initiate a Phase 1 clinical trial in the U.S. evaluating EO-3021 (SYSA1801) in 2023
- Management to host an investor conference call and webcast today at 5:00 p.m. ET
NEW YORK, July 28, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has entered into an exclusive license agreement with CSPC Megalith Biopharmaceutical Co., Ltd, a subsidiary of CSPC Pharmaceutical Group Limited (CSPC; HKEX: 01093) to develop and commercialize EO-3021 (SYSA1801), a differentiated, clinical stage antibody drug conjugate (ADC) targeting Claudin18.2, in all global territories outside Greater China (mainland China, Hong Kong, Macau and Taiwan). SYSA1801 is currently being evaluated by CSPC in a Phase 1, dose-escalation clinical trial in China. Elevation Oncology expects to initiate a Phase 1 clinical trial evaluating EO-3021 in the U.S. in 2023.
"This licensing transaction represents successful, continued execution of our business development strategy and expands our clinical-stage pipeline," said Shawn M. Leland, PharmD, RPh, Founder and Chief Executive Officer of Elevation Oncology. "We look forward to unlocking the potential of EO-3021 alongside our partner CSPC as we continue to build an industry-leading precision oncology company. EO-3021 is an exciting, differentiated ADC that has significant potential for the treatment of patients with solid tumors that express Claudin18.2, including those with genomically defined cancers. This transaction is a significant milestone for Elevation Oncology which further diversifies our company, expands our commercial potential and allows us to leverage our existing expertise in genomically defined cancers."
Claudin18.2 is a protein expressed across several types of solid tumors including many gastrointestinal cancers such as gastric, gastroesophageal junction (GEJ), and pancreatic cancer. EO-3021 is an ADC containing monomethyl auristatin E (MMAE) payload, a potent anti-mitotic agent. MMAE has been clinically validated as an effective anti-tumor payload and is the cytotoxic component of four U.S. Food and Drug Administration-approved ADCs.
"Claudin18.2 is a clinically validated oncology target that has significant potential in multiple gastrointestinal cancers and several other solid tumors, and could be best addressed by utilizing a weaponized antibody like EO-3021," said David Dornan, PhD, Chief Scientific Officer of Elevation Oncology. "High Claudin18.2 expression is associated particularly with gastrointestinal cancers, but can also frequently be found in lung, breast and liver cancer, representing an attractive commercial market opportunity. The targeting of Claudin18.2 with EO-3021 could have a transformative role in addressing the unmet medical need in patients whose tumors express Claudin18.2."
Under the terms of the agreement, Elevation Oncology will develop and commercialize EO-3021 in all global territories outside of Greater China. In exchange, CSPC will receive a one-time, upfront payment of $27 million. CSPC will also be eligible to receive up to $148 million in potential development and regulatory milestone payments and up to $1.0 billion in potential commercial milestone payments plus royalties on net sales.
"This agreement with Elevation Oncology brings our innovative pipeline overseas with the potential to help patients battling cancer. We are delighted to partner with Elevation Oncology to realize the full global potential for SYSA1801 (EO-3021) in meeting the unmet medical needs in pancreatic and gastric cancer, as well as other types of cancers," said Zhang Cuilong, Chief Executive Officer of CSPC. "Recognizing the value that Elevation Oncology has created in building an industry-leading operational platform for enrolling clinical trials in genomically defined patient populations, this partnership gives us confidence in the potential worldwide development of this program targeting Claudin18.2."
Conference Call and Webcast Information
Elevation Oncology will host an investor conference call and webcast today, Thursday, July 28, 2022, at 5:00 p.m. ET to discuss the licensing transaction with CSPC. To access the live call, please dial 1-877-870-4263 (local) or 1-412-317-0790 (international) at least 10 minutes prior to the start time of the call and ask to be joined into the Elevation Oncology investor call. The live, listen-only webcast of the conference call can be accessed by visiting the "Events" page within the "Investors" section of Elevation Oncology's website at www.elevationoncology.com. An archived replay of the webcast will be available on Elevation Oncology's website approximately two hours after the event.
About EO-3021
EO-3021 (also known as SYSA1801) is a differentiated, clinical stage antibody drug conjugate that targets Claudin18.2. Claudins are a family of proteins acting to maintain the tight junction that controls the interchange of molecules between cells and are mainly found in gastric, pancreatic, and lung tissues.1 Claudin18.2 is a specific subtype that is expressed in only cancer cells of the gastric epithelia.1 When the gastric epithelial cells become malignant, the tight junctions become disrupted, exposing the Claudin18.2 epitopes and allowing them to be targeted by anti-cancer agents.1 An Investigational New Drug application for EO-3021 has been cleared with the U.S. Food and Drug Administration.
About Elevation Oncology, Inc.
Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We aim to make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of tumor growth. Together with our peers, we work towards a future in which each tumor's unique genomic test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Our most advanced candidate, seribantumab, is intended to inhibit tumor growth driven by NRG1 fusions and is currently being evaluated in the Phase 2 CRESTONE study for patients with solid tumors of any origin that have an NRG1 gene fusion. Details on CRESTONE are available at www.NRG1fusion.com. The Company's other product candidate, EO-3021, is a differentiated, clinical stage antibody drug conjugate that targets Claudin18.2 and is currently being developed for the treatment of genomically defined solid tumors. For more information, visit www.ElevationOncology.com.
About CSPC Pharmaceutical Group Limited
CSPC is a leading pharmaceutical conglomerate in China with strong capabilities in research and development, manufacturing, and marketing of innovative drugs. The Company was listed on the Hong Kong Stock Exchange (stock code: HK1093) in 1994 and became a constituent stock of the Hang Sang Index in 2018. Currently, it is also a constituent stock of Hang Seng Composite Index, Hang Seng Healthcare Index, Hang Seng Mainland Healthcare Index, Hang Seng Stock Connect Index, Hang Seng (Hong Kong-listed) 100 Index and Hang Seng China Enterprise Index. CPSC has more than 24,000 employees. CSPC has a national top research and development team with research and development bases in Shijiazhuang, Shanghai, Beijing, and the United States, focusing on the discovery, research and development of small molecule targeted drugs, nanodrugs, monoclonal antibody drugs, bispecific antibody drugs, antibody-drug conjugates, mRNA vaccines, small nucleic acid drugs and biological drugs in the immune field. For more information, please visit its website at http://www.e-cspc.com
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, expectations relating to Elevation Oncology's licensing transaction with CSPC, Elevation Oncology's anticipated preclinical and clinical development activities, potential benefits of Elevation Oncology's product candidates, potential market opportunities for Elevation Oncology's product candidates and the ability of Elevation Oncology's product candidates to treat their targeted indications. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These forward-looking statements may be accompanied by such words as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "might," "plan," "potential," "possible," "will," "would," and other words and terms of similar meaning. Although Elevation Oncology believes that the expectations reflected in such forward-looking statements are reasonable, Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and results of biotechnology development and potential regulatory approval is inherently uncertain. Forward-looking statements are subject to risks and uncertainties that may cause Elevation Oncology's actual activities or results to differ significantly from those expressed in any forward-looking statement, including risks and uncertainties related to Elevation Oncology's ability to advance its product candidates, the timing and results of preclinical studies and clinical trials, approvals and commercialization of product candidates, the receipt and timing of potential regulatory designations, the impact of the COVID-19 pandemic on Elevation Oncology's business, Elevation Oncology's ability to fund development activities and achieve development goals, Elevation Oncology's ability to protect intellectual property, Elevation Oncology's ability to establish and maintain collaborations with third parties and other risks and uncertainties described under the heading "Risk Factors" in documents Elevation Oncology files from time to time with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release, and Elevation Oncology undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.
References
1 Zhang, et al. Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer. Chin J Cancer Res. 2020 Apr; 32(2): 263–270.
Elevation Oncology Investor and Media Contact
Candice Masse, 978-879-7273
Senior Director, Corporate Communications & Investor Relations
cmasse@elevationoncology.com
View original content to download multimedia:
SOURCE Elevation Oncology
|
https://www.wlbt.com/prnewswire/2022/07/28/elevation-oncology-expands-pipeline-through-exclusive-licensing-eo-3021-sysa1801-clinical-stage-anti-claudin182-antibody-drug-conjugate-cspc-pharmaceutical-group/
| 2022-07-28T13:34:09
|
en
| 0.930154
|
Monkeypox is in Cincinnati. The city’s health department confirmed two reported cases of the disease, which has been identified in nearly every state in the country.
Dr. Carl Fichtenbaum, a professor of infectious diseases at the University of Cincinnati and UC Health, said monkeypox has had limited outbreaks for decades, but now it’s spreading across the world.
Fichtenbaum said it spreads by having close contact with someone. He noted it needs to be sufficient contact, such as eating a meal or spending hours with someone.
“It’s a virus that causes a sort of mild flu-like illness and you get spots on your skin, blisters, pustules,” he said. “Most people do get a rash and it can start out like a little red bump and then almost look like white head where it gets a little cover on it and you can almost see some puss underneath it. Sometimes it can look like a blister and sometimes it comes up in a variety of different shapes and sizes and forms.”
He said the rash is why some doctors are having trouble identifying monkeypox.
“The rash doesn’t have to look uniform in some way and it can come in various different places of the body, it doesn’t have to be all over,” Fichtenbaum said. “It can be in just one place and I think that’s fooled some of the doctors who have been looking at people.”
Fichtenbaum believes the World Health Organization declared monkeypox a global health emergency to help contain it.
“When you list an emergency, what that does is send an alert to countries to enlist the support of their public health system to try and contain the spread of the disease,” Fichtenbaum said.
Fichtenbaum said there are likely more cases of monkeypox than what is reported in the U.S. due to a lack of testing and vaccine availability.
“Testing is pretty limited and that’s one of the big problems right now,” Fichtenbaum said. “They are probably people who have very atypical cases and so they’re not even being tested.”
Kimberly Wright, the supervising epidemiologist with the Cincinnati Health Department, said they’ve seen an uptick in calls from physicians requesting vaccines.
“We’re getting a lot of requests directly from providers who are requesting vaccines because they are patients who are coming to their practices saying they were exposed to monkeypox or a person with monkeypox and they are requesting the vaccine from us so we’re getting more calls,” Wright said.
Fichtenbaum said there are certain high-risk groups such as gay and bisexual men, but that doesn’t mean monkeypox will not impact other people.
“Anybody can get it if you come into close contact with someone else who has it — particularly skin-to-skin contact, it doesn’t matter who you are,” he said.
Still, the risk is low for the majority of the population.
“For most people who live in Cincinnati, they’re probably not going to come in contact with monkeypox, so I don’t think it’s the time for anyone to push the panic button,” Fichtenbaum said.
Fichtenbaum said anyone who thinks they might have monkeypox or are a close contact with someone who had monkeypox should call their doctor.
He noted there is a treatment called TPOXX that is available. It’s a medication that Fichtenbaum said has limited side effects and is one most people can tolerate. However, it isn’t available over-the-counter and is being prioritized for high-risk individuals because the supply is limited.
About the Author
|
https://www.journal-news.com/news/2-monkeypox-cases-reported-in-cincinnati/K6YYM44GE5BP7LOUOVBVB33RKY/
| 2022-07-28T13:34:12
|
en
| 0.968321
|
- Initial tranche supports the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and execution of Company's pipeline
NEW YORK, July 28, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50 million senior secured loan facility from funds managed by K2 HealthVentures, a leading healthcare-focused investment firm. The initial proceeds from the facility will primarily support the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and the execution of the Company's pipeline.
"This financing supports the expansion of our clinical oncology pipeline with an exciting new opportunity in precision oncology, furthering our mission to bring important new medicines to patients in need," said Joseph Ferra, Chief Financial Officer of Elevation Oncology. "We are pleased to partner with K2 HealthVentures, a premier partner known for its strategic investments in promising healthcare companies and assets, and we believe this transaction speaks to the significant potential of both seribantumab and EO-3021."
Austin Sherwindt, Managing Director at K2 HealthVentures, stated: "We are excited to partner with Elevation Oncology, and provide the company with enhanced financial flexibility to expand and diversify its portfolio, expand its commercial potential and address significant unmet needs in oncology. We believe in the power of precision oncology and the long-term potential of Elevation Oncology's pipeline development approach, and we look forward to continuing to partner with the company as it advances its clinical stage assets and further expands its precision-based portfolio of medicines."
The facility provides Elevation Oncology with up to $50 million in borrowing capacity in two tranches, with an initial tranche of $30 million available immediately. A second tranche, consisting of up to $20 million, will be available to Elevation Oncology in the future, subject to mutual agreement by Elevation Oncology and K2 HealthVentures.
Elevation Oncology plans to use the initial proceeds from the facility primarily to fund a one-time, upfront payment of $27 million to license EO-3021 (SYSA1801) from CSPC Pharmaceutical Group. Elevation Oncology expects to use any future proceeds from the facility to support the continued development of EO-3021 and seribantumab, for additional pipeline expansion, and for general corporate purposes. Following the licensing of EO-3021 and the initial tranche of the loan facility, Elevation Oncology expects its cash, cash equivalents and marketable securities to fund current operations into 2024.
About Elevation Oncology, Inc.
Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We aim to make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of tumor growth. Together with our peers, we work towards a future in which each tumor's unique genomic test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Our most advanced candidate, seribantumab, is intended to inhibit tumor growth driven by NRG1 fusions and is currently being evaluated in the Phase 2 CRESTONE study for patients with solid tumors of any origin that have an NRG1 gene fusion. Details on CRESTONE are available at www.NRG1fusion.com. Our other product candidate, EO-3021, is a differentiated, clinical stage antibody drug conjugate that targets Claudin18.2 and is currently being developed for the treatment of genomically defined solid tumors. For more information, visit www.ElevationOncology.com.
About K2 HealthVentures
K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. The investment team comprises collaborative, experienced professionals with diverse backgrounds in finance and operations, as well as deep domain knowledge across various healthcare sectors. A uniquely flexible, permanent capital structure enables the firm to provide creative, adaptive financing solutions and meet the evolving capital needs of its portfolio companies as they grow. K2HV is driven by dual goals of Profit and Purpose—aiming to fuel the growth of innovative companies that will ultimately improve the lives of patients and giving a percentage of investment profits back to underserved areas in healthcare. For more information, visit www.k2hv.com.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, expectations relating to Elevation Oncology's use of proceeds from the loan facility, Elevation Oncology's anticipated preclinical and clinical development activities, potential benefits of Elevation Oncology's product candidates, and Elevation Oncology's expectations about its cash runway. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These forward-looking statements may be accompanied by such words as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "might," "plan," "potential," "possible," "will," "would," and other words and terms of similar meaning. Although Elevation Oncology believes that the expectations reflected in such forward-looking statements are reasonable, Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and results of biotechnology development and potential regulatory approval is inherently uncertain. Forward-looking statements are subject to risks and uncertainties that may cause Elevation Oncology's actual activities or results to differ significantly from those expressed in any forward-looking statement, including risks and uncertainties related to Elevation Oncology's ability to advance its product candidates, the timing and results of preclinical studies and clinical trials, approvals and commercialization of product candidates, the receipt and timing of potential regulatory designations, the impact of the COVID-19 pandemic on Elevation Oncology's business, Elevation Oncology's ability to fund development activities and achieve development goals, Elevation Oncology's ability to protect intellectual property, Elevation Oncology's ability to establish and maintain collaborations with third parties and other risks and uncertainties described under the heading "Risk Factors" in documents Elevation Oncology files from time to time with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release, and Elevation Oncology undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date hereof.
Elevation Oncology Investor and Media Contact
Candice Masse, 978-879-7273
Senior Director, Corporate Communications & Investor Relations
cmasse@elevationoncology.com
View original content to download multimedia:
SOURCE Elevation Oncology
|
https://www.wlbt.com/prnewswire/2022/07/28/elevation-oncology-secures-50-million-loan-facility-with-k2-healthventures/
| 2022-07-28T13:34:16
|
en
| 0.942058
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nba/orlando-magic/articles/40206432
| 2022-07-28T13:34:22
|
en
| 0.738227
|
Envestnet Study, Fielded in Partnership with The Center for Generational Kinetics, Reveals that Advisors who Offer Compelling Digital Services Alongside Traditional In-Person Advice are Best-Positioned For Growth
BERWYN, Pa., July 28, 2022 /PRNewswire/ -- Envestnet published findings from its first national study, "The Intelligent Financial Life: The Unexpected Intersection Between Technology, Clarity, and the Human Connection," led in partnership with The Center for Generational Kinetics, which uncovered surprising trends, attitudes and behaviors that Americans across generations have around integrating financial advisors with new technology to help reach their financial goals.
For more insights from the research and to download a copy of "The Intelligent Financial Life National Study: The Unexpected Intersection Between Technology, Clarity, and the Human Connection," please visit: https://bit.ly/3BoNRhs.
The study provides research-based insights on what is needed to help people achieve The Intelligent Financial Life™ -- Envestnet's answer to investors' stress and confusion about money, and a way to connect every facet of their finances through an ecosystem of data-driven advice, solutions, intelligence, and technology.
"At Envestnet, we are focused on supporting financial advisors with the tools and knowledge needed to guide clients on the path to living an Intelligent Financial Life," said Mary Ellen Dugan, Chief Marketing Officer of Envestnet. "The findings in this study suggest that by connecting people's daily financial lives to their long-term goals, advisors can give their clients what they are looking for—a unified and connected experience for all things money, investing, and personal finance."
This report examined the key questions facing the industry through a different lens. Rather than comparing attitudes about technology-only solutions versus working with a human advisor, the study sought to understand how investors view each path, where they constructively intersect, and what that means for the industry.
"Americans across generations have a complicated financial relationship and they receive their information from many sources – including family, financial professionals and technology," said Jason Dorsey, Generations and Behavioral Researcher and Speaker, The Center for Generational Kinetics, LLC. "All these sources matter and consumers don't want to be delivered an 'either/or' experience. They are stitching together their own experience across human and digital resources."
Study findings fell within three distinct categories, showing that U.S. investors and future investors:
- Strongly believe the human element matters in their financial wellbeing. Although digital financial tools are growing in usage and trust, the human element, financial advisors and professionals, are still a key and arguably more important factor in establishing financial knowledge and gaining financial confidence. A majority of Americans studied trust a human financial advisor over digital advising options, and interestingly Millennials report the same preference as Gen X and Baby Boomers in managing their personal financials via human interaction.
- Are confused and craving clarity in what to do when it comes to money. Americans have different behaviors when it comes to how they organize their short-term and long-term finances, and how often they review their net worth. 39% of Americans studied do not formally organize their short-term personal finances, and surprisingly, 20% of affluent Americans don't either – meaning millions of Americans are not taking action to organize their short-term personal finances. And while 51% of study participants reveal they review their total net worth quarterly, yearly, less often or never, 25% have never reviewed their total net worth!
- Are firmly entrenched in accessing money through technology at their fingertips. Americans are increasingly viewing money as something to be engaged with, managed, invested and understood with the assistance of technology. 58% of Americans studied believe that financial apps, such as investment apps, money management apps, banking apps and more, are important to achieving their financial goals. And interestingly, this number rises to 76% when looking at Americans who currently work with a financial advisor.
"What is clear is that our industry must deliver a new digital human experience – one that is a balanced combination of human-centric help through trusted financial professionals, with integrated technology engagement via financial apps and embedded finance," added Ms. Dugan. "We have an incredible opportunity to understand what investors of all ages really want, need, and expect will be provided to help guide them on their journey toward financial wellbeing – allowing them to achieve their full financial potential."
The national study included 2,158 U.S. participants ages 25-65. This included 1,038 U.S. participants representing the general population, and 1,120 U.S. participants who have an annual household income or household net worth of $100,000 or more. The sample was weighted to the 2020 U.S. Census for age, gender, geography, and ethnicity. The national study was conducted online from December 13, 2021, to January 11, 2022.
Envestnet refers to the family of operating subsidiaries of the public holding company, Envestnet, Inc. (NYSE: ENV). Envestnet is Fully Vested™ in empowering advisors and financial service providers with innovative technology, solutions, and intelligence to help make financial wellness a reality for their clients through an intelligently connected financial life. More than 106,000 advisors and over 6,500 companies—including 16 of the 20 largest U.S. banks, 47 of the 50 largest wealth management and brokerage firms, over 500 of the largest RIAs, and hundreds of FinTech companies—leverage Envestnet technology and services that help drive better outcomes for enterprises, advisors, and their clients.
For more information, please visit www.envestnet.com, subscribe to our blog, and follow us on Twitter (@ENVintel) and LinkedIn.
Media Contact:
Dana Taormina
JConnelly for Envestnet
envestnetpr@jconnelly.com
(973) 647-4626
View original content to download multimedia:
SOURCE Envestnet, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/envestnet-national-study-examines-keys-unlocking-americans-complicated-financial-relationships/
| 2022-07-28T13:34:23
|
en
| 0.952349
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nba/orlando-magic/articles/40206829
| 2022-07-28T13:34:28
|
en
| 0.738227
|
Extends support throughout the entire lifecycle of cloud adoption
HERNDON, Va., July 28, 2022 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS) (news) today announced the general availability of ePlus Cloud Managed Services (ECMS) for Microsoft Azure. Designed to offload the task of managing Azure deployments, ePlus Cloud Managed Services allow organizations to focus on driving their business and competitive differentiation while ePlus helps optimize cloud costs and leverages proven security best practices to reduce risk.
ePlus Cloud Managed Services deliver fully US-based, 24x7x365 proactive support and specialized cloud expertise from certified engineers and technical architects who deeply understand cloud and how it fits into modern application deployments. The offering includes:
- Well-Architected configuration and automated deployment to speed time to market
- Security and governance of workloads running on Azure to decrease risk with hardened, best practice configuration and ongoing validation
- FinOps methodology for cost-optimized Azure consumption
"ePlus Cloud Managed Services are designed to alleviate many of the challenges we see our customers face when it comes to managing complex public cloud environments and workloads," said Justin Mescher, vice president of cloud and data center solutions at ePlus. "We help ease the transition to cloud by addressing the most common roadblocks—skillsets, cost management, and security—freeing time spent managing their Azure foundation so our customers can focus on driving innovation by optimizing and modernizing applications. ePlus Cloud Managed Services extend our best-of-breed approach to the ongoing management and optimization of Azure to complete the lifecycle of cloud adoption support."
For more information about ePlus Cloud Managed Services, visit the company website.
ePlus has an unwavering and relentless focus on leveraging technology to create inspired and transformative business outcomes for its customers. Offering a robust portfolio of solutions, as well as a full set of consultative and managed services across the technology spectrum, ePlus has proudly achieved more than 30 years of success in the business, carrying customers forward through adversity, rapidly changing environments, and other obstacles. ePlus is a trusted advisor, bringing expertise, credentials, talent and a thorough understanding of innovative technologies, spanning security, cloud, data center, networking, collaboration and emerging solutions, to organizations across all industry segments. With complete lifecycle management services and flexible payment solutions, ePlus' more than 1,500 associates are focused on cultivating positive customer experiences and are dedicated to their craft, harnessing new knowledge while applying decades of proven experience. ePlus is headquartered in Virginia, with offices in the United States, UK, Europe, and Asia‐Pacific. For more information, visit www.eplus.com, call 888-482-1122, or email info@eplus.com. Connect with ePlus on LinkedIn, Twitter, Facebook, and Instagram. ePlus, Where Technology Means More®.
ePlus®, Where Technology Means More®, and ePlus products referenced herein are either registered trademarks or trademarks of ePlus inc. in the United States and/or other countries. The names of other companies, products, and services mentioned herein may be the trademarks of their respective owners.
Statements in this press release that are not historical facts may be deemed to be "forward-looking statements." Actual and anticipated future results may vary materially due to certain risks and uncertainties, including, without limitation, the duration and impact of COVID-19 and the efficacy of vaccine roll-outs, which could materially adversely affect our financial condition and results of operations and has resulted worldwide in governmental authorities imposing numerous unprecedented measures to try to contain the virus that has impacted and may further impact our workforce and operations, the operations of our customers, and those of our respective vendors, suppliers, and partners; national and international political instability fostering uncertainty and volatility in the global economy including an economic downturn, an increase in tariffs or adverse changes to trade agreements, exposure to fluctuation in foreign currency rates, interest rates and downward pressure on prices; our ability to successfully perform due diligence and integrate acquired businesses; the possibility of goodwill impairment charges in the future; reduction of vendor incentive programs; significant adverse changes in, reductions in, or losses of relationships with one or more of our largest volume customers or vendors; the demand for and acceptance of, our products and services; our ability to adapt our services to meet changes in market developments; our ability to implement comprehensive plans to achieve customer account coverage for the integration of sales forces, cost containment, asset rationalization, systems integration and other key strategies; our ability to reserve adequately for credit losses; our ability to secure our electronic and other confidential information or that of our customers or partners and remain secure during a cyber-security attack; future growth rates in our core businesses; our ability to protect our intellectual property; the impact of competition in our markets; the possibility of defects in our products or catalog content data; our ability to adapt to changes in the IT industry and/or rapid change in product standards; our ability to realize our investment in leased equipment; our ability to hire and retain sufficient qualified personnel; and other risks or uncertainties detailed in our reports filed with the Securities and Exchange Commission. All information set forth in this press release is current as of the date of this release and ePlus undertakes no duty or obligation to update this information.
View original content to download multimedia:
SOURCE ePlus inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/eplus-announces-microsoft-azure-cloud-managed-services-general-availability/
| 2022-07-28T13:34:30
|
en
| 0.929619
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40206966
| 2022-07-28T13:34:34
|
en
| 0.738227
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207129
| 2022-07-28T13:34:37
|
en
| 0.738227
|
-- Conference Call Scheduled for 5:00 p.m. ET --
SAN DIEGO, July 28, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter ended June 30, 2022 as follows:
Please connect to the webcast at least 15 minutes prior to the start of the call to download any software that may be required. If participating by phone, please dial in approximately 15 minutes prior to the start of the call.
About Evofem Biosciences
Evofem Biosciences, Inc., (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. The Company expects to report top-line data this fall from its registrational Phase 3 EVOGUARD clinical trial evaluating Phexxi for two potential new indications – prevention of chlamydia and prevention of gonorrhea in women. Learn more at phexxi.com and evofem.com.
Phexxi® is a registered trademark of Evofem Biosciences, Inc.
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
(917) 673-5775
View original content to download multimedia:
SOURCE Evofem Biosciences, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/evofem-biosciences-report-second-quarter-2022-results-provide-corporate-update-thursday-august-4-2022/
| 2022-07-28T13:34:34
|
en
| 0.860676
|
Three new Lenovo monitors are the world's first devices to meet the Eyesafe Display Requirements 2.0, the world's most comprehensive certification standard for measuring blue light mitigation and color performance.
SHANGHAI and MINNEAPOLIS, July 28, 2022 /PRNewswire/ -- TÜV Rheinland Group, the world leader in independent third-party testing and certification, and Eyesafe, the world leader in screen time safety display solutions, today announced the first devices to meet the new Eyesafe® Display Requirements 2.0: the Lenovo G32qc-30 Curved Gaming Monitor, the Lenovo G34w-30 Ultra-Wide Curved Gaming Monitor, and the Lenovo ThinkVision T27p-30 Wide UHD Monitor.
Unveiled in May of this year, the Eyesafe® Certified 2.0 standard is the world's most advance set of certification requirements for measuring blue light emissions and color accuracy for the global display industry. Representing the next-generation blue light management standard for digital displays, it is built upon the resounding success of the first generation Eyesafe standard which has become the industry-leading benchmark for low blue light safety.
"We'd like to congratulate Lenovo on being the world's first to achieve this significant milestone," remarked Frank Holzman, Global Vice President of TÜV Rheinland Business Field Electrical. "The launch of the Eyesafe Certified 2.0 comes at a critical point in time as awareness of low blue light features has become much more pervasive among consumers and brands have begun to offer an array of different low blue light display options. TÜV Rheinland strongly feels that it is imperative that we offer a certification standard for brands that want to provide more precise and complete information to consumers."
"The new Eyesafe Certified 2.0 standard refines a much-needed level of specificity around the general concept of 'low blue light' and empowers consumers to make informed comparisons among competing solutions," added Holzman.
Based on the latest health research, the Eyesafe Certified 2.0 standard was developed in consultation with leading ophthalmologists and optometrists from around the world and outlines guidance for display manufacturers with new key metrics and parameters for measuring blue light toxicity. The Eyesafe Certified 2.0 designation empowers consumers to better understand how brands are addressing the issue of blue light mitigation.
"We want to offer a hearty and well-deserved congratulations to the team at Lenovo for their foresight and leadership around the issue of blue light and their commitment to total human health," said Justin Barrett, the CEO of Eyesafe. "We believe consumers deserve the peace-of-mind of knowing that their devices have passed the most rigorous set of requirements in the industry for measuring blue light emissions and color accuracy. Today is a huge win for Lenovo and a significant milestone for the entire display industry."
TÜV Rheinland and Eyesafe's decision to develop and release the new Eyesafe Certified 2.0 standard was driven by significant advancements in global health research, which has given both physicians in eyecare as well as engineers in the technology space a more thorough understanding of the potentially damaging heath impacts of continuous exposure to blue light on the human retina. These insights, coupled with significant and sustained changes in global device-use patterns since the onset of the pandemic, spurred the TÜV Rheinland and Eyesafe teams to create a next generation standard that would reflect and encompass all the new information available about the impacts of blue light on human health. The complete set of requirements in the new standard are available here.
"Lenovo is proud to be the first technology provider to introduce PC monitors that are certified against the rigorous and precise set of requirements within the new Eyesafe display standard," remarked Stefan Engel, Vice President and General Manager of Visuals Business within Lenovo's Intelligent Devices Group. "The reality is that people are spending more time in front of computers than ever before, and while the concept of 'low blue light' has become more popular, it only addresses part of the challenge. By meeting the Eyesafe Certified 2.0 standard, we're enabling our customers to have more control over their experience and fit the device to their specific needs."
The following certified Lenovo devices will be available globally this fall in select markets1:
- Lenovo G32qc-30 Monitor – a 31.5" WLED QHD curved gaming monitor equipped with a 165 Hz refresh rate, HDR effect support, dual speakers and gaming tools for an immersive, fast and fluid gaming experience.
- Lenovo G34w-30 Monitor – a 34" WQHD ultra-wide 1500R curved gaming monitor with a 21:9 panorama display ratio for wider visibility into more content.
- Lenovo ThinkVision T27p-30 Monitor – a 27" wide UHD monitor featuring a USB Type-C® port offering a single cable connection, and a 3-side near-edgeless bezel design for a seamless working experience across multiple screens.
All feature natural low blue light technology to reduce the emission of high frequency blue light from the panel without color distortion. Each will have the TÜV Rheinland Eyesafe certification seal clearly displayed on both the packaging and the device itself. Additional Lenovo products that meet the new standard will be made available later this year.
To learn more about Lenovo, click here. Additional information and resources regarding the TÜV Rheinland Eyesafe Certified 2.0 Display certification program is available here: eyesafe.com/standards.
LENOVO and THINKVISION are trademarks of Lenovo. USB Type-C® and USB-C® are registered trademarks of USB Implementers Forum.
Developed and supported by the Eyesafe Vision Health Advisory Board, the Eyesafe Display Requirements 2.0 are based on the growing body of research that demands that more precise indices are needed to differentiate competing low blue light protective measures while adding additional requirements for accurate color performance and energy displacement. The Eyesafe Certified 2.0 Display Standard has been developed to provide transparency to consumers and is further built upon existing standards and guidelines developed by the American National Standards Institute (ANSI), the International Commission on Non-Ionizing Radiation Protection (ICNIRP), Eyesafe and TÜV Rheinland. Recent studies have shown growing concerns over potential long-term eye health impacts from digital screen usage and cumulative blue light exposure, in addition to recognized impacts of device use on circadian rhythms and sleep patterns. For more information on the Eyesafe Standard, visit https://eyesafe.com/standards/. Blue light exposure research and studies on animals' cells have shown that blue light in a range of 415 to 455 nm generated the greatest phototoxic risk to retinal pigment epithelium cells, with photoreceptor cell apoptosis seen early after the retina is damaged by blue light. For further details, visit: www.eyesafe.com/research
150 years of safety: Since 1872, TÜV Rheinland's mission has been to make technology safe for people and the environment. From the steam engine to digitalization, what started as a regional association for the monitoring of steam boilers has evolved into a global testing service provider. Today, TÜV Rheinland ensures safety and quality in almost all areas of business and life. This shared commitment unites more than 20,000 employees. They generate annual revenues of 2 billion euros. TÜV Rheinland's experts test technical systems and products around the globe, support innovations in technology and business, train people in numerous professions, and certify management systems according to international standards. By ensuring safety and sustainability, TÜV Rheinland is also shaping the future. Since 2006, TÜV Rheinland has therefore been a member of the United Nations Global Compact for more sustainability and against corruption. Website: www.tuv.com
Simon Hung, PR Manager, TÜV Rheinland Greater China
+852 21921948
Simon.Hung@tuv.com
Eunice Wu, PR Supervisor, TÜV Rheinland Greater China
+86 21 60811868
Eunice.Wu@tuv.com
Eyesafe Inc. is the worldwide supplier of advanced blue light mitigating technology, solutions, and standards. With pioneering products and services, in collaboration with healthcare, Eyesafe is shaping the future of consumer electronics designed for human health. Eyesafe® Standards, Eyesafe® Technology, and the associated intellectual property portfolio is developed by a world-class team of eye doctors, engineers, and scientists with decades of experience in electronics, display materials, light management, optometrists and ophthalmology. The Eyesafe brand is trusted by consumers and integrated in millions of digital devices from Dell, HP, Lenovo, ZAGG and others. Eyesafe was recently ranked #5 in category in the Inc. 5000 Fastest-Growing Private Companies in America. Learn more at eyesafe.com
Arick Wierson
+1 952-999-1741
arick@eyesafe.com
1 On-shelf dates may vary by geography and products may only be available in selected markets. All offers subject to availability. Lenovo reserves the right to alter product offerings, features and specifications at any time without notice.
View original content to download multimedia:
SOURCE Eyesafe
|
https://www.wlbt.com/prnewswire/2022/07/28/eyesafe-tv-rheinland-announce-that-lenovo-will-be-worlds-first-brand-with-devices-meeting-eyesafe-certified-20-display-standard-low-blue-light/
| 2022-07-28T13:34:46
|
en
| 0.920223
|
LOS ANGELES, July 28, 2022 /PRNewswire/ -- FaZe Clan, the lifestyle and media platform rooted in gaming and youth culture, and the National Football League (NFL) today announced Donald De La Haye – also known as FaZe Deestroying – will take the '1ON1' series to cities across the country during NFL preseason.
Each '1ON1' series features episodes made up of incredibly talented wide receivers and defensive backs going head-to-head in multi-stage competitions. The first episode will kick off with the Miami Dolphins at The Baptist Health Training Complex on Friday, August 5th, followed by the Detroit Lions @ Ford Field on Saturday, August 6th. Each competition is free and open to the public for fans and all eligible athletes who wish to compete. To learn about additional dates and locations, view content and attend a '1ON1' session during one of the scheduled dates, check out the website HERE and follow FaZe Deestroying and NFL social channels.
The NFL preseason '1ON1' series is a continuation of activations planned between FaZe Clan and the NFL announced earlier this year during Super Bowl LVI Weekend. FaZe Clan and the activations created together are a notable part of the League's ongoing strategy in connecting with its youngest fans to continue modernizing the image of the brand. FaZe Deestroying's previous work with the NFL, a '1ON1' in Las Vegas during NFL Draft Weekend, was one the most successful 1ON1 events to date, with the video bringing in over 5M views. Watch HERE.
Commenting on today's announcement, Lee Trink, CEO of FaZe Clan, said, "Bringing Deestroying's '1ON1' series to the NFL is a prime example of FaZe Clan empowering and accelerating the next generation of creators. FaZe will continue to unlock new opportunities in support of talent like Deestroying as we develop IP and create new ventures together. Our partnership with the NFL embodies how FaZe and our talent deliver engaging content with established brands in new ways providing experiences that actually matter to Gen Z."
"Deestroying is so credible to the game of football and sits perfectly at the intersection of UGC content creation and the game," said Eddie Capobianco, VP of Culture Marketing at the NFL. "Our continued collaboration with Deestroying and FaZe Clan drives genuine connection particularly with our younger fans across diverse communities including Latinos, all while giving emerging athletes the opportunity to compete, have fun and most importantly, bond around the sport we all love in an exciting way. Our passionate football fans and gamers can't wait to watch and be a part of it all."
FaZe Clan and the NFL first began collaborating in 2019 around League events and participated in the first-ever virtual draft and Draft-a-thon in 2020 when they released an immediately sold-out merchandise collaboration. Earlier this year, FaZe Clan had a significant presence during the Super Bowl LVI Weekend - not only with the flag football game, but also with Snoop Dogg - now officially known as "FaZe Snoop" - wearing a FaZe Clan chain during his epic Super Bowl LVI Halftime Show performance. Most recently, FaZe Clan and the NFL teamed up with multiple activations during NFL Draft Weekend with a Draft pick announcement from FaZe Rug, a co-branded flag football rematch, and FaZe Deestroying's Las Vegas '1ON1' series.
Born in Costa Rica, Deestroying's path to stardom is uniquely his own. After moving to the U.S. with his family when he was seven years old, his talent and passion for football led to a full-ride scholarship as starting kicker for the University of Central Florida – where he first began creating his signature videos. His fast-paced rise into the spotlight has paved the way for other young athletes to seek alternative channels of success and financial opportunity beyond the conventional routes.
FaZe Clan (NASDAQ: FAZE) is a digital-native lifestyle and media platform rooted in gaming and youth culture, reimagining traditional entertainment for the next generation. Founded in 2010 by a group of kids on the internet, FaZe Clan was created for and by Gen Z and Millennials, and today operates across multiple verticals with transformative content, tier-one brand partnerships, a collective of notable talent, and fashion and consumer products. Reaching over 500 million followers across social platforms globally, FaZe Clan delivers a wide variety of entertainment spanning video blogs, lifestyle and branded content, gaming highlights and live streams of highly competitive gaming tournaments. FaZe Clan's roster of more than 85 influential personalities consists of engaging content creators, esports professionals, world-class gamers and a mix of talent who go beyond the world of gaming, including NFL star Kyler "FaZe K1" Murray, Lebron "FaZe Bronny" James Jr., Lil Yachty aka "FaZe Boat" and Snoop Dogg aka "FaZe Snoop." Its gaming division includes 11 competitive esports teams who have won 35 world championships. The content of any website referenced or hyperlinked in this communication is neither incorporated into, nor part of, this communication. For more information, visit www.fazeclan.com, investor.fazeclan.com and follow FaZe Clan on Twitter, Instagram, YouTube, TikTok, and Twitch.
The information in this communication includes "forward-looking statements" pursuant to the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included in this communication, regarding the company's strategy, future operations and financial performance, market opportunity prospects, plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words "budget," "could," "forecast," "future," "might," "outlook," "plan," "possible," "potential," "predict," "project," "seem," "seek," "strive," "would," "should," "may," "believe," "intend," "expects," "will," "projected," "continue," "increase," and/or similar expressions that concern strategy, plans or intentions, but the absence of these words does not mean that a statement is not forward-looking. Such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are based on the management's belief or interpretation of information currently available.
These forward-looking statements are based on various assumptions, whether or not identified herein, and on the current expectations of management and are not predictions of actual performance. Because forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions, whether or not identified in this communication, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Many factors could cause actual results and condition (financial or otherwise) to differ materially from those indicated in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the company. Forward-looking statements speak only as of the date they are made. While FaZe Clan may elect to update these forward-looking statements at some point in the future, FaZe Clan specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing FaZe Clan's assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.
Press Contacts:
FaZe Clan: chelsey.northern@fazeclan.com + chloe.snyder@fazeclan.com + alana.battaglia@fazeclan.com
NFL: Sammi.Liang@nfl.com
View original content to download multimedia:
SOURCE FaZe Clan
|
https://www.wlbt.com/prnewswire/2022/07/28/faze-clan-nfl-bring-1on1-series-with-faze-deestroying-multiple-cities-during-preseason/
| 2022-07-28T13:34:54
|
en
| 0.954461
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207130
| 2022-07-28T13:34:58
|
en
| 0.738227
|
EXTON, Pa., July 28, 2022 /PRNewswire/ -- First Resource Bancorp, Inc. (OTCQX: FRSB) announced financial results for the three months ended June 30, 2022.
Glenn B. Marshall, CEO, stated, "This year has had a very strong start with record quarterly results in the past two quarters. Strong Paycheck Protection Program (PPP) loan income in the prior year was fully replaced by organic loan income. It was a huge hurdle to grow year-to-date revenues in 2022 as compared to 2021 without that PPP income and our team not only met that goal, but they exceeded it."
Highlights for the second quarter of 2022 included:
- Net income of $1.4 million, exceeding the prior year second quarter by 31%
- Total interest expense declined 19% over the prior year second quarter
- Included in the list of 200 top-performing publicly traded banks with assets less than $2 billion published annually by American Banker, based on 2021 results
- Named the Best Community Bank and Best Commercial Bank on the Main Line by readers of Main Line Today
- Named a "Best Places to Work" company by the Philadelphia Business Journal
- Successfully formed a bank holding company, First Resource Bancorp, Inc., to own First Resource Bank as a wholly owned subsidiary
President and Chief Financial Officer, Lauren C. Ranalli, stated, "The significant accomplishments the Bank experienced in the second quarter is a reflection of long-term planning that was carefully executed. The formation of First Resource Bancorp, Inc. had been a topic of discussion for many years and we are thrilled to have brought this plan to fruition as it greatly enhances our capital options in the future. This success was only amplified by learning that we were once again named a Best Places to Work company. We focus just as hard on providing an engaging, fun and inclusive work environment as we do on producing strong financial results. Knowing that our employees value our efforts means everything. We truly believe that happy employees translate into happy customers."
Net income for the quarter ended June 30, 2022 was $1.4 million, or $0.47 per common share, which compares to $1.3 million, or $0.45 per common share, for the previous quarter and $1.1 million, or $0.36 per common share, for the second quarter of the prior year. Annualized return on average assets ("ROAA") was 1.19% for the quarter ended June 30, 2022 compared to 0.94% for the quarter ended June 30, 2021. Annualized return on average equity ("ROAE") was 15.03% for the quarter ended June 30, 2022 compared to 12.85% for the quarter ended June 30, 2021.
Total interest income increased $215 thousand, or 5%, from $4.5 million for the first quarter of 2022 to $4.7 million for the second quarter of 2022. This increase was driven by a 3% organic growth in loans, excluding PPP loans, coupled with an increased rate environment, partially offset by lower fees recognized as interest income in association with PPP loan forgiveness during the second quarter of 2022 as compared to the prior quarter. The Bank recognized $160 thousand of PPP fees in the first quarter of 2022 and $8 thousand in the second quarter of 2022, which represents both the amortization of PPP fees for loans based on the original maturity schedule and the balance of PPP fees recognized when the loans were forgiven by the Small Business Administration. PPP fees have been fully recognized as of June 30, 2022.
Total interest income was $4.7 million for the three months ended June 30, 2021 and 2022. A nominal $2 thousand decrease in total interest income year-over year was the result a decrease in yield in loans due to a reduction of PPP fees recognized, offset by increased volume of loans and investments. Traditional loan growth year-over-year is 17% when excluding PPP loans for both periods. The Bank recognized $614 thousand in PPP fees in the three months ended June 30, 2021 as compared to $8 thousand in the three months ended June 30, 2022.
Total interest expense increased 1% when comparing the second quarter of 2022 to the first quarter of 2022. This increase was the result of a 4 basis point increase in rate on money market accounts, offset by reductions in the average balances of time deposits and FHLB borrowings, quarter over quarter.
Total interest expense decreased 19% from $678 thousand for the three months ended June 30, 2021 to $551 thousand for the three months ended June 30, 2022. The majority of this decreased expense was related to a 14 basis point decline in the cost as well as a lower volume of time deposits, year over year. Interest expense on FHLB borrowings decreased 56% for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 due to FHLB advance prepayments completed in the fourth quarter of 2021.
Net interest income was $4.2 million for the quarter ended June 30, 2022 as compared to $4.0 million for the previous quarter, a $209 thousand, or 5%, increase. The net interest margin increased 11 basis points from 3.62% for the quarter ended March 31, 2022 to 3.73% for the quarter ended June 30, 2022. The overall yield on interest earning assets increased 10 basis points during the second quarter primarily due to an increase in loan balances and a decrease in low yielding cash and investments maintained on the balance sheet. The cost of interest-bearing deposits increased 1 basis point during the second quarter to 0.56%, with the majority of that increase attributed to higher cost money market accounts. The total cost of deposits remained unchanged at 0.40% quarter over quarter.
Net interest income for the six months ended June 30, 2022 was $8.2 million, a 7% improvement over net interest income of $7.6 million for the six months ended June 30, 2021. This growth was driven by a 2% increase in loan interest income, a 51% decrease in borrowings interest expense and an 18% decrease in deposit interest expense.
The provision for loan losses decreased from $22 thousand for the three months ended March 31, 2022 to $19 thousand for the three months ended June 30, 2022. The provision for loan losses decreased from $270 thousand for the three months ended June 30, 2021, to $19 thousand for the three months ended June 30, 2022.
Marshall stated, "Significant one-time recoveries of $269 thousand on two charge-offs that date back to 2019 and prior have provided a measurable benefit in the first half of 2022. These recovered funds were available to cover reserve requirements for the majority of our new loans produced in 2022 thereby reducing our normal provision for loan loss expense. Credit quality has remained strong."
The allowance for loan losses to total loans was 0.87% at June 30, 2022, as compared to 0.86% at December 31, 2021 and 0.87% at June 30, 2021. Excluding PPP loans, which are 100% guaranteed by the SBA, the allowance for loan losses to total loans was 0.87% at June 30, 2022, 0.86% at December 31, 2021, 0.93% at June 30, 2021. Non-performing assets consisted of non-performing loans of $244 thousand at June 30, 2022 and March 31, 2022. Non-performing assets to total assets were 0.05% at June 30, 2022 and March 31, 2022.
Non-interest income for the quarter ended June 30, 2022 was $266 thousand, as compared to $383 thousand for the previous quarter and $181 thousand for the second quarter of the prior year. Swap referral fee income received in the second quarter of 2022 was $85 thousand, as compared to $102 thousand in the first quarter of 2022 and zero in the second quarter of 2021. Gain on sale of SBA loans was zero in the second quarter of 2022, as compared to $94 thousand in the first quarter of 2022 and zero in the second quarter of 2021.
Non-interest income for the six months ended June 30, 2022 was $649 thousand as compared to $359 thousand for the same period in the prior year. Swap referral fee income of $187 thousand was received in the first six months of 2022 as compared to none in the first six months of 2021. Gain on sale of SBA loans was $94 thousand for the first six months of 2022 as compared to none in the first six months of 2021.
Non-interest expense increased $23 thousand, or 1%, in the three months ended June 30, 2022 as compared to the prior quarter. Increases in salaries and employee benefits, professional fees and other expenses were partially offset by a decrease in occupancy and equipment. Non-interest expense increased $43 thousand, or 2%, when comparing the second quarter of 2022 to the second quarter of 2021. This increase was primarily attributed to higher salaries and benefits, professional fees, and other costs, partially offset by lower occupancy and equipment and data processing costs. Non-interest expenses to average assets were 2.32% for the three months ended June 30, 2022 as compared to 2.35% for the previous quarter and 2.36% for the second quarter of the prior year.
Deposits grew a net $3.2 million, or 1%, from $412.5 million at March 31, 2022 to $415.7 million at June 30, 2022. During the second quarter, noninterest-bearing deposits increased $1.4 million, or 1%, from $116.9 million at March 31, 2022 to $118.3 million at June 30, 2022. Interest-bearing checking balances increased $1.6 million, or 4%, from $39.7 million at March 31, 2022 to $41.3 million at June 30, 2022. Money market deposits increased $1.5 million, or 1%, from $188.1 million at March 31, 2022 to $189.6 million at June 30, 2022. Certificates of deposit decreased $1.3 million, or 2%, from $67.9 million at March 31, 2022 to $66.5 million at June 30, 2022. Between June 30, 2021 and June 30, 2022, total deposits grew 5%, with strong checking and money market growth partially offset by a decline in non-interest bearing deposits and certificates of deposit.
Ranalli noted, "Deposit rates have started to feel some upward pressure due to the Federal Reserve's current aggressive rate hike plan. We continue to focus on growing checking deposits and will manage the deposit cost of funds as much as possible."
The loan portfolio grew $13.1 million during the second quarter from $405.5 million at March 31, 2022 to $418.7 million at June 30, 2022. Excluding PPP loan activity, the loan portfolio increased $13.3 million, or 3%, from $405.3 million at March 31, 2022 to $418.6 million at June 30, 2022, with strong growth in commercial business loans, commercial real estate loans and consumer loans partially offset by a decline in construction loans.
Total stockholder's equity increased $1.1 million, or 3%, from $36.3 million at March 31, 2022 to $37.4 million at June 30, 2022, primarily due to net income generated, partially offset by a decline in the unrealized gain/loss position of the investment portfolio. During the quarter ended June 30, 2022, book value per share grew 35 cents, or 3%, to $12.75.
About First Resource Bancorp, Inc.
First Resource Bancorp, Inc. is the holding company of First Resource Bank. First Resource Bank is a locally owned and operated Pennsylvania state-chartered bank with three full-service branches, serving the banking needs of businesses, professionals and individuals in the Delaware Valley. The Bank offers a full range of deposit and credit services with a high level of personalized service. First Resource Bank also offers a broad range of traditional financial services and products, competitively priced and delivered in a responsive manner to small businesses, professionals and residents in the local market. For additional information visit our website at www.firstresourcebank.com. Member FDIC.
This press release contains statements that are not of historical facts and may pertain to future operating results or events or management's expectations regarding those results or events. These are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements may include, but are not limited to, statements about our plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts. When used in this press release, the words "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", or words of similar meaning, or future or conditional verbs, such as "will", "would", "should", "could", or "may" are generally intended to identify forward-looking statements. These forward-looking statements are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are either beyond our control or not reasonably capable of predicting at this time. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ materially from the results discussed in these forward-looking statements. Readers of this press release are accordingly cautioned not to place undue reliance on forward-looking statements. First Resource Bank disclaims any intent or obligation to update publicly any of the forward-looking statements herein, whether in response to new information, future events or otherwise.
View original content to download multimedia:
SOURCE First Resource Bank
|
https://www.wlbt.com/prnewswire/2022/07/28/first-resource-bancorp-inc-announces-record-quarterly-results-second-quarter-2022-net-income-grew-31-over-prior-year/
| 2022-07-28T13:35:00
|
en
| 0.973291
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207264
| 2022-07-28T13:35:04
|
en
| 0.738227
|
12 Jihadis with links to Bangladeshi terror group Ansarul Islam arrested in Assam: Police.
- Country:
- India
12 Jihadis with links to Bangladeshi terror group Ansarul Islam arrested in Assam: Police.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Ansarul Islam
- Bangladeshi
Advertisement
|
https://www.devdiscourse.com/article/Newsalert/2125513-12-jihadis-with-links-to-bangladeshi-terror-group-ansarul-islam-arrested-in-assam-police
| 2022-07-28T13:35:05
|
en
| 0.869143
|
Streamlined processes empowers insured families and agents with faster receipt of funds
FOLSOM, Calif., July 28, 2022 /PRNewswire/ -- One Inc, the leading digital payments network for the insurance industry, today announced that the Georgia Farm Bureau Mutual Insurance Company (GFBMIC), the largest domestic property and casualty insurance company in the State of Georgia, has selected One Inc's ClaimsPay® digital payments platform to provide an improved claim payment experience for its members. The implementation will enhance the outbound claims payment process, providing new and improved options to allow for faster receipt of funds.
GFBMIC currently partners with Sapiens Insurance, a leading global provider of software solutions for the insurance industry. The combination of Sapiens' cloud native, core suite of insurance applications and One Inc's payments solutions and related delivery capabilities, will increase the scale, speed to market, and customer satisfaction as insurance companies embrace digital transactions.
"Our partnership with One Inc emphasizes our longstanding commitment to innovation and the significant value we place on our customer relationships," said GFBMIC General Manager, George Monk. "Eighty percent of Georgia Farm Bureau's vendors are already in the One Inc network, so it was an easy decision for GFBMIC to partner with them. The combined strengths of One Inc and Sapiens will enable us to fully maximize digital transformation and increase customer engagement."
"Georgia Farm Bureau was seeking a proven, flexible and modern solution with a capacity for delivering a feature-rich and modern claims platform to empower their policyholders with the most innovative insurance capabilities," said Ian Drysdale, CEO at One Inc. "Integrating Sapiens and One Inc's enterprise platform will be highly beneficial to GFBMIC'S business operations by meeting today's industry demands and preparing them for the future."
About One Inc:
One Inc is modernizing the insurance industry through a unified and frictionless payment network. Focusing only on the insurance industry, One Inc helps carriers transform their operations by reducing costs, increasing security, and optimizing customer experience. The comprehensive end-to-end digital payments platform provides expanded payment options, multi-channel digital communications, and rapid digital claim payments, even for the most complex insurance use cases. As one of the fastest growing digital payments platforms in the insurance industry, One Inc manages billions of dollars per year in premiums and claims payments. For more information, please visit www.oneinc.com.
About Georgia Farm Bureau Mutual Insurance Company:
Georgia Farm Bureau Mutual Insurance Company, which began operations in 1959, is the largest domestic property and casualty insurance company in the State of Georgia. As a mutual insurance company, GFBMIC is owned by its policyholders who are members of Georgia Farm Bureau. As members of Georgia Farm Bureau, policyholders support Georgia agriculture and are eligible for numerous additional benefits.
For more on GFB, please visit https://www.gfb.org/
About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. Backed by 40 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers' compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit sapiens.com or follow us on LinkedIn.
View original content to download multimedia:
SOURCE One Inc
|
https://www.wlbt.com/prnewswire/2022/07/28/georgia-farm-bureau-mutual-insurance-company-selects-one-inc-provide-modernized-approach-claim-payments/
| 2022-07-28T13:35:07
|
en
| 0.917256
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207265
| 2022-07-28T13:35:10
|
en
| 0.738227
|
Arrested leader Partha Chatterjee suspended from TMC, removed from all posts: Party's national gen secy Abhishek Banerjee.
- Country:
- India
Arrested leader Partha Chatterjee suspended from TMC, removed from all posts: Party's national gen secy Abhishek Banerjee.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Partha Chatterjee
- Abhishek Banerjee
- Party
Advertisement
|
https://www.devdiscourse.com/article/Newsalert/2125614-arrested-leader-partha-chatterjee-suspended-from-tmc-removed-from-all-posts-partys-national-gen-secy-abhishek-banerjee
| 2022-07-28T13:35:12
|
en
| 0.89625
|
NEW YORK, July 28, 2022 /PRNewswire/ -- GoldenTree Loan Management II ("GLM II") and its affiliated investment manager GoldenTree Asset Management LP (along with other affiliated investment managers "GoldenTree"), announced the closing of a $487 million collateralized loan obligation ("CLO") to be managed by GLM II. With the closing of this CLO, GoldenTree Loan Management US CLO 14 ("GLM US CLO 14"), GoldenTree has issued 19 CLOs totaling over $11 billion under its GLM CLO strategy. Since its inception in January 2017, the GLM strategy was intended to be compliant with applicable Risk Retention regulations. While a US Court of Appeals ruling on February 9, 2018 led to the repeal of US risk retention rules for open market CLOs, GLM CLOs are intended to continue to comply with European Union and United Kingdom Risk Retention regulations.
GLM US CLO 14 will initially be backed by a 97% ramped $478 million portfolio of primarily senior secured loans as of closing and will have a five-year reinvestment period and a two-year non call period. The CLO was arranged by a bank syndicate including BofA Securities as structuring lead, and Morgan Stanley and Wells Fargo Securities as co-leads. The syndicate globally distributed the investment grade and BB rated notes issued by the CLO, while GLM II invested in the CLO's equity as well as B rated notes.
GLM US CLO 14 issued $315 million of AAA rated senior notes with a coupon of S+1.70%, along with lower rated senior, mezzanine and junior notes, for an overall weighted average coupon of S+2.39%.
Since its inception in 2000, GoldenTree has issued over $21 billion of CLOs/CBOs, with over $13.5 billion currently outstanding. GoldenTree's investment team is comprised of more than 70 individuals covering around 20 industries and having, on average, 14 years of experience. In addition, GoldenTree has been an active investor in structured credit since 2007 and currently manages over $5 billion of structured products investments across the firm.
About GoldenTree
GoldenTree is an employee-owned, global asset management firm that specializes in opportunities across the credit universe in sectors such as high yield bonds, leveraged loans, private credit, distressed debt, structured products, emerging markets, private equity and credit-themed equities. GoldenTree was founded in 2000 by Steve Tananbaum and is one of the largest independent asset managers focused on credit. GoldenTree manages nearly $47 billion for institutional investors, including leading public and corporate pensions, endowments, foundations, insurance companies and sovereign wealth funds. GoldenTree has over 270 employees, with offices in New York, West Palm Beach, Charlotte, London, Dublin, Singapore, Sydney and Tokyo. For more information, please visit www.goldentree.com.
For further information contact:
View original content:
SOURCE GoldenTree Loan Management
|
https://www.wlbt.com/prnewswire/2022/07/28/goldentree-announces-closing-487-million-clo-under-glm-strategy/
| 2022-07-28T13:35:14
|
en
| 0.95749
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207299
| 2022-07-28T13:35:16
|
en
| 0.738227
|
A rights group says it filed a legal complaint in Paris alleging Saudi crown prince's complicity in journalist's killing, reports AP.
A rights group says it filed a legal complaint in Paris alleging Saudi crown prince's complicity in journalist's killing, reports AP.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
|
https://www.devdiscourse.com/article/Newsalert/2125666-a-rights-group-says-it-filed-a-legal-complaint-in-paris-alleging-saudi-crown-princes-complicity-in-journalists-killing-reports-ap
| 2022-07-28T13:35:20
|
en
| 0.933936
|
High 5 Plumbing explains the benefits of having a career in the home service industry
DENVER, July 28, 2022 /PRNewswire/ -- High 5 Plumbing, a family-owned and operated plumbing company serving residents in the greater Denver metropolitan area, is dedicated to helping the home service industry thrive. With a shortage of skilled plumbing technicians, the company is encouraging new high school graduates or anyone looking for a new career to consider choosing a life in the trades.
"Right now, we are an industry that is high in demand but limited on the number of plumbers available to work," said Levi Torres, co-owner of High 5 Plumbing. "Far too often, there is a negative stigma associated with working in the trades that isn't true. Working in the trades is fulfilling because you are helping people day in and day out. You get to make a good living without going into debt. There are countless benefits to choosing a life in the trades."
When compared to the average salary of an upstart graduate fresh out of a four-year university, trade jobs pay more. Torres explains that new trade school graduates can earn well above $50,000 yearly with those wages nearing six figures after earning certifications and additional training.
In addition, high school graduates who attend a trade school are less likely to incur high levels of debt. According to Forbes, the average cost to attend a four-year university in 2021-22 was approximately $10,740. Those attending a trade school paid as little as $5,000.
Torres said given the national landscape, taking advantage of lower school tuition and higher salaries gives those looking for a career the chance to enter a field that is starving for technicians.
"On a nationwide scale, there is a high demand for skilled laborers in the home service industry," Torres said. "Companies are looking to hire individuals that can perform the work at a high level. With the jobs available, technicians have plenty of companies to choose from. It's important for us to spread the word that the trades are a viable option for those looking for a career.
"Going to a four-year college isn't the right fit for everyone. There are some that prefer a more hands-on approach right out of high school. For me, I started in the plumbing industry at the age of 16 and never looked back. Learning a trade is an excellent opportunity to enter a career that is meaningful while also earning a great living."
For more information on High 5 Plumbing, visit https://www.high5plumbing.com/.
About High 5 Plumbing
Founded in 2012, High 5 Plumbing is a local, family-owned company serving residents in the greater Denver metropolitan area. With a professional team that has extensive experience and a commitment to service, High 5 Plumbing offers comprehensive plumbing, sewer and drain services. The company was built on the values of solving plumbing problems and serving every customer with professionalism and respect. For more information about High 5 Plumbing, visit https://www.high5plumbing.com/.
MEDIA CONTACT:
Heather Ripley
Ripley PR
(865) 977-1973
hripley@ripleypr.com
View original content to download multimedia:
SOURCE High 5 Plumbing
|
https://www.wlbt.com/prnewswire/2022/07/28/good-life-denver-plumber-discusses-working-trades/
| 2022-07-28T13:35:21
|
en
| 0.963124
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207508
| 2022-07-28T13:35:22
|
en
| 0.738227
|
NEW YORK, July 28, 2022 /PRNewswire/ -- Silverbullet, today announces its partnership with the leading brewer HEINEKEN USA, as it supports the company in the continued development and execution of its consumer data strategy. This collaboration is a testament to the digital transformation journey that HEINEKEN USA have been on to recruit and connect with.
Silverbullet has been appointed as HEINEKEN USA's chosen specialist partner due to their legacy in supporting global brands to step into the new data-driven marketing age. HEINEKEN USA selected Silverbullet to enable them to tap into the data opportunity through state-of-the-art technology, providing them with the right skills, mindset, and experience to deliver and execute a future-proofed strategy centred around the consumer.
"HEINEKEN USA have been working towards unlocking and utilising the data available to us for some time. If we can measure user behaviour, and glean insights from our consumers, we can continue to drive relevance and consistently provide high quality experiences. Towards the end of 2021, we engaged Silverbullet to build on previous learnings and help us take our strategy to the next level. Their domain expertise has been invaluable" Rebekah Kennedy, Consumer Data Director at Heineken USA.
During the past five months, Silverbullet has undertaken a comprehensive acceleration program for HEINEKEN USA. The Silverbullet team executed an in-depth discovery initiative, provided thorough gap analysis, and designed a tailor-made data strategy roadmap in collaboration with the brand, to outline the vision and tangible steps to unlock the value of consumer data.
"We couldn't be more excited to continue our partnership with HEINEKEN USA, as we move into the next phase of the project in bringing their enhanced consumer data strategy to life. We love working closely with a forward thinking cross-functional marketing team at the organisation, who are very determined to enable great experiences for their consumers across brands" says Andrea Ghibaudi, Vice President Enterprise Strategy at Silverbullet. "The ambition and enthusiasm HEINEKEN USA has brought to the project, has been a real inspiration, and I can't wait to see what the future brings."
About Silverbullet
Silverbullet is a data and digital transformation company that delivers future-proofed solutions for a privacy-first, post-cookie era.
Our combination of technology and expert professional services encompasses first-party data strategy and customer journey activation advisory, adtech and martech services, and a contextual intelligence engine that generates powerful business outcomes and customer-centric experiences.
Headquartered in London, UK, the Group employs 70+ people in five countries, across The Americas, Europe, and Asia Pacific.
View original content:
SOURCE Silverbullet
|
https://www.wlbt.com/prnewswire/2022/07/28/heineken-usa-partners-with-silverbullet-accelerate-its-data-strategy-deliver-meaningful-consumer-experiences-scale/
| 2022-07-28T13:35:27
|
en
| 0.921225
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/las-vegas-raiders/articles/40207608
| 2022-07-28T13:35:28
|
en
| 0.738227
|
5G spectrum auction stretches to 4th day; bids worth Rs 1,49,623 crore received on 3rd day: Telecom Minister Ashwini Vaishnaw.
5G spectrum auction stretches to 4th day; bids worth Rs 1,49,623 crore received on 3rd day: Telecom Minister Ashwini Vaishnaw.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Ashwini Vaishnaw
Advertisement
|
https://www.devdiscourse.com/article/Newsalert/2125671-5g-spectrum-auction-stretches-to-4th-day-bids-worth-rs-149623-crore-received-on-3rd-day-telecom-minister-ashwini-vaishnaw
| 2022-07-28T13:35:28
|
en
| 0.962141
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40206141
| 2022-07-28T13:35:34
|
en
| 0.738227
|
Ketamine-Assisted Therapy is offered as part of a holistic corporate wellness program.
PROVO, Utah, July 28, 2022 /PRNewswire/ -- HempLucid, a leading provider of plant-based wellness supplements, is the first startup to offer medically supervised Ketamine-Assisted Therapy (KAP) as an employee benefit.
Ketamine is a general anesthetic, first used on the battlefields of Vietnam because it did not slow the heartrate like other anesthetics. Today, ketamine is used by first responders to calm people trying to take their own lives, and as an emerging medical treatment for depression.
"The interesting and exciting part is that it came out of neuroscience research, instead of by chance, said Gerard Sanacora, M.D., Ph.D., a psychiatrist at Yale Medicine involved in many ketamine studies.
Former first responder turned HempLucid CEO Chase Hudson's advocacy of psychedelic assisted therapies was cemented as a co-producer of Reborn, which chronicles Lamar Odom's use of psychedelic-assisted therapies during his recovery from drug addiction.
"We are in a new era," said Chase Hudson, CEO HempLucid.
"We know mental and physical health are deeply connected. HempLucid's corporate wellness program is the necessary bridge for our employees while our health care system catches up," he continued.
HempLucid's ketamine-infusion pilot program started in 2019 with executive leadership participation, including Hudson. In 2022, HempLucid, which now covers the full cost of ketamine infusions for employees, formalized the offering as a health care benefit through a first of its kind partnership with Canadian firm, Numinus Wellness.
The employee benefit ensures access to KAP to any employee with a mental health diagnosis. Traditional therapy is covered through HempLucid's existing health care plan and HempLucid continues to cover ketamine infusions. The combination of traditional therapy and ketamine infusions is the medical therapy known as KAP.
HempLucid's corporate wellness program also includes holistic approaches including massage, cryotherapy, hypobaric chambers, float tanks and weekly team building events.
"Our approach is holistic. We want to our employees to have access to all pathways to healing. As individuals and as a team, we have seen incredible shifts, in productivity, temperament, and empathy in ourselves and as a team. These benefits are now part of our corporate core." said Hudson.
HempLucid, a is a leading provider of premium wellness products, including mushroom and CBD supplements. By celebrating and empowering others to heal in harmony with nature, HempLucid's mission is to create innovative products that inspire others to become aware of their healing path. HempLucid's commitment to exemplary products and extraordinary corporate responsibility is driven by the company's core. HempLucid views healing and wellness through a holistic lens and stands on it. The company's core values of quality, education, self-worth and connection, compassion, and revolution. Current product offerings include plant-based edibles, topicals, tinctures, and capsules. HempLucid is based in Provo, Utah and founded by Chase Hudson in 2016.
Media Contact:
Lara Miller
hemplucid@avaansmedia
View original content to download multimedia:
SOURCE HempLucid
|
https://www.wlbt.com/prnewswire/2022/07/28/hemplucid-becomes-first-startup-provide-psychedelic-therapy-employee-healthcare-benefit/
| 2022-07-28T13:35:34
|
en
| 0.955926
|
TMC will not support anyone found involved in corruption: Party MP Abhishek Banerjee.
- Country:
- India
TMC will not support anyone found involved in corruption: Party MP Abhishek Banerjee.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
|
https://www.devdiscourse.com/article/agency-wire/2125617-tmc-will-not-support-anyone-found-involved-in-corruption-party-mp-abhishek-banerjee
| 2022-07-28T13:35:35
|
en
| 0.959834
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40206156
| 2022-07-28T13:35:40
|
en
| 0.738227
|
NORTHBROOK, Ill., July 28, 2022 /PRNewswire/ -- Hilco Real Estate, LLC announces a sealed bid deadline of September 1, 2022, for the sale of a 131.5± acre stone quarry in Tolland, Conn., with six acres of land partially mined.
There is approximately 14 million tons of aggregate present on site at this Connecticut stone quarry according to a January 2022 Continental Placer report. The aggregate in the ground consists of two basic rock types: Muscovite Quartzite and the heavier Biotite-Amphibole gneiss. Commercial stone was the previous use for the mined aggregate. Additional value in this aggregate is seen in both building and construction use. There is currently an active mining permit issued by the Town of Tolland, which allows 10 acres to be permitted for mining at a time.
The site is located off the east side of Mountain Spring Road, two miles north of I-84, with access to the interstate from exit 67, making logistics and transportation to other areas quick and easy. The city of Hartford is approximately 20 minutes west from the quarry site in Tolland. The Tolland, Connecticut region has a unique country feel. However, the area's appearance does not reflect the economic activity surging throughout. With convenient access points and a centralized location, the property is near other towns including Coventry, Ellington, Mansfield, Stafford, Vernon, and Willington.
Jonathan Cuticelli, vice president at Hilco Real Estate, stated, "This sale represents an outstanding opportunity as it contains a significant amount of usable aggregate and a wide variety of future usage options as it sits near several major interstates and roadways in the Tolland and North Central Connecticut area. It presents a great option for operators looking to expand or relocate and capitalize on an established, yet growing market." He added, "There's huge upside for investors to buy and add value through both continued and new efforts."
On-site inspection dates are set for August 11 and 25 at 11 a.m. ET. Both dates are by appointment only. For more information on the sale and on-site tours, please contact Jonathan Cuticelli at (203) 561-8737 or jcuticelli@hilcoglobal.com.
For further information on the property, an explanation of the sale process, bidding procedures or to obtain access to property due diligence documents, please visit HilcoRealEstate.com or call (855) 755-2300.
Hilco Real Estate ("HRE"), a Hilco Global company (HilcoGlobal.com), is headquartered in Northbrook, Illinois (USA). HRE is a national provider of strategic real estate disposition services. Acting as an agent or principal, HRE uses its experience to advise and execute strategies to assist clients in deriving the maximum value from their real estate assets. By leveraging multi-faceted sales strategies and techniques, aggressive repositioning and restructuring experience, a vast and motivated network of buyers and sellers, and substantial access to capital, HRE exceeds expectations even in the most complex transactions.
View original content to download multimedia:
SOURCE Hilco Real Estate
|
https://www.wlbt.com/prnewswire/2022/07/28/hilco-real-estate-announces-sale-1315-ac-connecticut-stone-quarry/
| 2022-07-28T13:35:40
|
en
| 0.93789
|
NIIT Q1 net profit falls 14% to Rs 44.3 cr
The total number of MTS customers stands at 68, it said.The Skills and Careers Group SNC posted net revenue of Rs 92.3 crore during Q1, up 145 per cent year-on-year and 16 per cent quarter-on-quarter.
- Country:
- India
NIIT Ltd on Thursday posted a 14 per cent drop in consolidated net profit to Rs 44.3 crore for the June quarter as earnings were affected by a Rs 10.5 crore reduction in treasury income year-on-year.
The net profit of the talent development company stood at Rs 51.4 crore in the quarter ended June 30, 2021.
During the quarter, the company recorded net revenue of Rs 404.8 crore, up 34 per cent year-on-year and eight per cent on a sequential basis.
EBITDA or earnings before interest, taxes, depreciation and amortisation stood at Rs 74 crore, up five per cent year-on-year, and the EBITDA margin stood at 18.3 per cent, the company said in a statement. Profit After Tax was recorded at Rs 44.3 crore in the just concluded quarter, 14 per cent lower year-on-year. ''Q1 PAT affected by Rs 10.5 crore reduction in treasury income YoY, led by mark-to-market impact on fixed income MF investments,'' the company explained in a statement.
Vijay K Thadani, Vice Chairman and Managing Director of NIIT Ltd, said, ''In face of increasing global uncertainty and rapid macro-economic changes, NIIT continued its growth momentum resulting in a strong revenue growth of 8 per cent QoQ (quarter-on-quarter) and 34 per cent (year-on-year)''. Its Corporate Learning Group (CLG) recorded net revenue of Rs 312.5 crore, up 18 per cent year-on-year and six per cent sequentially. CLG added 4 new MTS (Managed Training Services) customer contracts as well as one contract expansion and one contract renewal during the quarter. The revenue visibility for CLG, at the end of the quarter, was USD 304 million. The total number of MTS customers stands at 68, it said.
The Skills and Careers Group (SNC) posted net revenue of Rs 92.3 crore during Q1, up 145 per cent year-on-year and 16 per cent quarter-on-quarter.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- NIIT Ltd
- Training Services
- treasury
- EBITDA
- Learning Group
- Vijay K Thadani
ALSO READ
U.S. Treasury diplomat nominee aims to curb China's lending influence
Deputy U.S. Treasury chief says Russian oil price cap plan can aid inflation fight
Deputy U.S. Treasury chief says Russian oil price cap plan can aid inflation fight
U.S. Treasury's Yellen to meet South Korea's Yoon on final leg of Asia trip
U.S. Treasury's Yellen welcomes Ukraine debt freeze, calls on creditors to join
|
https://www.devdiscourse.com/article/business/2125516-niit-q1-net-profit-falls-14-to-rs-443-cr
| 2022-07-28T13:35:43
|
en
| 0.944358
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40206199
| 2022-07-28T13:35:46
|
en
| 0.738227
|
COLUMBUS, Ohio, July 28, 2022 /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN) announced that its prime rate is increasing from 4.75 percent to 5.5 percent, effective July 28, 2022.
The rate was last changed on June 16, 2022, when Huntington increased its prime rate from 4 percent to 4.75 percent.
Huntington Bancshares Incorporated (Nasdaq: HBAN) is a $179 billion asset regional bank holding company headquartered in Columbus, Ohio. Founded in 1866, The Huntington National Bank and its affiliates provide consumers, small and middle‐market businesses, corporations, municipalities, and other organizations with a comprehensive suite of banking, payments, wealth management, and risk management products and services. Huntington operates more than 1,000 branches in 11 states, with certain businesses operating in extended geographies. Visit Huntington.com for more information.
View original content to download multimedia:
SOURCE Huntington Bancshares Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/huntington-bancshares-incorporated-increases-its-prime-rate-55-percent/
| 2022-07-28T13:35:47
|
en
| 0.940855
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40206519
| 2022-07-28T13:35:52
|
en
| 0.738227
|
KOLKATA WEEKLY TEA REPORT
Exporters were interested on some bolder brokens and fannings.There was a good demand for this weeks Orthodox offerings and 12,93,170 kg of different leaf was sold at an average price of Rs 348.84 per kg.
- Country:
- India
A mixed trend in demand for different categories of teas was marked during recent sale-30 which was held on 26th and 27 the July 2022, a Kolkata Tea Traders Association official said today.
According to official data of CTTA, the total offerings amounted to 1,61,441 packages comprising 74,302 packages of CTC, 55,845 packages of Orthodox, 4,298 packages of Darjeeling leaf and 26,996 packages of Dust teas.
CTC leaf met with strong demand and 17,42,935 kg of different categories was sold at an average price of Rs 246.39 per kg. Around 50.25 per cent of total quantity was sold above Rs 250 per kg. Liquoring Assams was irregular around last. Medium sorts followed similar trend. Hindustan Unilever was active and TCPL remained selective. Good support from western India was marked. Other internal operaters also saw good enquiry. Exporters were interested on some bolder brokens and fannings.
There was a good demand for this week's Orthodox offerings and 12,93,170 kg of different leaf was sold at an average price of Rs 348.84 per kg. Around 80.97 per cent of total quantity was consumed at higher price level. Well made whole leaf was sold at firm rates while brokens was irregular around last. Remainder tended lower following quality. Leafy fanning and cleaner secondaries sold at firm rates. Browner, stalkier secondaries and smaller fannings were irregular and at times tended lower. Middle East and CIS were active. But Hindustan Unilever operated selectively.
Darjeeling leaf registered fair demand during this week. Total demand was 4,298 kg and average price was marked at Rs 440.35 per kg. About 39.88 per cent of total quantity was demanded at over Rs 500 per kg. Whole leaf grade maintained quality around last levels. Brokens and fannings followed similar trend with some outlots being witnessed. Fair support from internals and active role from exporters also witnessed.
In case of Dust offerings, the demand was also good and 7,62,918 kg of different quality was sold at an averege price of Rs 261.07 per kg. More than 56.47 per cent of leaf was sold at higher price level. Liquoring Assams was irregular around last and browner sorts tended easier with some withdrawals. Hindustan Unilever and TCPL saw good support. Other internals also operated.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
|
https://www.devdiscourse.com/article/business/2125519-kolkata-weekly-tea-report
| 2022-07-28T13:35:51
|
en
| 0.978007
|
The collaboration equips brand and agency ad buyers with added transparency for display and video ad formats in mobile gaming environments
NEW YORK, July 28, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a leader in digital media quality, today announced a partnership with Anzu, an in-game advertising leader. This partnership enables global brands and agencies to effectively monitor the quality of their in-game media investments in mobile gaming environments. Through this collaboration, IAS provides advertisers with Invalid Traffic (IVT) measurement and reports on Viewability through the IAS Signal platform.
"Gaming continues to emerge as a medium with broad appeal and growing reach. By partnering with Anzu, we now deliver in-game measurement and transparency for advertisers within gaming environments," said Tom Sharma, Chief Product Officer of IAS. "This integration sets the platform for quality standards within ad-supported gaming and allows advertisers to better understand and control the quality of their media on Anzu."
In-game environments have posed various challenges for verification measurement throughout the ad tech industry, such as multiple forms of device types, game developers, and platforms, all of which make it difficult to use a single tech suite for verification coverage. This strategic collaboration further delivers ad transparency into mobile gaming environments, continuing IAS's progress related to in-game brand safety, suitability, IVT, and viewability measurement everywhere in the digital advertising ecosystem.
"Anzu's new partnership with IAS is the next step in standardizing in-game viewability and performance in the mobile gaming industry, which is projected to reach $136 billion worldwide this year," said Itamar Benedy, Co-Founder and CEO of Anzu. "This new partnership means advertisers can now get enhanced visibility into the effectiveness of their campaigns. This further strengthens the already robust metrics and reporting advertisers benefit from when running in-game ad campaigns with Anzu."
"This important measurement advancement will help accelerate advertisers' ability to scale their in-game media investments by further demonstrating the high performance of the Anzu platform," said Joe Cady, EVP Advanced Advertising & Partnerships, NBCUniversal. "We are excited to see Anzu and IAS partner to expand insights and streamline measurement operations for marketers as they evaluate their in-game media effectiveness."
For more information, visit https://integralads.com/.
Contacts
press@integralads.com
Integral Ad Science (IAS) is a global leader in digital media quality. IAS makes every impression count, ensuring that ads are viewable by real people, in safe and suitable environments, activating contextual targeting, and driving supply path optimization. Our mission is to be the global benchmark for trust and transparency in digital media quality for the world's leading brands, publishers, and platforms. We do this through data-driven technologies with actionable real-time signals and insight. Founded in 2009 and headquartered in New York, IAS works with thousands of top advertisers and premium publishers worldwide. For more information, visit integralads.com.
Anzu is the world's most advanced in-game advertising solution. Available across mobile, PC, console, and Roblox, Anzu's blended in-game ads put players first and help the world's biggest advertisers, including American Eagle, PepsiCo, and Vodafone, reach audiences in a non-disruptive and highly engaging way. Anzu also helps leading game studios like Ubisoft and Saber Interactive monetize their titles with ad placements that complement the gameplay, resulting in reliable revenue streams. Backed by WPP, Sony Innovation Fund, NBCUniversal, HTC, and other prominent investors, Anzu has raised $37M to make advertising in games better. Better for brands, better for game developers, and better for gamers. Learn more at https://www.anzu.io/.
View original content to download multimedia:
SOURCE Integral Ad Science, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/ias-anzu-partner-provide-media-quality-measurement-in-game-advertising-environments/
| 2022-07-28T13:35:54
|
en
| 0.941416
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40206934
| 2022-07-28T13:35:58
|
en
| 0.738227
|
Pakistan's current account deficit increases to 4-year high of USD 17.4 bn in FY22
Pakistans current account deficit CAD increased to a 4-year high of USD 17.4 billion in the fiscal year of 2021-22, indicating more troubles for the ailing economy of the cash-strapped country.The State Bank of Pakistan SBP on Wednesday reported that the country recorded a CAD of USD 17.406 billion in FY22 compared to a gap of just USD 2.82 billion in FY21.According to Dawn newspaper, the massive CAD speaks a lot about the severe problem of the balance of payments.
- Country:
- Pakistan
Pakistan's current account deficit (CAD) increased to a 4-year high of USD 17.4 billion in the fiscal year of 2021-22, indicating more troubles for the ailing economy of the cash-strapped country.
The State Bank of Pakistan (SBP) on Wednesday reported that the country recorded a CAD of USD 17.406 billion in FY22 compared to a gap of just USD 2.82 billion in FY21.
According to Dawn newspaper, the massive CAD speaks a lot about the severe problem of the balance of payments. The deficit of over USD 17.4 billion is more troubling in the wake of no inflows as loans while the commercial markets are not ready to accept Pakistan's bonds due to higher risks.
The current account deficit has exceeded the SBP's projection for the deficit in FY22. The CAD increased to 4.6 per cent of GDP in FY22, up from 0.8 pc in FY21. In November 2021, the SBP issued its Annual Report and said the current account deficit is projected in the range of 2pc to 3pc of GDP during FY22.
Reports appearing in local and foreign media suggest that Pakistan can't unlock the dollar inflows until the International Monetary Fund executive board approves its staff-level agreement reached on July 15.
Finance Minister Miftah Ismail has been hinting at an early deal with the IMF, but with the passage of time, the trust deficit is rising; the currency market reflects the trust deficit by depreciating the local currency on a day-to-day basis.
The CAD in June FY22 was much higher than in May as it rose to USD 2.275 billion in June compared to USD 1.430 billion in May. The CAD in June FY21 was USD 1.637 billion.
''A surge in oil imports saw CAD rise to USD 2.3 billion in June despite higher exports and remittances," the SBP tweeted on Wednesday. ''So far in July, oil imports are much lower and the deficit is expected to resume its moderating trajectory," it added.
The central bank said 3.3 million tonnes of oil were imported in June, a 33pc increase over May.
''Together with higher global prices, this more than doubled the oil import bill from USD 1.4 billion to USD 2.9 billion. By contrast, non-oil imports ticked down," said the SBP.
The higher oil import bill was held for a higher current account deficit in June, but the entire fiscal year noted a very high current account deficit as the second quarter noted the biggest deficit of USD 5.565 billion.
Further details showed that exports of goods in FY22 were USD 32.45 billion while service exports were USD 6.97 billion.
The imports of goods were USD 72.05 billion, while the imports of services were USD 12.14 billion. The balance of trade in goods and services showed a net deficit of USD 44.77 billion in FY22 compared to USD 31.15 billion a year ago.
The ongoing fiscal year will face a tough time with poor inflows and higher outflows while the economic growth rate will be half of the growth achieved in the previous fiscal year, the paper said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
|
https://www.devdiscourse.com/article/business/2125520-pakistans-current-account-deficit-increases-to-4-year-high-of-usd-174-bn-in-fy22
| 2022-07-28T13:35:59
|
en
| 0.964526
|
TAMPA, Fla., July 28, 2022 /PRNewswire/ -- Tampa, Florida, cabinet company has completed its expansion plans. The planned expansion to their Tampa headquarters and distribution center includes building out a new facility and doubling the number of employees.
Innovation Cabinetry, a luxury all-wood residential cabinetry distributor, is located just north of the Tampa International Airport, at 7030 Anderson Road, where it employs 34 people. The company recently planned and executed a new 128,000-square-foot manufacturing and warehouse facility near 9252 East Columbus Drive, Ste 300 east of state route 301.
The new property accommodates two expansions, manufacturing, and a warehouse facility for Innovation Cabinetry. "We've added leading-edge automated equipment, software, and most importantly, highly specialized staff to expand our product offering," states John Huang, President and CEO of Innovation Cabinetry, Tampa." MADE IN AMERICA" is our future. I feel very proud to have the opportunity to expand my business here in Florida. For me, manufacturing in the Tampa Bay area means greater control over our products' quality, costs, and timeframes." Feedback from their customers has been fantastic. The first product to roll off the lines is a revolutionary outdoor cabinet collection- Endura. This unique collection will expand their customer's business while encouraging everyone to live a healthier lifestyle outdoors."
The multi-million-dollar expansion has created jobs in accounting, engineering, training, purchasing, project management, and other roles.
"Innovation Cabinetry has been thriving in Tampa since we established a presence here in 2005," said Mr. Huang. "It made perfect sense for us to expand our headquarters in this location, where we have excellent access to the interstate and plenty of room to grow."
For additional information or images regarding INNOVATION CABINETRY or this release, call toll-free at 1-888-206-1088 and visit the INNOVATION CABINETRY website at www.innovationcabientry.com.
ABOUT US: Innovation Cabinetry is an innovative provider of residential cabinetry for interior and exterior use. Founded in 2005 and based in Tampa, Florida, Innovation Cabinetry is one of America's fastest growing and most successful cabinet companies.
The 17-year history of our company began with the passion for providing only the highest quality cabinets with an absolute commitment to our customers. Today our diverse product offering includes cabinetry solutions for virtually every indoor and outdoor application. Our research and development department and selected designers are continually developing and sourcing new products for the ever-changing cabinetry market. We attribute our success not only to new innovative cabinetry products but to the strong relationships we have forged in the cabinet industry. Therefore, Innovation Cabinetry is a quality you can trust, a luxury you can afford.
View original content to download multimedia:
SOURCE Innovation Cabinetry
|
https://www.wlbt.com/prnewswire/2022/07/28/innovation-cabinetry-expands-doubling-workforce-tampa-bay-area/
| 2022-07-28T13:36:00
|
en
| 0.941737
|
If you spot news anchor Chris Cuomo buying Mega-Millions today, there’s an obvious reason — Cuomo will be making a lot less money than he used to make. Getting fired from CNN turned out to be very expensive.
According to the New York Post, Cuomo’s new anchor job with NewsNation, a new cable news network, will pay him $1 million per year.
That’s $5 million less than the $6 million per year that he was being paid by CNN. Cuomo is still probably in the 1 percent of the nation’s richest people, but has fallen to the bottom half.
Cuomo got dismissed from CNN earlier this year when he was accused of using his position as news anchor to help his brother — former New York Governor Andrew Cuomo — fight off sexual harassment claims. Cuomo denies those charges, but his reputation is like a tattoo — hard to get rid of.
So he was able to find a job, but on a new network where the payroll is much lower. And he was probably lucky to get that job.
It could be worse, at least Cuomo isn’t getting paid per viewer — he’d be making even less money.
It was an erroneous report Tuesday, but it became reality Wednesday — Tony Dow, who played Wally Cleaver, big brother to the Beaver, died at the age of 77.
When the story broke Tuesday, the Internet jumped on it. Hours later, Dow’s family refuted the story and it had to be corrected. One day later, however, Dow’s son confirmed what generations of TV viewers had feared — that Dow had died.
This story touched a lot of people because of the show’s longevity. “Leave it to Beaver” debuted in 1958 and has been on the air — in first run episodes and in syndication — for 65 years.
And because the show is timeless — just as relevant today as it was in 1958 — viewers had a connection with it. And they had a connection with Dow.
You can’t mention Tony Dow without mentioning that he starred on “Leave it to Beaver.” That’s how good he was playing the role.
It was impossible to watch television during 2020 without seeing Dr. Anthony Fauci at least once a day.
He was the news source for millions of viewers on COVID-19, telling Americans what they needed to do to stay safe.
He was criticized by some, but he was praised by many for his serious approach to a serious problem. He was also very accessible — Dr. Fauci was everywhere.
Next year he’ll be on PBS. The network announced that Fauci will be featured on an episode of “American Masters” titled “Tony — A Year in the Life of Dr. Anthony Fauci.”
Actually, it will be more than one year. Cameras followed Dr. Fauci for 14 months, starting in Jan. 2021, about 10 months after the pandemic hijacked America.
Fauci has had a 50-year career working in public health. This is just a small chunk of it. But it’s an important chunk of it.
John Sterling has been the radio voice of the New York Yankees since 1989, but he recently cut back on his schedule because, at the age of 84, he no longer likes to travel.
So the question floating around Yankee Stadium has been: Who will be the next John Sterling?
The front-runner is more well-known to hockey fans than baseball fans. Brendan Burke, the TV voice of the New York Islanders, is the favorite to take over from Sterling, according to a story in the New York Post.
Burke has filled in for Sterling this season, but it’s tough being a baseball broadcaster — you have to work at a high level for 162 games. And you have to be a great storyteller.
At 38, Burke may lack experience, but he has the enthusiasm. And that’s what you need to handle a long baseball season.
Matt Buckler is television and radio editor of the Journal Inquirer.
Follow Matt Buckler for more television, radio, and sports coverage on the JI's Twitter @journalinquirer, and see his articles on the Journal Inquirer Facebook page.
|
https://www.journalinquirer.com/living/bucklers_airtime/report-chris-cuomo-takes-a-huge-cut-in-pay/article_8c96f61e-0e6b-11ed-8cb1-3b21b15ce4c6.html
| 2022-07-28T13:36:02
|
en
| 0.98316
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40207100
| 2022-07-28T13:36:04
|
en
| 0.738227
|
– New Social Component Empowers Learners To Ask and Answer Questions In Dedicated Learning Community –
ATLANTA, July 28, 2022 /PRNewswire/ -- Intellum, the leader in EdTech for Business, today announced Community, the third component in the Intellum social learning suite and the first in-platform community experience built specifically for corporate education initiatives.
Intellum offers all of the features and functionality associated with an LMS and an LXP and is the only education solution to include content authoring, live event management, and social learning in a single platform. The introduction of Community rounds out Intellum's social learning suite, which also includes group activity streams and both one-to-one and group chat to help organizations engage and educate users through social learning.
Social learning research shows that employees learn largely through observing and imitating the behavior modeled by experienced and successful co-workers and peers. Intellum's new Community offering provides learners with a dedicated space to search for answers, identify experts, and demonstrate their own expertise by asking and responding to questions and voting on the answers associated with concepts and topics of interest.
This empowers learners to do two distinct things: quickly and easily find "just-in-time" answers to pressing questions and author "user-generated content" that is meaningful and increases the learner's visibility among her/his peers.
Because Community lives within the Intellum Platform as part of the broader social experience, administrators can easily embed communities directly into learning initiatives, encouraging users to present questions to a specific group of peers while consuming the curriculum. This presents a compelling reason for learners to stay engaged and to come back to the learning environment more frequently.
"We have been helping clients drive significant learner engagement for years by allowing users to comment on learning content and support each other through cohort-focused activity streams and group chat experiences. But over time we recognized that something was missing," said Chip Ramsey, CEO of Intellum. "Social experiences can be fleeting. Clients need to capture their learners' questions and answers in a way that provides long-term value to the education initiative, so we decided to build our own Q&A community into the platform. By integrating formalized curriculum, informal learning, live events and social learning, we make the whole much more valuable than the pieces."
Intellum has a rich history of facilitating social learning. In 2009, the company created Tribe Social (now known as Intellum Social), the first social collaboration tool purpose-built for education. Intellum Social has evolved to include three core social learning components:
- Groups are modern vertical activity streams that encourage learners to share links, videos, images, files, and polls to kickstart conversation, collaboration, and engagement with educational content.
- Chat allows users to engage in 1:1 or group chats and can be embedded into any experience on the platform, including live events like instructor-led training and Webinars to drive real-time user engagement.
- Community gives learners a dedicated space to search for answers, identify experts, and demonstrate their own expertise by asking and responding to questions and voting on the answers associated with concepts and topics they are interested in.
When utilized together, the three components in the Intellum Social suite provide organizations with everything needed to introduce, improve and capitalize on the science of social learning.
Community is available now, and included within the Intellum Social module. For more information, visit: www.intellum.com/platform/extensions
Intellum provides the #1 customer, partner, and employee education platform that large brands and fast-moving companies rely on to engage audiences and improve product knowledge, utilization, retention, and revenue. Intellum's scientific, data-driven approach is based on 20+ years of industry experience and the Intellum Platform includes all of the tools an organization needs to create, deploy, manage, track, and continuously improve highly personalized, engaging educational experiences. To learn more, visit Intellum.com.
View original content to download multimedia:
SOURCE Intellum, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/intellum-unveils-community-third-experience-platforms-complete-social-learning-suite/
| 2022-07-28T13:36:07
|
en
| 0.940341
|
UK's biggest container port Felixstowe faces disruption as staff vote to strike
Staff at Britain's largest container port, Felixstowe, have voted in favour of strike action in a dispute over pay, the Unite union said on Thursday, warning of huge disruption across the supply chain. The dockworkers join a growing wave of employees, in a range of sectors from rail to telecoms, resorting to industrial action as pay rises fail to keep pace with inflation which is expected to hit double digits in Britain by the end of the year.
- Country:
- United Kingdom
Staff at Britain's largest container port, Felixstowe, have voted in favour of strike action in a dispute over pay, the Unite union said on Thursday, warning of huge disruption across the supply chain.
The dockworkers join a growing wave of employees, in a range of sectors from rail to telecoms, resorting to industrial action as pay rises fail to keep pace with inflation which is expected to hit double digits in Britain by the end of the year. Unite said workers at Felixstowe Docks, which is operated by Hutchison Ports, had been offered a pay increase of 5%. Hutchison did not immediately respond to a request for comment.
"Strike action would bring Felixstowe to a standstill and would cause major logistical problems for maritime and road haulage transport entering the port," Unite said in a statement. Unite's regional officer Miles Hubbard said the industrial action would "inevitably create huge disruption across the UK's supply chain".
The union did not give specific dates for the strike action, which will take place next month and was supported by 92% of workers who voted. Earlier this month Unite said it was also balloting hundreds of dockworkers in Liverpool for possible strike action.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Report: Mistakes, not Liverpool fans, caused CL final fiasco
Soccer-Liverpool defender Williams seals loan switch to Blackpool
Soccer-Rangers sign defender Ben Davies from Liverpool
Soccer-Liverpool's Alisson recovering but will miss Salzburg friendly -Klopp
Olympics-Britain should launch bid with Liverpool and Manchester says campaigner
|
https://www.devdiscourse.com/article/business/2125521-uks-biggest-container-port-felixstowe-faces-disruption-as-staff-vote-to-strike
| 2022-07-28T13:36:07
|
en
| 0.955494
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40207162
| 2022-07-28T13:36:10
|
en
| 0.738227
|
ATLANTA, July 28, 2022 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset management firm, today announced the final close of Invesco Credit Partners Fund II (the "Fund"), a global distressed credit and special situations fund. The Fund is managed by Invesco Senior Secured Management ("ISSM"), an indirect subsidiary of Invesco Ltd.
The Fund held its final closing on June 30, 2022, with $644 million from committed fund capital and co-investment vehicles, exceeding the original fundraising target. Capital was raised from a global institutional investor base across North America, Europe/Middle East and Asia Pacific (including Australia). Limited partners include public and private pensions, insurance companies, endowments and foundations, asset managers and family offices.
The Fund focuses on distressed credit and special situations opportunities in developed global markets. The strategy primarily targets small capitalization companies where markets are generally less efficient and capital deployment tends to be less cycle dependent. The distressed team leverages ISSM's broader private credit platform and its extensive resources, relationships and infrastructure as a competitive differentiator. The investment strategy, led by Paul Triggiani, Head of Distressed Credit and Special Situations for Invesco, has a dedicated team of investors all with extensive experience in distressed investing, special situations and private equity.
"Our primary focus is on small capitalization companies where we can target both inefficiencies as well as asymmetric returns while seeking to limit downside risk through a focus on senior positions in capital structures," said Triggiani. "Today's market environment continues to provide a robust pipeline of opportunities both in the U.S. as well as in Europe."
Invesco Ltd. (Ticker NYSE: IVZ) is a global independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. Our distinctive investment teams deliver a comprehensive range of active, passive and alternative investment capabilities. With offices in more than 20 countries, Invesco managed US $1.4 trillion in assets on behalf of clients worldwide as of June 30, 2022. For more information, visit www.invesco.com/corporate.
ISSM is a fully integrated, global private credit platform with capabilities across broadly syndicated loans/CLO, direct lending, and distressed credit and special situations. ISSM managed over US $40 billion in assets under management as of June 30, 2022.
Contact: Beverly Khoo, 332-323-8029, Beverly.Khoo@invesco.com
View original content to download multimedia:
SOURCE Invesco Ltd.
|
https://www.wlbt.com/prnewswire/2022/07/28/invesco-announces-final-close-invesco-credit-partners-fund-ii/
| 2022-07-28T13:36:14
|
en
| 0.945058
|
Anti-abortion advocates, emboldened by the recent reversal of Roe v. Wade, are setting their sights on what they say is a first step in placing restrictions on Connecticut’s abortion rights: requiring minors to notify their parents when seeking an abortion.
The advocates are calling on lawmakers to draft a bill in the coming legislative session, which begins in January, that would mandate people under 16 to notify their parents prior to getting an abortion.
Though such a proposal has failed in the past, leaders of anti-abortion organizations see new momentum in the wake of the June Supreme Court ruling abolishing the 49-year-old law that guaranteed the right to an abortion nationally. Abortion remains legal in Connecticut because of legislation passed in 1990 codifying Roe v. Wade into state statute.
“There’s a massive mental and almost metaphysical shift involved in the overturning of Roe v. Wade that’s going to affect us, even in a blue state like Connecticut,” said Peter Wolfgang, executive director of the Family Institute of Connecticut. “No one can claim anymore that there is a right in the United States Constitution to abortion.
“The law is a teacher that’s going to eventually work on people’s minds and their spirits. Over time, I think, they’re going to be more open to the idea that abortion is not some sort of sacrosanct right in the U.S. Constitution but that abortion is a political issue like other political issues.”
Wolfgang and others say their ultimate goal is to repeal the 1990 law legalizing abortion in Connecticut, but they acknowledge the effort could take years or even decades in a liberal state. Democrats maintain strong majorities in the House and Senate, though the legislature is seeing a wave of departures as the fall election approaches.
For now, anti-abortion advocates are pressing for a bill on parental notification. Wolfgang said the requirement would facilitate “parental guidance for such a difficult decision” and would help curb the sexual exploitation of minors. He pointed to the case of Adam Gault, a former dog trainer in West Hartford who was convicted in 2008 of kidnapping and sexually assaulting a teenage girl. The girl’s lawyer said Gault raped and impregnated her, then forced her to have an abortion.
“In Connecticut, you need parental permission to get a body piercing or to go to the suntan parlor. But you can get an abortion without your parents even knowing about it,” Wolfgang said.
“We believe in the sanctity of life, and we also believe in the cohesion, the importance of protecting families,” said Chris Healy, executive director of the Connecticut Catholic Conference. “One way that happens is you instill parental responsibilities and rights in parents to manage and supervise and work with their children to bring them into adulthood.”
Bill O’Brien, vice president of Connecticut Right to Life, hopes more candidates with anti-abortion views will win seats in the General Assembly this fall.
Parental notification “has been tried several times in the past and hasn’t gotten too much traction,” he said. “But, of course, we will have a new legislature next year. We’ll see what happens. We’d like to push it.”
O’Brien said some minors are pressured into having an abortion, and parental notification could bring about support.
“It could be the boyfriend pushing [an abortion], it could be the boyfriend’s parents pushing it because they don’t want him stuck with child support or something,” he said. “It could be a coach, it could be an employer, anybody that’s putting pressure on her. The parents should be aware of that and be able to give her support if she wants to carry that child.”
Thirty-six states require parental involvement in a minor’s decision to have an abortion, according to the Guttmacher Institute, a research organization that supports abortion rights. Nine states require parental notification (with one mandating the notification of both parents), 21 require the consent of a parent (with three mandating the consent of both parents), and six require both consent and notification.
The laws vary by state. Some states require identification for parental consent. Others ask for proof of parenthood. Most of the 35 states with these laws allow for judicial bypass, which permits a minor to obtain approval from a court. Some states provide exceptions under certain circumstances, such as a medical emergency, rape or incest.
Leaders of abortion-rights groups oppose these restrictions.
In a post on its website, the American Civil Liberties Union noted that, “most teens who do not involve a parent have very good reasons for not doing so.”
“Many come from families where such an announcement would only exacerbate an already volatile or dysfunctional family situation,” officials from the organization wrote. “Experience shows that teens’ fears are well-founded. For example, one of the very first teens who was forced to notify a parent under Colorado’s parental notice law was kicked out of her home when her mother learned of the pregnancy. Her mother took the money the teen had saved for the abortion and threatened to disown her if she went through with the procedure. When the teen called the clinic to reschedule her appointment, she was living in a friend’s car.
“Far from strengthening her family and helping her make an informed decision, the law ruined her relationship with her mother and left her homeless with an unwanted pregnancy.”
Advocates for Youth, an organization that advocates for abortion and contraception access, reproductive justice and LGBTQ rights and health, among other issues, noted that parental involvement laws disproportionately affect minors from immigrant families.
“[Some] states require parents and youth to provide government-issued identification either at the provider or to obtain notarized consent documentation,” officials wrote on their website. “This poses a barrier to immigrant youth with undocumented parents who fear immigration enforcement as well as to youth who are unaccompanied or whose parents have been detained or deported.”
Other states “require proof of parenthood in the form of a birth certificate to provide parental consent, posing another barrier,” they wrote.
And though judicial bypass is available in most states, many minors are unaware of it or do not understand how to get it, or they may not have the transportation necessary to get to court, the group noted.
“Parental involvement mandates may risk more harm to young people by delaying their medical care,” said Gretchen Raffa, vice president of public policy, advocacy and organizing with Planned Parenthood Votes! Connecticut. “The idea that forcing family communication will help young people – it actually could do the opposite and cause delays to them receiving time-sensitive care that they need.
“From the logistical burdens to the emotional stress, these types of parental involvement laws do the opposite of what advocates for parental involvement actually want them to do.”
Liz Gustafson, state director of NARAL Pro-Choice Connecticut, said some minors won’t pursue needed services if they are forced to involve a parent.
“Ideally, a young person who faces an unintended pregnancy can seek the advice of a parent in their lives,” she said. “The majority of young people do, in fact, tell a parent about an unplanned pregnancy. But if for whatever reason a young person cannot go to a parent, they should be able to turn to a trusted adult and get the health care and information they need.”
Connecticut’s law requires counseling for minors seeking an abortion, including a suggestion that they consult with a parent or family member.
Legislative leaders say despite the demise of Roe v. Wade, it’s unlikely that abortion restrictions such as parental notification would succeed in Connecticut.
“I don’t foresee the bill getting out of a committee, or maybe not even coming to a vote in the committee, unless it’s offered as an amendment,” said Senate President Pro Tem Martin Looney, a Democrat from New Haven. “I don’t see it making any headway.”
“As Speaker of the House, no bill could be called without my consent,” said House Speaker Matthew Ritter, D-Hartford. “Would I call that bill? No.
“Not everybody is in a situation where they are able to, because of circumstances, have that relationship or approach their parents. I have always said it’s a woman’s choice, period. And so I would not look to amend the laws we have on the books at all.”
Even so, advocates on both sides of the issue are looking ahead to the election and how it could shift momentum in one direction or the other. Bob Stefanowski, a Republican from Madison who is challenging Gov. Ned Lamont, has pledged support for a parental notification law.
“Consistent with the majority of other states, Connecticut should consider a parental notification requirement for minors under 16 seeking an abortion, except in the case of rape or incest,” Stefanowski has said.
Lamont, a Democrat, is opposed. “My instinct is that 98% of people, younger people, talk to their parents if they feel comfortable, they feel like it’s safe, it’s the right thing to do,” he has said.
Abortion-rights advocates say they’re hoping not to lose ground in November. More than 30 seats in the state legislature are expected to be open this fall.
“Abortion is definitely on the ballot this election,” Raffa said. “It’s more important than ever to get people elected in those open seats … who are going to prioritize comprehensive reproductive health care and protecting and expanding access to abortion, and fight back against anti-abortion politicians who are trying to roll back our rights.”
|
https://www.journalinquirer.com/politics_and_government/ct-anti-abortion-advocates-press-for-parental-notification-legislation/article_32e6556e-0e6c-11ed-9e22-e3139594fa35.html
| 2022-07-28T13:36:16
|
en
| 0.965226
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40207239
| 2022-07-28T13:36:16
|
en
| 0.738227
|
Bajaj Finance shares continue to rally; jump nearly 11 pc
- Country:
- India
Shares of Bajaj Finance continued to rally on Thursday, climbing nearly 11 percent after the company reported its highest-ever consolidated quarterly net profit for the June quarter.
The stock jumped 10.68 percent to settle at Rs 7,076.30 apiece on the BSE. During the day, it zoomed 11.15 percent to Rs 7,107.
On the NSE, it rallied 10.46 percent to Rs 7,065.50 apiece.
The stock was the biggest winner on both the BSE Sensex and NSE Nifty.
The 30-share BSE benchmark ended 1,041.47 points or 1.87 percent higher at 56,857.79 and the Nifty advanced 287.80 points or 1.73 percent to 16,929.60.
In two days, the company's market valuation has rallied by Rs 49,430.89 crore to Rs 4,28,419.89 crore on the BSE.
On Wednesday, shares of Bajaj Finance rose over 2 percent after the earnings announcement.
Bajaj Finance on Wednesday reported its highest-ever consolidated quarterly net profit at Rs 2,596 crore for the June quarter, helped by robust income.
The company had reported a net profit of Rs 1,002 crore in the year-ago period.
Total income rose 38 percent to Rs 9,283 crore during the quarter as against Rs 6,743 crore in the corresponding period last year.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Nifty
- Bajaj Finance
|
https://www.devdiscourse.com/article/business/2125529-bajaj-finance-shares-continue-to-rally-jump-nearly-11-pc
| 2022-07-28T13:36:17
|
en
| 0.948311
|
Smith.ai, the legal industry's leader in virtual receptionist services, will help Filevine customers accelerate business growth and free up time with dependable call, chat and messaging support
SALT LAKE CITY, July 28, 2022 /PRNewswire/ -- Filevine, a leading legal work platform, today announced a new partnership with Smith.ai, a leading 24/7 customer engagement platform known for its bilingual virtual receptionist and intake services. Filevine will refer customers to Smith.ai and transition users of Ringbird, Filevine's in-house receptionist service, to Smith.ai as well. The partnership with Smith.ai and sunsetting of Ringbird enable Filevine to offer the industry's best virtual receptionist service to its clients while focusing its resources on product innovation and customer success.
"Filevine strives to offer the tools that legal teams need to thrive in their industry," said Ryan Anderson, CEO of Filevine. "As Filevine grows and evolves, we want to invest in differentiating our core technology while partnering with providers who are the best in their respective fields. Smith.ai is the top virtual receptionist service and can scale with Filevine as we and our customers grow."
Founded in 2015 in Palo Alto, CA, Smith.ai operates a remote team of highly skilled agents across North America. Founders Aaron Lee and Justin Maxwell leveraged their superlative leadership experiences at The Home Depot, Apple and Google to develop a smarter, more effective and technology-centered solution for small businesses to engage leads and clients — without sacrificing the human touch.
Thanks to answering, intake and scheduling support from Smith.ai's live agents and artificial intelligence (AI), law firm owners and staff experience more time for productive work, with the peace of mind that new and existing customers are never kept waiting. Smith.ai has helped to boost revenue and free up time for billable work for thousands of law firms including Colorado Lawyer Team, whose CEO, Justie Nicol, credits Smith.ai as her "secret to business growth and client happiness."
Smith.ai integrates with Filevine, ensuring that calls are automatically logged in the platform. Virtual receptionists cover inbound and outbound communication over phone, chat and SMS, and can perform appointment scheduling, lead screening, client intake and more.
"Over many years, Smith.ai has had the privilege to serve top law firms including numerous Filevine customers. We understand the level of professionalism required in the legal industry and go above and beyond to achieve it," said Jon Diller, Chief Services Officer at Smith.ai. "We're excited to begin this partnership with Filevine and look forward to serving its customers."
About Filevine
Filevine is changing the way legal work gets done for law practitioners and their clients. As the leading legal work platform, Filevine is dedicated to empowering all organizations with tools to simplify and elevate complex, high-stakes legal work. Powering everything from document management and client communication to legal drafting and deadline and task management, over 25,000 legal professionals use Filevine daily to deliver excellence in every contract, deadline, and result. Filevine is the top legal software company on the Inc. 5000 list, has been named one of the Utah Business Fast 50 and is among the top 50 fastest-growing privately-owned software companies according to the 2021 Inc. 5000 list.
About Smith.ai
Smith.ai is a superior customer engagement service for small to medium-sized businesses, many of which are law firms and other service-based operations. Our live, North America-based receptionists answer calls, texts, and website chats; engage leads through sales outreach campaigns; qualify and intake new clients; book appointments; and accept payments. Through a combination of exceptional human talent and AI technology, Smith.ai works seamlessly with in-house teams to dramatically improve responsiveness, client happiness, productivity, and marketing results, 24/7. To learn more, visit https://smith.ai.
Media
aharris@nextpr.com
Filevine
Justin Witt
justinwitt@filevine.com
(801) 657-5228
https://filevine.com
Smith.ai
Maddy Martin
maddy@smith.ai
(650) 727-5598
https://smith.ai
View original content to download multimedia:
SOURCE Filevine
|
https://www.wlbt.com/prnewswire/2022/07/28/legal-platform-filevine-selects-smithai-preferred-partner-247-call-answering-intake-services/
| 2022-07-28T13:36:20
|
en
| 0.930482
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40207442
| 2022-07-28T13:36:23
|
en
| 0.738227
|
TVS Motor reports net profit of Rs 297 cr for Apr-Jun qtr
- Country:
- India
TVS Motor Company on Thursday said its consolidated net profit stood at Rs 297 crore for the first quarter that ended June 30.
It had reported a net loss of Rs 15 crore in the COVID-19 hit April-June quarter of the last fiscal.
The maker of two and three-wheelers reported a total income of Rs 7,348 crore in the first quarter. It was Rs 4,692 crore a year ago.
On a standalone basis, the company reported a net profit of Rs 321 crore while the same stood at Rs 53 crore in the year-ago period.
The first quarter numbers were not strictly comparable with the first quarter of last year due to lockdowns, the company stated.
It noted that the overall two and three-wheeler sales, including exports, rose to 9.07 lakh units in the quarter ended June 2022 against 6.58 lakh units registered in the quarter ended June 2021.
The motorcycle sales rose to 4.34 lakh units in the June quarter compared to 4.05 lakh units in the year-ago period.
Similarly, scooter sales for the June 2022 quarter rose to 3.06 lakh units against 1.38 lakh units in the year-ago period.
TVS said it recorded the highest two-wheeler exports of 2.96 lakh units in the first quarter compared to 2.9 lakh units a year ago.
The company's board approved the issue of non-convertible debentures (NCDs) aggregating to Rs 125 crore on a private placement basis, it added.
Shares of the company closed 2.35 percent up at Rs 869.20 apiece on the BSE.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- TVS Motor Company
- lakh
|
https://www.devdiscourse.com/article/business/2125533-tvs-motor-reports-net-profit-of-rs-297-cr-for-apr-jun-qtr
| 2022-07-28T13:36:25
|
en
| 0.954411
|
Nonprofit Aims to Grant 100 Wishes Each Day During Peak Summer Season
PHOENIX, July 28, 2022 /PRNewswire/ -- From July 1 to Aug. 31, Make-A-Wish has a goal to grant 100 wishes each day with help from its "Summer of Wishes FUNdraising Challenge." The challenge encourages online streamers and content creators to join the growing list of celebrities who have rallied their online followings in support of Make-A-Wish. Influencers who are interested in participating can set up a fundraising page through Tiltify to help grant life-changing wishes for children with critical illnesses during the organization's busiest wish granting season.
Although summer is a time for rest and relaxation for many, wish kids and their families continue to fight against their critical illnesses, taking an exhausting and traumatic toll. A wish helps entire families find relief from that traumatic stress and experience transformative joy. In fact, in a recent study, 9 out of 10 wish alumni say their wish made them feel more joyful, confident and hopeful for the future, while the same number of wish parents say their child's emotional well-being improved with a wish.
Participants in the "Summer of Wishes FUNdraising Challenge" can either donate directly to Make-A-Wish or host their own virtual fundraiser, allowing them to invite friends, family and followers to make financial donations. Either way, these efforts will make a huge splash in the lives of children with critical illnesses, their families, and everyone involved in granting their wish. Participants will join the growing community of renowned content creators and supporters who have hosted virtual fundraisers and livestreams in support of Make-A-Wish in the past.
Make-A-Wish plans every wish with one goal: to transform the life of a child with a critical illness. Care and attention are given to every detail, and each donation supports wish-granting needs and empowers the kids Make-A-Wish serves, bringing them hope for today – and tomorrow.
For more information about Make-A-Wish and to join the "Summer of Wishes FUNdraising Challenge," visit wish.org/summerofwishes.
About Make-A-Wish
Make-A-Wish creates life-changing wishes for children with critical illnesses. Headquartered in Phoenix, Arizona, Make-A-Wish is the world's leading children's wish-granting organization, operating in every community in the United States and in nearly 50 countries worldwide. Together with generous donors, supporters, staff and more than 24,000 volunteers across the U.S., Make-A-Wish delivers hope and joy to children and their families when they need it most. Make-A-Wish aims to bring the power of wishing to every child with a critical illness because wish experiences can help improve emotional and physical health. Since 1980, Make-A-Wish has granted more than 520,000 wishes worldwide; more than 350,000 wishes in the U.S. and its territories alone. For more information about Make-A-Wish America, visit wish.org.
View original content to download multimedia:
SOURCE Make-A-Wish Foundation of America
|
https://www.wlbt.com/prnewswire/2022/07/28/make-a-wish-launches-summer-wishes-fundraising-challenge-aimed-online-streamers-content-creators/
| 2022-07-28T13:36:27
|
en
| 0.933588
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nfl/cincinnati-bengals/articles/40207705
| 2022-07-28T13:36:29
|
en
| 0.738227
|
Indian Navy takes delivery of Indigenous Aircraft Carrier 'Vikrant'
- Country:
- India
The Indian Navy on Thursday took delivery of the country's first indigenously built aircraft carrier 'Vikrant' from its manufacturer, Cochin Shipyard Ltd, ahead of its scheduled commissioning next month.
The aircraft carrier, built at a cost of around Rs 20,000 crore, successfully completed the fourth and final phase of sea trials three weeks back.
With the delivery of 'Vikrant', India has joined a select group of nations having the niche capability to indigenously design and build an aircraft carrier.
The Indian Navy described the delivery of the Indigenous Aircraft Carrier (IAC) as ''historic'' as it coincides with the celebrations to commemorate the 75th anniversary of India's independence.
The warship is set to operate MiG-29K fighter jets, Kamov-31 helicopters and MH-60R multi-role helicopters.
It has over 2,300 compartments, designed for a crew of around 1700 people, including specialised cabins to accommodate women officers.
Vikrant has a top speed of around 28 knots and a cruising speed of 18 knots with an endurance of about 7,500 nautical miles.
The IAC is 262 metres long, 62 metres wide and it has a height of 59 metres. Its construction began in 2009.
''Indian Navy has created maritime history today by taking delivery of the prestigious IAC Vikrant from her builder Cochin Shipyard Limited (CSL),'' the Navy said in a statement.
It said the ship is powered by four gas turbines totalling 88 MW power and has a maximum speed of 28 Knots. The IAC project has been implemented under the three phases of contract between the ministry of defence and Cochin Shipyard Ltd, beginning May 2007. The ship's keel was laid in February 2009.
''With an overall indigenous content of 76 per cent, the IAC is a perfect example of the nation's quest for 'Aatma Nirbhar Bharat' (self-reliant India) and provides thrust to government's 'Make in India' initiative,'' the navy said. ''The ship would be capable of operating air wing consisting of 30 aircraft comprising of MIG-29K fighter jets, Kamov-31, MH-60R multi-role helicopters, in addition to indigenously manufactured Advanced Light Helicopters (ALH) and Light Combat Aircraft (LCA) (Navy),'' it said.
The Navy said the aircraft carrier would soon be commissioned into the force and it would bolster India's position in the Indian Ocean Region (IOR) and its quest for a blue water Navy.
The aircraft carrier is likely to be commissioned on August 15.
''Vikrant has been built with a high degree of automation for machinery operation, ship navigation and survivability, and has been designed to accommodate an assortment of fixed wing and rotary aircraft,'' the Navy said. PTI MPB TIR TIR
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
|
https://www.devdiscourse.com/article/business/2125535-indian-navy-takes-delivery-of-indigenous-aircraft-carrier-vikrant
| 2022-07-28T13:36:33
|
en
| 0.962858
|
Procure-to-Pay Veteran, Mary Flynn Barton joins as SVP of NA Sales to fuel growth following Medius's OnPay Solutions acquisition earlier this year
STOCKHOLM, July 28, 2022 /PRNewswire/ -- Medius, a leading provider of AP Automation and wider spend management solutions, announces the appointment of a new Senior Vice President for its sales function across North America.
Based in Alabama, Mary Flynn Barton is an award-winning and top revenue-generating technology sales leader and spend management expert. Mary joins the company to build the sales teams and help develop a deep understanding of the Medius customer journey.
Mary joins Medius from iDonate, where she was the CRO responsible for all sales, marketing, and customer success functions. Prior to that, she spent a decade at Coupa in various positions throughout the company and ultimately became the sales lead for its North Central Region.
Mary graduated from Loyola University in New Orleans and has lived throughout the US in New Orleans, Austin, San Francisco, Dallas, and Minneapolis and is now proud to call Daphne, Alabama home.
Mary joins Medius as the company invests in its US operations. Earlier in 2022, Medius acquired US-based OnPay Solutions with the acquisition acting as a driving force for the SaaS leader to grow its sales and channel sales functions to improve the end-to-end invoice-to-pay processes for its customers. Furthermore, Mary's appointment is the latest in a series of senior leadership hires at Medius, most recently including Tanya Wills as VP of Channel Sales and Alliances.
Mary Flynn Barton, SVP of Sales North America, comments: "It's an exciting time to be working in SaaS and fintech. AP is a critical function where businesses can quickly improve control, reduce risk, drive efficiency, and reduce costs. In uncertain economic times, AP Automation is an area of digital transformation that pays dividends back to companies. I'm looking forward to bringing my experience to Medius as we're investing for significant growth in North America."
Jim Lucier, CEO of Medius, comments: "Mary has amazing experience in the SaaS Procure-to-Pay space, and it's clear that she has a great passion for delivering value to customers, for leadership at all levels, and making her teams successful. She's an excellent professional and cultural fit for us at Medius, and we are lucky to have her. As we continue our rapid growth in North America to transform the lives of financial teams, talent like this is incredibly valuable. I am excited to see the positive impact Mary has."
CONTACT:
For more information, please contact:
Dan Bird, Fight or Flight for Medius
Dan.Bird@fightflight.co.uk +44 7885 670798 / Medius@fightflight.co.uk +44 330 133 0985
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Medius
|
https://www.wlbt.com/prnewswire/2022/07/28/medius-continues-investment-us-with-appointment-new-senior-vice-president-sales/
| 2022-07-28T13:36:34
|
en
| 0.954744
|
The best-in-class membership software helps travel creators acclimate to the new travel media landscape.
SAN FRANCISCO, July 28, 2022 /PRNewswire/ -- Memberful, the leading membership software for independent entrepreneurs and creators, today announced that it is expanding further into the travel industry after a successful year-long partnership with El Camino Travel.
The travel industry for creators has been one-dimensional, dictated by brands and their campaign terms which require hours of a creator's time for one compensated post. For brands, this can lack authenticity and connection to the audience. For creators, it often results in being under-compensated due to the time required to create content. Creators in other industries have seen the acceleration of membership and subscription-based models, but travel has lagged.
Post pandemic, brands will favor creators with hyper-focused and creative content curated to a specific audience. As a result, creators have a unique opportunity to build a better business model where they can sustainably monetize their audience and take back their time. Memberful allows travel creators to establish a genuine connection with their audience and create a new business model that sustains their passion for travel.
"There is a symbiotic relationship between the travel industry and Memberful," says Tiffany Perko, Head of Marketing at Memberful. "The partnership with El Camino Travel has proven to us that membership is an important component of the travel creator landscape. Memberful is excited to continue to enable this at scale."
Memberful has taken hold of the travel industry as its subscription-based model begins to develop the future of travel. Katalina Mayorga, CEO of El Camino Travel, says, "We believe that members see the value in connecting with other similarly-valued individuals and that this aspect of membership will continue to grow. In addition, there is no limit to the kind of perks and benefits companies can offer their members."
The award-winning travel platform launched its ECT Clubhouse community during the pandemic, which led them to Memberful as a resource to manage its membership model. "Having the opportunity to connect with more of our travelers on a deeper level, with membership, has been invaluable," adds Mayorga.
The partnership with Memberful has also allowed El Camino Travel to utilize membership management functions like automatic subscriber tagging to send targeted emails directly to its community members to increase engagement.
As an online community, connection is a large part of the experience. With Memberful, El Camino Travel can make it easier and more enjoyable for travelers to connect before and after trips. A direct line of communication with the El Camino Travel team has been an additional benefit.
Founded in 2013, Memberful provides best-in-class membership software for entrepreneurs and independent content creators, including publishers, educators, podcasters, and more. Through Memberful, customers can quickly sell memberships to their audience and build sustainable businesses. For more information, visit www.memberful.com.
As an award-winning and leading travel platform for the bold woman traveler, El Camino Travel offers a one-stop digital shop of unparalleled community, travel resources, and small group trips that travelers cannot find anywhere else. Seamless access to its services and products empowers more women to travel confidently, directly tap into the niche cultures of a locale, and have the ungoogleable adventures that bring destinations to life through their most authentic lens. For more information, visit http://www.elcamino.travel/.
Media Contact:
Kymberlee Bolden
kymberlee@tribebuildermedia.com
929-367-8993
View original content:
SOURCE Memberful
|
https://www.wlbt.com/prnewswire/2022/07/28/memberful-expands-its-market-share-travel-industry/
| 2022-07-28T13:36:41
|
en
| 0.953982
|
China omits mention of GDP growth goal, aims for 'best possible' results instead
- Country:
- China
China will try hard to achieve the best possible results for the economy this year, state media said on Thursday after a high-level meeting of the ruling Communist Party, dropping previous calls that it will strive to meet its 2022 growth target. In the second half, China should "stabilize employment and prices, maintain economic operations within a reasonable range, and strive to achieve the best possible results," Xinhua news agency reported after the 25-member Politburo chaired by President Xi Jinping met to assess the economy.
The world's second-largest economy narrowly avoided contracting in the second quarter due to widespread COVID-19 lockdowns. Analysts said Beijing's full-year growth target of around 5.5% had been looking increasingly unattainable. China last missed its growth target in 2015. The first-half gross domestic product grew only 2.5% from a year earlier, pointing to huge pressure in the second half, amid fears of a global recession, uncertainties from the Ukraine war, and worries of recurring COVID lockdowns.
After an April Politburo meeting, state media reported that China will "work hard to realize the annual economic and social development targets." On June 22, Xi, at the opening of a BRICS forum, said China would take more measures to achieve its annual economic goals while minimizing the impact of its COVID-19 prevention and control measures as much as possible.
But during an inspection tour in the central city of Wuhan on June 28, Xi said China will "strive to reach a relatively good level of economic development this year". Similarly, last week, Premier Li Keqiang said at the World Economic Forum China will "strive for relatively good results in economic development for the whole year".
Xinhua said on Thursday that large provinces must take lead in growing China's economy, and those in a position to achieve their economic goals should do so. "The upshot is that the Politburo meeting reinforces our view that stimulus will remain relatively restrained this year and that the economy will continue to operate well below potential over the coming quarters," said Julian Evans-Pritchard, senior China economist at Capital Economics.
Full-year GDP growth is expected to reach 4.0%, according to a Reuters poll of economists this month. To stabilize the economy, authorities have deepened tax credit rebates, accelerated local government special bond issuances to buoy infrastructure investments, and lowered car purchase taxes.
The economic pressures coincide with a once-in-five-year Communist Party Congress this autumn, where Xi is expected to secure a precedent-breaking third leadership term. While much of the rest of the world has been trying to live with the virus, Xinhua reported after the Politburo meeting that China would stick to the "dynamic zero-COVID" policy.
"Persistence is victory," Xinhua said. STABILISING PROPERTY
With China's property market lurching from one crisis to another, developers being short on liquidity and laden with debt, and buyers launching nationwide mortgage boycotts, the country's top leaders vowed to stabilize the real estate and financial sectors. Local governments must ensure the delivery of property projects, should properly resolve risks of some rural banks, and crack down on financial crimes, Xinhua reported.
The property market poses huge risks to China's economy systematically, said Liu Ligang, Asia-Pacific head of economic analysis at Citi Global Wealth Management. "The Politburo asked local governments to ensure the delivery of houses, but if major property developers defaulted generally, I am afraid it is not a problem that local governments can resolve," Liu said.
"It may become a nationwide problem which will impact the country's financial system severely."
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Some Beijing travelers asked to wear COVID monitoring bracelets, sparking outcry
US military assistance irks Beijing amid its quest to dominate Taiwan
Shanghai, Beijing's Q2 economic output contracts - stats bureau
Chinese investment mushrooms in Pakistan, Beijing to set up transport plant in Sindh
China a mute spectator as Sri Lanka's political upheaval poses long-term implications for Beijing
|
https://www.devdiscourse.com/article/business/2125536-china-omits-mention-of-gdp-growth-goal-aims-for-best-possible-results-instead
| 2022-07-28T13:36:41
|
en
| 0.944707
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40206941
| 2022-07-28T13:36:44
|
en
| 0.738227
|
#1 Cloud ERP to help credit union expand and streamline operations as a part of its digital evolution
AUSTIN, Texas, July 28, 2022 /PRNewswire/ -- Meridian, Canada's second largest credit union and the largest in Ontario, has selected Oracle NetSuite to help modernize and streamline its business practices to better serve its Members. With NetSuite, Meridian will be able to take advantage of an efficient integrated financial system to support its growth and ongoing digital transformation.
Meridian has $28.5 billion in assets under management and offers a full range of banking products and services for saving, borrowing, investing, online and mobile banking, wealth management, and business banking to its 365,000 members with 90 branches in Ontario. To meet increasing demand from membership growth and support its expanding operations, Meridian is automating and modernizing its existing financial systems. After careful evaluation, Meridian selected NetSuite to establish a technology foundation that will support its current and future growth and selected Deloitte Canada, a NetSuite Alliance partner, as its consulting partner.
"NetSuite will give us the tools to navigate today's complexities by ensuring we can quickly and easily produce accurate and timely financial reports and budgets while maintaining effective controls," said Tara Daniel, Senior Vice President and Chief Financial Officer, Meridian Credit Union. "Moving to NetSuite and having one system to manage our business paves the way to complete digital transformation across our platforms."
With NetSuite, Meridian will be able to unify and manage its financial operations on a single cloud business system. NetSuite will help Meridian to streamline and accelerate month end financial reporting, increase transparency across its organization and drive efficiencies with the use of extensive financial reporting and budgeting tools that offer real-time analytics. By gaining a unified view into its business, Meridian will be equipped with the adaptability needed to meet changing member, customer and market demands.
"Meridian is looking to the future to help its members save money and anticipate roadblocks before they become an issue," Sam Levy, SVP of Sales, Oracle NetSuite. "With NetSuite, Meridian Credit Union and its employees will have everything they need, all in one place, so they can focus on what matters."
Oracle NetSuite
For more than 20 years, Oracle NetSuite has helped organizations grow, scale and adapt to change. NetSuite provides an integrated system that includes financials / Enterprise Resource Planning (ERP), inventory management, HR, professional services automation and omnichannel commerce, used by more than 31,000 customers in 217 countries and dependent territories.
Learn more at https://www.netsuite.com. Like us on Facebook, and follow us on LinkedIn, Instagram, and Twitter.
Trademarks
Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.
View original content to download multimedia:
SOURCE Oracle NetSuite
|
https://www.wlbt.com/prnewswire/2022/07/28/meridian-selects-netsuite-help-expand-streamline-operations/
| 2022-07-28T13:36:47
|
en
| 0.94302
|
Sri Lanka needs to begin debt restructuring talks with creditors before bailout package can be sanctioned: IMF
Sri Lanka owes China USD 6.5 billion in financing, including a credit bank swap and development bank loans, according to data from the Institute of International Finance Earlier this month, IMF Managing Director Kristalina Georgieva said it hopes to complete the negotiations with Sri Lanka on a bailout package as quickly as possible and the moment there is a government in the country.
- Country:
- Sri Lanka
Cash-strapped Sri Lanka must begin debt restructuring talks with its creditors, including China before it can hope of getting the bailout package sanctioned by the IMF, the Washington-based lender has said. The island nation of 22 million is in the midst of an unprecedented economic crisis that has led to severe shortages of fuel and other essentials. "Sri Lanka had a balance of payment crisis. The foreign exchange reserves ran dry and there was nothing they could use to pay for basic necessities and pharmaceuticals and energy," International Monetary Fund Chief Economist Pierre-Olivier Gourinchas said on Wednesday while responding to questions on Twitter Space. Gourinchas said the IMF is deeply concerned about the economic situation in Sri Lanka and is looking forward to working with the new government headed by President Ranil Wickremesinghe. ''Sri Lanka needs to reach a debt restructuring agreement with creditors, including China before an agreement can be reached between the IMF and the Sri Lankan Government,'' he explained. "We are deeply concerned about the impact the crisis is having, especially on poor and vulnerable groups. We have seen the reports. We have seen the difficulties they are facing," he added. Sri Lanka owes China USD 6.5 billion in the financing, including a credit bank swap and development bank loans, according to data from the Institute of International Finance Earlier this month, IMF Managing Director Kristalina Georgieva said it hopes to complete the negotiations with Sri Lanka on a bailout package ''as quickly as possible'' and the ''moment there is a government'' in the country. Last week, Sri Lanka's Parliament elected Ranil Wickremesinghe, an ally of Rajapaksa, as Gotabaya Rajapaksa's successor, who resigned after fleeing to Singapore.
Sri Lanka needs about USD 5 billion in the next six months to cover basic necessities for its 22 million people, who have been struggling with long queues, worsening shortages and power cuts. The country's inflation topped 50 per cent in June after two years of money printing and an attempted float botched with a surrender requirement, which sent the rupee sliding to 360 to the US dollar from 200.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
U.S. Treasury diplomat nominee aims to curb China's lending influence
China reports 338 new COVID cases for July 12 vs 424 a day
China's H1 yuan-denominated exports rose 13.2% y/y, imports up 4.8%
China's Wuhan reports one case of cholera
U.S. destroyer sails near disputed S.China Sea islands, China says it 'drove' ship away
|
https://www.devdiscourse.com/article/business/2125537-sri-lanka-needs-to-begin-debt-restructuring-talks-with-creditors-before-bailout-package-can-be-sanctioned-imf
| 2022-07-28T13:36:48
|
en
| 0.955028
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40207110
| 2022-07-28T13:36:50
|
en
| 0.738227
|
SHENZHEN, China, July 28, 2022 /PRNewswire/ -- Meten Holding Group Ltd. ("Meten Holding Group" or the "Company") (NASDAQ: METX), an omnichannel training company headquartered in China providing language and workplace training services and actively developing metaverse, blockchain and cryptocurrency mining businesses, today provided updates on its blockchain and digital currency business.
As previously disclosed in a press release in December 2021, Meten Holding Group established the joint venture, Met Chain Co., Limited ("Met Chain"), specializing in the research and development ("R&D"), production, and sales of cryptocurrency mining equipment. Since its formation, Met Chain has generated revenue of approximately US$4.86 million from sales of cryptocurrency mining equipment and providing cryptocurrency mining equipment sales services, despite the tumbled prices of cryptocurrencies. The Company expects to see an increase in the orders Met Chain receives and Met Chain is expected to generate revenue exceeding US$20 million by the end of 2022.
As previously disclosed in a press release in February 2022, the Company purchased 600 XP mining machines from Bitmain Technologies Ltd. with an aggregate computing power of approximately 100PH/s. Some of these mining machines have been delivered and put into operation.
As a part of the Company's strategy to develop its metaverse business, the Company has established an NFT department to focus on NFT-related investment, strategy, and projects. The Company is current proactively seeking potential collaborations with well-known IP providers.
Mr. Jason Zhao, Chairman of Meten Holding Group, commented, "We are excited to see these achievements in this challenging market and another approach to move toward our metaverse initiative. Although the cryptocurrency market suffered from difficult microeconomic factors and tightening monetary policies, the financial results of Met Chain reflected the Company's efforts and dedication to the cryptocurrency business and our resolution to transform into a metaverse technology company thoroughly. The establishment of the NFT department is significant and complementary to the transformation. Look forward, we will continue the development in our business and look forward to growing our business further in the long term."
About Meten Holding Group Ltd.
Meten Holding Group Ltd., formerly known as Meten EdtechX Education Group Ltd., is an omnichannel training company headquartered in China providing language and workplace training services. In addition to its training services, Meten Holding Group actively develops metaverse, blockchain and cryptocurrency mining businesses to align with its future business development strategy. Meten Holding Group is committed to developing blockchain related businesses in North America, including cryptocurrency mining, mining farm construction, and mining pool and data center operation. Meten Holding Group actively explores metaverse business, such as Metaverse vocational education courses, with its competitive advantages and technology.
For more information, please visit: https://investor.metenedu-edtechx.com.
Safe Harbor Statement
This announcement contains forward-looking statements that involve risks and uncertainties. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the future performance of Met Chain, the joint venture company; the future development of and the Company's ability to succeed in its new line of digital currency business; the continuing impact of the COVID-19 pandemic and the emergence of new variants; the Company's ability to attract students without a significant decrease in course fees; the Company's ability to continue to hire, train and retain qualified teachers; the Company's ability to maintain and enhance our brands; the Company's ability to effectively and efficiently manage the expansion of the Company's school network and successfully execute the Company's growth strategy; the outcome of ongoing, or any future, litigation or arbitration, including those relating to copyright and other intellectual property rights; competition in the English language training sector in China; changes in the Company's revenues and certain cost or expense items as a percentage of the Company's revenues; the expected growth of the Chinese English language training and private education market; Chinese governmental policies relating to private educational services and providers of such services; health epidemics and other outbreaks in China; and general economic conditions in China. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no duty to update such information, except as required under applicable law.
For investor and media inquiries, please contact:
Ascent Investor Relations LLC
Tina Xiao
+1 917-609-0333
tina.xiao@ascent-ir.com
View original content:
SOURCE Meten Holding Group Ltd.
|
https://www.wlbt.com/prnewswire/2022/07/28/meten-holding-group-ltd-provides-updates-its-blockchain-digital-currency-business/
| 2022-07-28T13:36:54
|
en
| 0.942886
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40207135
| 2022-07-28T13:36:56
|
en
| 0.738227
|
Dr Reddy's Laboratories Q1 net profit jumps 108 per cent to Rs 1,188 crore
Dr Reddy's Laboratories on Thursday reported a consolidated net profit of Rs 1,187.60 crore for the first quarter of the current financial year as compared to Rs 570.80 crore in the corresponding period of the last year, registering a year-on-year growth of 108 per cent.
- Country:
- India
Dr Reddy's Laboratories on Thursday reported a consolidated net profit of Rs 1,187.60 crore for the first quarter of the current financial year as compared to Rs 570.80 crore in the corresponding period of the last year, registering a year-on-year growth of 108 per cent. The company's revenue from operations rose by 6 per cent YoY to Rs 5,215.40 crore for the quarter ended June 30 as compared to Rs 4,919.40 crore recorded in the corresponding quarter last year.
Commenting on the results, Dr Reddy's Laboratories Co-Chairman and Managing Director G V Prasad said, "Our underlying business revenues adjusted for covid products contribution during last year have grown well. The profits were aided by a few non-recurring incomes, offsetting the near-term headwinds. We continue to improve the health of our core businesses through productivity improvement and robust product pipelines". Dr Reddy's Laboratories' EBITDA margin rose to 34.1 per cent during the April-June 2022 quarter from 20.7 per cent recorded in the corresponding period of the last year.
The company reduced its spending on Research & Development (R&D) during the quarter. During the first quarter of the current financial year, the company's spending on R&D fell to 8.3 per cent of revenues from 9.2 per cent in the corresponding period of the last year. (ANI)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Reddy
- Research & Development
- G V Prasad
|
https://www.devdiscourse.com/article/business/2125538-dr-reddys-laboratories-q1-net-profit-jumps-108-per-cent-to-rs-1188-crore
| 2022-07-28T13:36:56
|
en
| 0.941395
|
Micro Focus cited for 'strongest performer in the market' for testing tools and breadth of functionalities
SANTA CLARA, Calif., July 28, 2022 /PRNewswire/ -- Micro Focus (LSE: MCRO) (NYSE: MFGP) today announced that its SaaS offerings for the LoadRunner family of performance engineering solutions have achieved a leader position in the GigaOm Radar for Cloud Performance Testing Tools in 2022. LoadRunner SaaS received consistently high marks across key criteria and evaluation metrics for cloud performance testing tools. In fact, the report said, "The LoadRunner product line from Micro Focus is still the strongest performer in this market, with the largest set of functionalities."
According to the report, LoadRunner SaaS solutions received its high rating because of capabilities not available from competitors. "Simulated network behavior is a game changer for achieving real user experience testing and is unique in this market. The ability to consume the output of open-source testing tools as the basis for high-scale testing is also unique in this cloud market. The breadth of what network functions can be tested and how the tests can be structured confirms this solution's positioning as a Leader," the report said.
"LoadRunner has been at the forefront of best-in-class performance engineering solutions for decades," said Vicky Giavelli, Director of Performance Engineering Product Management at Micro Focus. "With cloud and SaaS offerings now the de-facto way of doing business, LoadRunner leads the way for how dev teams deploy high performing applications, allowing them to engineer quality and optimize performance at any point in the DevOps pipeline."
Micro Focus believes that performance testing must evolve into a proactive, continuous performance engineering discipline. Hence, LoadRunner is right-sized for different users, exploits test reuse, and delivers a scalable, shared infrastructure that helps establish a performance engineering ecosystem.
The GigaOm report also provided a recap of some other LoadRunner SaaS advantages. "Benefits include fluid licensing to avoid shelfware, stiff competition on price with its peers, and its ability to work with open-source development tools, which allows for easier integration with developers and DevOps teams."
The LoadRunner family of performance engineering solutions includes LoadRunner Professional, LoadRunner Enterprise, LoadRunner Cloud and LoadRunner Developer. These help teams deliver high-performing apps that surpass customer expectations through end-to-end performance engineering.
For More Information
Please visit the Micro Focus page for the GigaOm Radar Report for Performance Testing Tools.
Join Micro Focus on LinkedIn and follow @MicroFocus on Twitter.
*Source: GigaOM Radar for Performance Testing Tools, June 2022
Micro Focus is one of the world's largest enterprise software providers, focused on solving the IT dilemma—how to balance today's needs with tomorrow's opportunities. We deliver mission-critical technology that helps tens of thousands of customers worldwide manage core IT elements of their business. Strengthened by our strategic services and support organizations, and an extensive partner network, our broad set of technologies for security, IT operations, application delivery, governance, modernization, and analytics provides the innovative solutions organizations need to run and transform— at the same time.
GigaOm provides technical, operational, and business advice for IT's strategic digital enterprise and business initiatives. Enterprise business leaders, CIOs, and technology organizations partner with GigaOm for practical, actionable, strategic, and visionary advice for modernizing and transforming their business. GigaOm's advice empowers enterprises to successfully compete in an increasingly complicated business atmosphere that requires a solid understanding of constantly changing customer demands.
Contact: microfocus@pancomm.com
View original content to download multimedia:
SOURCE Micro Focus
|
https://www.wlbt.com/prnewswire/2022/07/28/micro-focus-loadrunner-saas-solutions-named-leader-by-gigaom-radar-cloud-performance-testing-tools-report/
| 2022-07-28T13:37:01
|
en
| 0.924249
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40207156
| 2022-07-28T13:37:02
|
en
| 0.738227
|
Sundaram Home Finance clocks Q1 net profit at Rs 47.26 cr
- Country:
- India
Sundaram Home Finance has reported a net profit of Rs 47.26 crore for the quarter ending June 30, 2022 up by 18 per cent over the same period last financial year, the company said on Thursday.
The city-based company, engaged in housing finance, had reported net profits at Rs 40.03 crore during the corresponding quarter previous year.
Disbursements during the quarter under review grew to Rs 796 crore from Rs 249 crore registered same quarter previous year, a company statement said here.
''We have seen the positive disbursements trend from Q4 of last year continuing into Q1 this year driven by an increasing demand for home loans in Tier II and III towns in the southern markets,'' Sundaram Home Finance MD Lakshminarayanan Duraiswamy said.
The company said it achieved disbursements of close to Rs 800 crore for the second quarter in succession. ''In Q4 of last financial year, Sundaram Home Finance had registered disbursements of Rs 794 crore,'' the statement said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
|
https://www.devdiscourse.com/article/business/2125540-sundaram-home-finance-clocks-q1-net-profit-at-rs-4726-cr
| 2022-07-28T13:37:03
|
en
| 0.952291
|
Micro-Tech's Y-Shaped Tracheal Stent System is the world's first self-expanding Y-stent for bypassing respiratory tract stenoses in the area around the carina
ANN ARBOR, Mich., July 28, 2022 /PRNewswire/ -- Micro-Tech Endoscopy USA, an industry leader in the development of diagnostic and therapeutic devices in the gastroenterology space, has announced a distribution partnership with innovator in pulmonology, Thoracent. Thoracent will be the U.S. distributor of Micro-Tech's Y-Shaped Tracheal Stent System, a flexible, self-expanding device with an innovative over-the-wire delivery system designed to aid the management of airway tumors in the trachea without invasive surgery.
"Collaborating with Thoracent to distribute this y-stent system—a first in the U.S.—highlights the power of endoscopy as a great area of innovative healthcare practice," stated Chris Li, President of Micro-Tech. "While this is our first technology expansion into pulmonology, this device is in line with Micro-Tech's continued effort to deliver the best technology available to improve the effectiveness, safety, and potential of scope-based care."
The Y-Shaped Tracheal Stent System is designed to treat narrowing of trachea around the carina, often as a result of malignant neoplastic diseases such as trachea cancer. The stent covering restricts tumor ingrowth and the nitinol woven mesh offers a self-expanding, flexible, compliant structure that helps keep the airway open. Sutures on the stent allow for repositioning or removal of the device. Notably, patients are able to remain on ventilation during positioning of the device, which has not been possible previously.
"The Micro-Tech Y-Stent is a welcome addition to the Thoracent airway stent portfolio, offering physicians an effective tool to treat their patients with malignant airway obstruction of the carina region of the airway," said Thoracent CEO Brian Lynch. "Partnering with Micro-Tech and their superior supply chain solutions, we can leverage our distribution power to widen access to this technology and advance pulmonary care at scale."
For more information about Thoracent and Micro-Tech's Y-Shaped Tracheal Stent System, visit thoracent.com. To learn more about Micro-Tech Endoscopy or for information about partnering with Micro-Tech on a device, visit mtendoscopy.com.
Since 2000, Micro-Tech Endoscopy has been focused on creating top-quality products for endoscopic diagnosis, and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, Micro-Tech is committed to bringing better devices to market, with unparalleled speed, at an economical price, and without the burden of contracts. Micro-Tech does not compromise on quality and does not believe customers should either.
Micro-Tech Endoscopy has operations in America, Asia, and Europe and leverages this global reach to rapidly commercialize and refine the products it brings to its clinician partners. Micro-Tech's team has a wealth of experience in the field and in-depth understanding of both product and use cases.
With the health care industry transforming rapidly, Micro-Tech Endoscopy is dedicated to setting the pace as a disruptor. Micro-Tech is more than a medical technology company, it is building a community of healthcare innovators and making health care more value-driven.
Founded in 2017, Thoracent distributes medical devices to the US medical market. Thoracent is a multi-year honoree on the Inc 5000 list of fastest growing privately held companies.
Our relationships with top doctors in the US pulmonology & gastroenterology markets allow us to successfully provide new technology to meet established demand. We are committed to delivering unique, cutting-edge products to our customers.
Contacts
Micro-Tech Endoscopy USA, Inc.
Stephanie Reynolds / Emmie McMinn
stephanie.reynolds@trailrunnerint.com
emmie.mcminn@trailrunnerint.com
Thoracent Inc.
Sharri Thomas
customercare@thoracent.com
View original content to download multimedia:
SOURCE Micro-Tech Endoscopy
|
https://www.wlbt.com/prnewswire/2022/07/28/micro-tech-endoscopy-announces-distribution-partnership-with-thoracent-bring-leading-tracheal-y-stent-system-us-market/
| 2022-07-28T13:37:07
|
en
| 0.926109
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40207426
| 2022-07-28T13:37:08
|
en
| 0.738227
|
LB Brewers partners with Haldiram's for its iced-tea, Borecha Icey
Beverage start-up company, Latambarcem Brewers (LB Brewers) has partnered with Haldiram's to market its iced-teas 'Borecha Icey' and is aiming a turnover of Rs 20 crore in the current financial year.
- Country:
- India
New Delhi [India], July 28 (ANI/NewsVoir): Beverage start-up company, Latambarcem Brewers (LB Brewers) has partnered with Haldiram's to market its iced-teas 'Borecha Icey' and is aiming a turnover of Rs 20 crore in the current financial year. The Goa-based LB Brewers manufactures craft beer and non-alcoholic functional beverages such as premium iced teas, kombucha and zero sugar seltzers having annual capacity of 150,000 & 100,000 cases respectively.
Commenting on the tie-up with Haldiram's, one of India's most popular brands for snacks and sweets, Aditya Ishan Varshnei, Co-founder and CEO of Latambarcem Brewers said, "We are excited to have entered into a marketing tie-up with renowned Haldiram's Group. Under this partnership our premium iced-tea beverage Borecha Icey will be available at 100+ outlets of Haldiram's spread across Delhi-NCR." "We appreciate that Haldiram's has decided to promote healthy and functional beverages through its outlets," he said.
LB Brewers is expecting tremendous response to its healthy drinks. The demand for healthy food and beverages has surged during the last two years because of multiple factors including the COVID pandemic. Initially, the co-branded Borecha will be available in three different flavours at Haldiram's outlets and depending upon the response and customer feedback, LB Brewers would consider introducing more flavours of Borecha at Haldiram's.
"We are targeting to sell at least 70,000 cases valuing Rs 10 crore during this fiscal and we are anticipating significant jump in both volume and value terms over the next 2 years. In fact, in 2023-24, we are expecting over a 500 per cent jump in our business," Varshnei said. "Borecha is made from natural ingredients and is a low-sugar product - something today's health-conscious customer would prefer to other iced teas available in the market," he added.
'Borecha', a natural cold brewed iced tea available in a can, is available in over 15 states. It is available through e-commerce channels such as Amazon and other notable high-end retail outlets across the country. Besides the iced tea, LB Brewers is also into the craft beer segment having its own brewery in Goa. During the last financial year, the company sold 25,000 cases of beer and 40,000 cases of 'Borecha' valuing at Rs 3 Crores and Rs. 2 Crore respectively.
LB Brewers, however, did not disclose the financials of the arrangement. Goa-based Latambarcem Brewers, manufactures craft beer and functional beverages like iced tea, was formed in 2017 to bridge the gap in the Indian craft-beer market. Co-founded by Aditya Ishan Varshnei and Anish Varshnei, it has manufacturing facilities in Goa. The startup manufactures functional beverages, under the brand name Borecha, and a range of craft beers under the brand 'Maka Di'. Its long-term goal is to manufacture and sell high-quality beer, at par with global standards. Latambarcem has a team of up to 50 full-time employees working across departments.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
|
https://www.devdiscourse.com/article/business/2125543-lb-brewers-partners-with-haldirams-for-its-iced-tea-borecha-icey
| 2022-07-28T13:37:11
|
en
| 0.958062
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/nhl/montreal-canadiens/articles/40207706
| 2022-07-28T13:37:14
|
en
| 0.738227
|
– Preliminary Phase 1b data demonstrated clinical activity, defined as stable disease or better
– Company determines RP2D to be 360 mg/m2 and will begin Phase 2 recruitment
– Annamycin has Fast Track Status and Orphan Drug Designation from FDA for the treatment of soft tissue sarcoma
HOUSTON, July 28, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced it has completed the safety review of the fourth cohort in a dose escalation clinical trial evaluating Annamycin for the treatment of soft tissue sarcoma (STS) lung metastases, thus concluding the Phase 1b portion of its U.S. Phase 1b/2 clinical trial. Preliminary results from the study continue to document clinical activity for Annamycin in the treatment of STS. The safety review committee (SRC) has deemed the dose of 390 mg/m2 to be safe after conclusion of the fourth cohort. Notwithstanding that there was safety at this dose level, tolerability issues present at the 390 mg/m2 dose level caused delays in follow-on cycles and the reduction of subsequent doses, suggesting that a Recommended Phase 2 Dose (RP2D) below 390 mg/m2 was warranted.
With this in mind and with the recommendation of the SRC, the Company has determined that the RP2D will be 360 mg/m2 for the first three subjects in the Phase 2 portion of the study. The SRC will then review the clinical safety data at this dose and determine whether the RP2D should be further reduced to 330 mg/m2 prior to proceeding with the additional 22 subjects. In addition to continuing to assess safety, including gathering additional information about short-term side effects and possible risks, this Phase 2 portion of the study will also explore the efficacy of Annamycin as a single agent for the treatment of subjects with STS lung metastases for whom prior chemotherapy has failed, and for whom new chemotherapy is considered appropriate.
In the Phase 1b portion of the study, 15 subjects were enrolled and treated per the protocol in four cohorts to determine the maximum tolerable dose and/or the RP2D. Each cohort had three subjects, except for the fourth cohort, which (per the protocol) was expanded to six subjects after a dose-limiting toxicity (DLT) occurred in a single subject. The Company concluded the Phase 1b portion after the fourth cohort of 390 mg/m2 was documented to be safe. Up to 28 subjects, to account for potential over enrollment, will be enrolled at the RP2D in Phase 2 to focus more on quantifying efficacy as well as providing additional safety information.
"As we end the Phase 1b portion of this trial, the preliminary data continue to be encouraging," said Moleculin Chairman and CEO Walter Klemp. "Of the fifteen subjects treated per the protocol, two continue with treatment, and eight subjects have been followed without evidence of disease progression for two months or greater, with three of the eight free of disease progression for 120 days or more. These data are early-stage, and we look forward to developing confirmatory data from future studies. However, based on the data available thus far, we believe Annamycin has the potential to bring a new and effective treatment option to patients with significant unmet needs."
Mr. Klemp added, "We're also encouraged by the pace of recruitment to date for this trial. To have completed the Phase 1b in just over one year was faster than we expected, especially for a rare disease like STS lung metastases. This is encouraging as we open the Phase 2 portion of the study."
The summary of interim Phase 1b data, which are preliminary and subject to change, from the four cohorts of the study are as follows:
First Cohort (210 mg/m2):
- Two subjects received 6 cycles of Annamycin, initially having stable disease, and were then discontinued due to progressive disease.
- One subject received 1 cycle, but then discontinued from the study because of a Dosing Delay greater than the time between doses permitted by the protocol. At the End of Study scan performed 39 days post initiation of treatment, the subject had stable disease. The subject was followed and continued to exhibit disease free progression up to 61 days after treatment, at which point the subject began a different therapy.
Second Cohort (270 mg/m2):
- In one subject, the end of cycle 2 scan showed a partial response (≥30% reduction in tumor size), and when scanned at the end of cycle 4 the subject showed stable disease. The subject subsequently discontinued from the study, electing to undergo surgical resection to potentially eradicate the disease. The subject is continuing to be followed and at the last follow-up no disease progression was reported at 272 days.
- One subject was discontinued from the study when the end of cycle 2 scan revealed progressive disease.
- One subject received 1 cycle of treatment and discontinued treatment due to a Dosing Delay. The End of Study scan revealed progressive disease.
Third Cohort (330 mg/m2):
- One subject received 1 cycle and was discontinued when an interim, unscheduled scan revealed progressive disease.
- One subject was discontinued from the study when the end of cycle 2 scan revealed progressive disease.
- One subject was treated with 2 cycles and the end of cycle 2 scan revealed stable disease. The subjected elected to withdraw from receiving any further treatment. The subject was followed and no disease progression was reported at 146 days. The subject elected at that time to discontinue from further follow-up in the study.
Fourth Cohort (390 mg/m2):
Efficacy data for this cohort are incomplete as not all subjects have received their scans and treatment is ongoing.
- One subject received 3 cycles of treatment without evidence of any DLTs, with the last 2 cycles at a reduced dose of 292 mg/m2 due to a drug tolerability issue that did not qualify as a DLT. The subject exhibited stable disease at the end of cycle 2. The subject showed progressive disease in the end of treatment scan on the 78th day.
- One subject was discontinued from the study after 2 cycles with cycle 2 administered at a reduced dose of 292 mg/m2. The subject discontinued receiving cycles because of a DLT of febrile neutropenia, and the cohort was expanded per the protocol. The end of cycle 2 scan revealed stable disease. The subject initiated additional therapy unrelated to the study on the 68th day and will continue to be followed for Overall Survival.
- One subject received 3 cycles of treatment without evidence of any DLTs, with the last 2 cycles administered at reduced doses, due to drug tolerability. The subject exhibited stable disease at the end of cycle 2. The subject showed progressive disease in an unscheduled scan on the 79th day.
- One subject received 4 cycles without evidence of any DLTs, with the last three cycles administered at a reduced dose of 292 mg/m2, due to drug tolerability. The end of cycle 4 scans revealed stable disease. The subject is ongoing in the study.
- One subject received 3 cycles without evidence of any DLTs, with the last two cycles administered at a reduced dose of 292 mg/m2, due to drug tolerability. The end of cycle 2 scans revealed stable disease. The subject is ongoing in the study.
- One subject received 1 cycle without evidence of any dose-limiting toxicities and is ongoing in the study.
- One subject received a markedly lower dose than the specified 390 mg/m2 in a protocol violation by the site, also without evidence of any DLTs. That subject's safety data, but not efficacy, is deemed to be evaluable in the study.
"Consistent with our earlier and ongoing acute myeloid leukemia trials, in the subjects evaluated to date we have seen a complete absence of cardiotoxicity in our trials," Mr. Klemp said. "Again, these are early-stage data, but we're seeing consistent results in this regard across our Annamycin studies, and we think they're important because, even though anthracyclines are considered a cornerstone chemotherapy for many types of cancer including STS lung metastases, all currently approved anthracyclines are significantly cardiotoxic. Annamycin was designed to overcome this problem and we believe it has the potential to become the first non-cardiotoxic anthracycline approved for use. If these data continue and our product is approved, Annamycin may not only reduce the risk of many current anthracycline treatment regimens, but it could also enable longer treatment periods with reduced concern for cardiac risk."
Annamycin currently has Fast Track Status and Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of soft tissue sarcoma, in addition to Orphan Drug Designation for the treatment of relapsed or refractory acute myeloid leukemia. For more information about the Phase 1b/2 study evaluating Annamycin for the treatment of STS lung metastases, please visit clinicaltrials.gov and reference identifier NCT04887298.
Study Design
In Phase 1b, Annamycin was administered as an intravenous (IV) infusion over 2 hours on Day 1, followed by 20 days off (1 cycle = 21 days). Subjects visit the study site every 21 days (±3 days) at which time safety monitoring – including for adverse events (AEs), as well as a physical examination, laboratory evaluations (clinical chemistry, complete blood count), vital signs, weight measurements, Eastern Cooperative Oncology Group (ECOG) performance status, and electrocardiograms (ECGs) – is performed, followed by an IV infusion of study drug. Cardiac function is followed by echocardiogram (ECHO) scans at screening, at the end of the first two cycles and then following every other cycle thereafter, at the End of Treatment visit, and if feasible, during follow up at 6 months (±1 month) and 1 year (±1 month) after study drug discontinuation. As long as the Investigator considers that the benefits of treatment with Annamycin continue to outweigh the risks, treatment will continue every 21 days until tumor progression is observed or unacceptable toxicity occurs.
Tumor response is monitored every 6 weeks (±1 week) from Cycle 1 Day 1 during treatment, at the End of Treatment visit, and then every 3 months (±1 month) until disease progression using RECIST 1.1 criteria. Those subjects who leave the study after a maximum response is achieved and who do not start another therapy will be followed every 3 months (±1 month) for progression-free survival (PFS). If a subject receives further therapy after discontinuing from the study, they will be followed only for overall survival (OS) and if feasible, follow-up ECHO scans at 6 months (±1 month) and 1 year (±1 month) will be conducted after study drug discontinuation.
About Annamycin
Annamycin is the Company's next-generation anthracycline that has been shown in animal models to accumulate in the lungs at up to 30-fold the level of doxorubicin. Importantly, Annamycin has also demonstrated a lack of cardiotoxicity in multiple early-stage human clinical trials, including ongoing trials for the treatment of acute myeloid leukemia (AML) and STS lung metastases. For that reason, although additional data will be necessary, the Company believes Annamycin may not face the same usage limitations imposed on doxorubicin, one of the most common currently approved anthracyclines. Annamycin is currently in development for the treatment of AML and STS lung metastases and the Company believes the drug may have the potential to treat additional indications.
About Moleculin Biotech, Inc.
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company's lead program, Annamycin, is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.
Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers.
For more information about the Company, please visit www.moleculin.com and connect on Twitter, LinkedIn and Facebook.
Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation the final determination of the RP2D, the ability of Annamycin to demonstrate safety and efficacy in subjects, and the ability of the STS lung metastases clinical trial to continue the recruitment of subjects and the ability of Annamycin to eventually be approved by the FDA. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including 'believes,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'projects,' 'intends,' 'potential,' 'may,' 'could,' 'might,' 'will,' 'should,' 'approximately' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. "Risk Factors" in our most recently filed Form 10-K filed with the Securities and Exchange Commission ("SEC") and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Investor Contact:
JTC Team, LLC
Jenene Thomas
(833) 475-8247
MBRX@jtcir.com
View original content to download multimedia:
SOURCE Moleculin Biotech, Inc.
|
https://www.wlbt.com/prnewswire/2022/07/28/moleculin-concludes-phase-1b-opens-recruitment-phase-2-clinical-trial-annamycin-treatment-soft-tissue-sarcoma-lung-metastases/
| 2022-07-28T13:37:14
|
en
| 0.947663
|
The new head of the Virginia Port Authority board of commissioners knows a thing or two about transportation.
Aubrey Layne, a former state official with Govs. Ralph Northam and Terry McAuliffe’s administrations, was appointed chairman at the body’s monthly meeting, the Virginia Port Authority announced July 20.
Under McAuliffe, Layne was secretary of transportation from 2014 to 2018. He was appointed secretary of finance under Northam’s administration and served in that role from 2018 to 2021.
Layne said the board’s main responsibilities will continue to be financial oversight of the port, as well as making sure the right senior leaders are hired in order to run the entity.
He also wants to continue to work with Gov. Glenn Youngkin’s administration and focus on economic development.
Inside Business
“Really important to me is that we are not only providing jobs for the port but providing opportunities for businesses to relocate here,” Layne said.
Layne’s extensive knowledge of Virginia’s transportation system would be a massive asset for the port, Virginia Port Authority CEO and Executive Director Stephen Edwards said.
“Equally important is knowledge he gained from working under two governors and the relationships he developed in Richmond during that time,” Edwards added.
Layne said he hoped to use his Richmond connections to continue to secure funding for capital improvement projects. He’s also working with Virginia lawmakers for more federal grant funding. The Port of Virginia is funded through its operations, but uses state and federal money to pay for infrastructure projects.
After working for two governors, Layne accepted a position at Sentara Healthcare in 2021 and works as a vice president and chief of staff. He oversees legislative affairs, corporate social responsibility, real estate, construction, marketing and communications and the hospital system’s nursing school.
In addition to Layne, four other new board members were appointed, including:
- Shaza Andersen, Trustar Bank CEO,
- James Burnett, W.M. Jordan Co. vice president and chief financial officer,
- Michael Coleman, CV International Inc. and Capes Shipping president and CEO, and
- John Kirk III, Associated Asphalt chairman.
Trevor Metcalfe, 757-222-5345, trevor.metcalfe@pilotonline.com
|
https://www.pilotonline.com/business/vp-bz-aubrey-layne-port-board-0729-20220728-zafucz3yh5cmjdvpmx4onbwlfe-story.html
| 2022-07-28T13:37:18
|
en
| 0.962591
|
Bajaj Finserv shares jump over 10 pc after June qtr earnings; mcap climbs Rs 21,681 cr
- Country:
- India
Shares of Bajaj Finserv on Thursday zoomed over 10 percent after the company reported a 57 percent jump in net profit in the June quarter.
The stock rallied 10.14 percent to Rs 14,652.30 apiece on the BSE. During the day, it climbed 11.08 percent to Rs 14,777.85.
On the NSE, it advanced 10.09 percent to Rs 14,650 apiece.
The company's market valuation also jumped from Rs 21,681.19 crore to Rs 2,33,383.19 crore on the BSE.
On Thursday, Bajaj Finserv reported a 57 percent jump in net profit at Rs 1,309 crore in the first quarter ended June, on healthy earnings by its subsidiary companies.
In the year-ago period, the company had posted a net profit of Rs 833 crore.
The company's consolidated total income during the April-June period of 2022-23 was up 14 percent to Rs 15,888 crore, Bajaj Finserv said in a regulatory filing.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Bajaj Finserv
- 14
- 652.30
|
https://www.devdiscourse.com/article/business/2125545-bajaj-finserv-shares-jump-over-10-pc-after-june-qtr-earnings-mcap-climbs-rs-21681-cr
| 2022-07-28T13:37:19
|
en
| 0.93866
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/mlb/baltimore-orioles/articles/40206460
| 2022-07-28T13:37:20
|
en
| 0.738227
|
Entrepreneurial Internship Program Builds Model For Partnership Between Higher Education And Start-Ups, Emphasizes Benefits Of Entrepreneurial Internships Regardless Of Major
SAN FRANCISCO, July 28, 2022 /PRNewswire/ -- The Nasdaq Entrepreneurial Center, a non-profit committed to growing inclusion and access for entrepreneurs worldwide, today celebrated the fifth anniversary of its unique collaboration in entrepreneurial education with Lehigh University through Lehigh@NasdaqCenter. The immersive campus extension for Lehigh University students has established a new partnership model between higher education and the private sector, giving students scaffolded internship experiences with early-stage start-ups, which equally benefit the start-ups by providing them with support around talent management.
With a goal of advancing the entrepreneurial mindset of students in any discipline, 1,000 students across 65 majors have experienced entrepreneurship through Lehigh@NasdaqCenter programs, classes and mentorship. Programs include the flagship Startup Academy, where students are placed in start-up internships, which are framed by weekly classes, mentor pairings in their professional area of interest, and Intern Management Workbooks; the Global Entrepreneurial Fellowship, which immerses students in startup internships across the globe; the remote Silicon Valley Innovation Internship; and an array of resources, including the Lehigh@NasdaqCenter podcast and multiple toolkits.
Key program learnings to-date include:
- When an entrepreneurial internship experience is mapped with mindset training, key skills relating to confidence and resilience are exponentially developed, regardless of whether the student plans to pursue a career at a start-up.
- Peer support systems (especially in a pairing environment) is a key to building the social infrastructure students need to venture into a new experience and feel they can navigate the many unknowns of start-ups.
- This partnership taught the students and start-ups how to invest in themselves as leaders. On both sides, it gives on-the-job training around how you grow leadership development.
- Startup onboarding is a challenging and daunting task. Helping startups invest in themselves and prioritize building and developing their onboarding early in the company lifecycle is likely to help with retention and support the founder journey.
- The initiative also highlighted the importance for the start-ups of spending time on things that impact your staff and community even if they don't have a clear return. The human talent layer is an essential one, and the highest cost of talent for start-up is on the retention layer.
"The 'curriculum' of the future will occur both inside and outside of the classroom. The entrepreneurial mindset and pursuit of value creation should be universally taught across higher education," said Lehigh President Joseph J. Helble.
"Lehigh University is leading the way internationally on entrepreneurial studies and talent development, and the impact of this model will help enrich students and start-ups far beyond the program," said Nicola Corzine, executive director of the Nasdaq Entrepreneurial Center.
Lehigh@NasdaqCenter rang the Nasdaq Opening Bell from the Nasdaq Entrepreneurial Center on Tuesday, July 26 to commemorate the program's five-year anniversary. Lehigh@NasdaqCenter partners closely with Lehigh's Western Regional Office (WRO) on academic programs, student recruitment, alumni relations, university events, development, corporate and industry partnerships and career services.
The Nasdaq Entrepreneurial Center is a non-profit committed to growing inclusion and access for entrepreneurs worldwide. The Center meets the real-time needs of entrepreneurs through educational programming and then shares its learnings with policy-leaders, capital allocators and academic institutions. Established with the support of the Nasdaq Educational Foundation, the Center has been a resource for more than 50,000 entrepreneurs since its inception in 2014, a majority of whom come from underrepresented audiences. For more information please visit: http://thecenter.nasdaq.org/.
Located in Pennsylvania's beautiful Lehigh Valley, Lehigh University is one of the nation's most distinguished private research universities. Through academic rigor, an entrepreneurial mindset and collaborative opportunities we challenge our students to become the leaders of the future: http://www.lehigh.edu.
Media Contact:
Extension PR
thecenter@extensionpr.com
Lori Friedman
Director of Media Relations, Lehigh University
lof214@lehigh.edu
(323) 377-4312
View original content:
SOURCE Nasdaq Entrepreneurial Center
|
https://www.wlbt.com/prnewswire/2022/07/28/nasdaq-entrepreneurial-center-lehigh-university-celebrate-fifth-anniversary-lehighnasdaqcenter-an-innovative-academic-in-residence-partnership/
| 2022-07-28T13:37:21
|
en
| 0.928987
|
WASHINGTON — Cigarette maker Altria’s $13-billion investment in the troubled vaping company Juul has gone up in smoke — now worth less than 5% of its original value as U.S. regulators move to ban its e-cigarettes.
Altria slashed the value of its Juul investment again Thursday, pegging its value at under $500 million as it reported second-quarter earnings. Previously, the Marlboro maker had valued its stake in the company at $1.6 billion.
Despite the losses Altria said it was maintaining its investment deal with Juul, including an agreement not to market competing vaping products.
“At this time, we continue to believe that these investment rights are beneficial to us,” Altria said in a prepared statement.
Altria, based in Richmond, Virginia, is Juul’s largest investor with a 35% ownership stake. Altria executives signed the $12.8-billion pact in 2018, betting that Juul’s popular vaping devices represented a lucrative new opportunity in the vaping market.
But last month the U.S. Food and Drug Administration announced plans to ban the small cartridge-based e-cigarettes, saying Juul had failed to provide key information about potentially harmful chemicals in its nicotine formula. The decision surprised industry observers and experts given that the FDA has authorized several competing e-cigarettes and Juul spent years gathering data to support its application.
In yet another twist to the company’s fortunes, the FDA reopened its review of Juul’s application earlier this month after a federal court blocked the ban from immediately taking effect. For now, Juul is able to continue selling its products while the FDA review continues.
|
https://www.pilotonline.com/business/vp-nw-altria-juul-value-20220728-qbszx33icfdbrgrauzuntlbkre-story.html
| 2022-07-28T13:37:24
|
en
| 0.960348
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/mlb/baltimore-orioles/articles/40206545
| 2022-07-28T13:37:26
|
en
| 0.738227
|
Vedanta net profit rises 5 pc to Rs 4,421 crore in April-June
- Country:
- India
Vedanta on Thursday reported a marginal 4.6 percent rise in its consolidated net profit at Rs 4,421 crore in the April-June quarter due to higher sales volume, commodity prices, and strategic hedging gains.
The diversified natural resources company had posted a consolidated net profit of Rs 4,224 crore in the year-ago period, Vedanta Ltd said in a BSE filing.
Its consolidated income during the April-June period increased to Rs 39,355 crore from Rs 29,151 crore in the year-ago period, the filing said.
The consolidated expenses of the company during the first quarter increased to Rs 32,095 crore from Rs 21,751 crore in the year-ago period, the filing said.
Vedanta's chief executive officer Sunil Duggal said that this year the company's key priorities will be delivery on committed volumes, timely execution of projects for growth, value addition, vertical integration and cost reduction across its key businesses, and proactive commodity price risk management.
In the first quarter of the ongoing fiscal, the company's depreciation and amortization increased by 16 percent year-on-year to Rs 2,464 crore on account of higher depletion charges in oil and gas and higher ore production at Zinc India.
In the reporting quarter, the finance cost increased by two percent year-on-year to Rs 1,206 crore, mainly on account of rising in average borrowings, partially offset by a reduction in the average interest rate of borrowings.
The company's gross debt rose by Rs 8,031 crore in the first quarter of FY23 to Rs 61,140 crore.
The full profit for the quarter, including profits of jointly-controlled entities, rose by 6 percent to Rs 5,592 crore, the company said.
Vedanta Ltd, a subsidiary of Vedanta Resources Ltd, has operations in oil and gas, zinc, lead, silver, copper, iron ore, steel, and aluminum and power across India, South Africa, and Namibia.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Vedanta Resources Ltd
- Sunil Duggal
- Namibia
- India
- South Africa
- Vedanta Ltd
- Vedanta
ALSO READ
UNSC reform negotiations could go on for another 75 years without any progress: India
India's inflation above tolerance for 6th consecutive month; here's what analysts have to say
India denies 'baseless and speculative' media reports about facilitating President Gotabaya's visit to the Maldives
India trump Pakistan in latest ICC ODI Team Rankings
ENG vs IND: Rohit Sharma becomes first Indian to hit 250 ODI sixes
|
https://www.devdiscourse.com/article/business/2125550-vedanta-net-profit-rises-5-pc-to-rs-4421-crore-in-april-june
| 2022-07-28T13:37:26
|
en
| 0.939388
|
MILTON, ON, July 28, 2022 /PRNewswire/ -- Storage & Transfer Technologies (STT), a wholly owned subsidiary of Carmeuse, in partnership with Schenck Process, is excited to launch a new lime injection system for electric arc furnace steel plants globally. This collaboration combines the expertise of each company's focus on lime handling, dense phase conveyance and lime manufacturing to bring an effective offering to the market. Customized to meet each steel plant's site and lime requirements, the system components include truck offloading, silo storage, pneumatic conveying, piping and controls up to the injection nozzle. This system can be installed in new sites or integrated into existing sites.
Safe, efficient, accurate, and reliable operation is ensured through decades of knowledge in lime manufacturing, lime conveyance and steel industry experience.
"No other company can bring together this range of expertise from how the raw material characteristics and manufacturing impact the flowability, to how lime is transferred through the system, up to point of application" says Phil Piggott, Vice President of Sales & Marketing at Carmeuse. Quinn Shortal, Operations Director at STT notes that "each site has its own unique needs, and we work together with our customers to ensure the system is designed to fit specific requirements and exceed their expectations."
"We are very excited to partner with STT to provide the steel industry a more comprehensive and accurate lime injection solution, which is the culmination of many years of development and testing of injection technology by Schenck Process and builds upon its core competency in precision weighing and feeding" says Brad Suter, Director of Sales at Schenck Process.
For more information, visit: https://www.sttsystems.com/systems/lime-injection-systems
STT is a global company, founded in 1970, that designs, installs and maintains lime storage, handling, and slaking systems. We engineer solutions that fit our customers' needs and exceed their safety, efficiency, and reliability standards. We support our customers throughout the full life cycle of their system from design concept to installation through maintenance. STT is a wholly owned subsidiary of Carmeuse.
For further company news and information, please visit www.sttsystems.com
Carmeuse is a global manufacturer of lime and limestone products used in a variety of applications, founded in 1860 with a presence in Western, Central and Eastern Europe, North and South America, Africa, the Middle East, and Asia. With global headquarters located in Louvain-la-Neuve (Belgium), the Carmeuse Group has approximately 4,500 employees and serves over 8,500 customers annually through a network of 80 plants and 50 limestone quarries.
For further company news and information, please visit www.carmeuse.com
Schenck Process is a global provider of sustainable products, integrated solutions, and services in mission-critical applications for bulk materials. Headquartered in Darmstadt, Germany, the Group has around 3,100 employees with a presence in over 21 countries across 6 continents focused on the food and mining markets, alongside chemicals and performance materials, and infrastructure and energy.
The product offering includes solutions for industrial weighing, feeding, conveying, pulverizing and classification, screening, mixing and blending, and associated digital applications.
For further company news and information, please visit www.schenckprocess.com
View original content:
SOURCE Storage & Transfer Technologies (STT)
|
https://www.wlbt.com/prnewswire/2022/07/28/new-lime-injection-solution-eaf-steel-plants-due-global-partnership-between-storage-amp-transfer-technologies-stt-schenck-process/
| 2022-07-28T13:37:29
|
en
| 0.940961
|
Here are our picks for upcoming events and happenings worth splurging time and money on (though some events are free):
Mystical Arts of Tibet
Deriving from the Sanskrit word for circle, mandalas serve as crucial imagery in many eastern religions, including Jainism, Hinduism, Shintoism and Buddhism.
This weekend, Tibetan monks of the Drepung Loseling Monastery will be at the American Theatre in Hampton to create a sand-painted mandala.
In Tibetan Buddhism, mandalas are referred to as Dul-Tson-Kyil-Kur (meaning mandala of colored powders) and represent the journey from human ignorance to enlightenment through intricate jewel-toned compositions. Dul-Tson-Kyil-Kur are designed to be washed away — the belief that as the sands disperse they foster healing for people and the earth.
Opening ceremony is noon to 6 p.m. Thursday; the work continues 10 a.m to 6 p.m. Friday and Saturday; noon to 2 p.m. with a closing ceremony 3 p.m. American Theatre, 125 East Mellen St. Hampton. Free.
Blue Water Road Trip Tour
Kehlani, who uses they/them pronouns, is making a pit stop in Portsmouth Friday with her Blue Water Road Trip Tour.
Weekend Scoop
They are often compared to urban contemporary soul artists like Sade, Lauryn Hill, and Erykah Badu but the Oakland, California native boasts accolades as far back as 2016. Kehlani has since accrued a multitude of Grammy nominations for their sumptuous R&B musings and chart toppers. They’ll be performing with Rico Nasty, who is known for her punk-rap persona and gravelly vocals and up-and-coming R&B singer Destin Conrad.
8 p.m. Friday, Atlantic Union Bank Pavilion; 16 Crawford Circle, Portsmouth; tickets start at $30 for lawn seating. ticketmaster.com
Rock N’ Roll Cowboy Tour
If country music is more your thing (we are in the South, after all), country-rock powerhouse Jason Aldean will be coming to Virginia Beach on Saturday with opening performances by Gabby Barrett and John Morgan. Expect to hear his recent 2022 single, “That’s What Tequila Does,” alongside trademark hits such as “Big Green Tractor” and “Dirt Road Anthem.”
7:30 p.m., Veterans United Home Loans Amphitheater, 3550 Cellar Door Way, Virginia Beach. Tickets start at $39.75; livenation.com
Grease Is the Word
Yes, it’s still got groove — and meaning.
The OG Jersey Boy himself, Frankie Valli takes the Chrysler Hall stage with the Four Seasons following on Sunday. With its last leg coinciding with Italian Heritage month (October), and following the recent deaths of notable Italian-American pop culture icons Tony Sirico (The Sopranos) and Paul Sorvino (Goodfellas), Valli’s revival tour is not only apt but welcome. With Valli’s signature falsetto and timeless discography, this will be a performance you won’t be able to take your eyes off of.
7 p.m. Sunday, Chrysler Hall, 215 St Paul’s Blvd., Norfolk. Tickets start at $57.www.ticketmaster.com
|
https://www.pilotonline.com/entertainment/vp-db-entertainment-roundup-072922-20220728-vdbhyw733vd5rb7hymjreucfme-story.html
| 2022-07-28T13:37:30
|
en
| 0.925203
|
You need to enable JavaScript to run this app.
|
https://sportspyder.com/mlb/baltimore-orioles/articles/40207117
| 2022-07-28T13:37:32
|
en
| 0.738227
|
TVS Motor Company Posts Highest Ever Revenue, EBITDA and Profit in Q1
Hosur, Tamil Nadu, India NewsVoir TVS Motor Company reported operating revenue of Rs. 6,009 Crores for the quarter ended June 2022 as against Rs. 3,934 Crores reported in the quarter ended June 2021. Electric Scooter sales registered 0.09 Lakh units in the quarter ended June 2022 as against 0.01 lakh units in the quarter ended June 2021.
- Country:
- India
TVS Motor Company reported operating revenue of Rs. 6,009 Crores for the quarter ended June 2022 as against Rs. 3,934 Crores reported in the quarter ended June 2021. The Company reported EBITDA of Rs. 599 Crores for the first quarter of 2022-23 as against EBITDA of Rs. 274 Crores in the first quarter of 2021-22. The company's EBITDA margin for the quarter is at 10% as against the EBITDA margin of 7% reported in the first quarter of 2021-22. The Company reported Profit Before Tax (PBT) of Rs. 432 Crores in the first quarter of 2022-23 as against Rs. 102 Crores in the first quarter of 2021-22. During the current quarter, the Company reported Profit After Tax (PAT) of Rs. 321 Crores as against Rs. 53 Crores during the first quarter of 2021-22. The first quarter numbers are not strictly comparable with the first quarter of last year due to lockdowns. Sales The overall two-wheeler and three-wheeler sales including exports registered sales of 9.07 Lakh units in the quarter ended June 2022 as against 6.58 Lakh units registered in the quarter ended June 2021. Motorcycle sales registered 4.34 Lakh units in the quarter ended June 2022 as against 4.05 Lakh units in the quarter ended June 2021. Scooter sales for the quarter ended June 2022 are 3.06 Lakh units as against the sales of 1.38 Lakh units in the first quarter of 2021-22. The Company recorded the highest two-wheeler exports in this quarter registering 2.96 Lakh units as against 2.90 Lakh units in the quarter ended June 2021. Three-wheeler sales for the quarter under review are 0.46 Lakh units as against 0.39 Lakh units during the first quarter of 2021-22. Electric Scooter sales registered 0.09 Lakh units in the quarter ended June 2022 as against 0.01 lakh units in the quarter ended June 2021. New Product Launches During the quarter, the Company launched the TVS iQube Electric scooter in three variants that come loaded with a best-in-class on-road range of 140 km on a single charge. They offer a host of intelligent connected features such as 7" TFT touchscreen and clean UI, infinity theme personalisation, voice assist and TVS iQube Alexa skillset, intuitive music player control, OTA updates, fast charging with a plug-and-play carry along charger, vehicle health and safety notifications, multiple Bluetooth, and Cloud Connectivity options, 32 litre storage space. The company also launched, TVS NTORQ XT with never seen hi-tech features like the industry's first Hybrid TFT console and TVs SmartXonnectTM, which has 60+ hi-tech features including "SmartXtalk", "SmartXtrack". The scooter also features "TVS IntelliGO" technology. Both the products have received extremely good responses from the customers. About TVS Motor Company TVS Motor Company is a reputed two and three-wheeler manufacturer globally, championing progress through Sustainable Mobility with four state-of-the-art manufacturing facilities in Hosur, Mysuru, and Nalagarh in India and Karawang in Indonesia. Rooted in our 100-year legacy of Trust, Value, and Passion for Customers and Exactness, we take pride in making internationally aspirational products of the highest quality through innovative and sustainable processes. We are the only two-wheeler company to have received the prestigious Deming Prize. Our products lead in their respective categories in the J.D. Power IQS and APEAL surveys. We have been ranked the No. 1 Company in the J.D. Power Customer Service Satisfaction Survey for consecutive four years. Our group company Norton Motorcycles, based in the United Kingdom, is one of the most emotive motorcycle brands in the world. Our subsidiaries in the personal e-mobility space, Swiss E-Mobility Group (SEMG), and EGO Movement have a leading position in the e-bike market in Switzerland. TVS Motor Company endeavors to deliver the most superior customer experience across the 80 countries in which we operate.
For more information, please visit www.tvsmotor.com.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
UNSC reform negotiations could go on for another 75 years without any progress: India
India's inflation above tolerance for 6th consecutive month; here's what analysts have to say
India denies 'baseless and speculative' media reports about facilitating President Gotabaya's visit to the Maldives
India trump Pakistan in latest ICC ODI Team Rankings
ENG vs IND: Rohit Sharma becomes first Indian to hit 250 ODI sixes
|
https://www.devdiscourse.com/article/business/2125553-tvs-motor-company-posts-highest-ever-revenue-ebitda-and-profit-in-q1
| 2022-07-28T13:37:34
|
en
| 0.954814
|
Mid Atlantic Dairy Queen pledged $5 million to Children’s Hospital of The King’s Daughters’ “Lighting the Way” campaign, the fundraiser for the system’s mental health hospital in Norfolk.
The Franklin-based Dairy Queen operator and longtime CHKD benefactor plans to raise the funding through a “round up” campaign at the registers of its 14 mid-Atlantic Dairy Queen restaurants. Customers can round up to the nearest dollar through the end of the year to support CHKD. On July 28′s Miracle Treat Day, $1 from every Blizzard will be donated to CHKD. Coin canisters and employee donations will also go toward the $5 million pledge.
“Our fans and our team love giving to CHKD, so we keep raising the bar on our pledges,” said Mitch Sandlin, CEO of Mid Atlantic Dairy Queen. “The enthusiasm for CHKD never ends, and the community continues to step up to support the projects the children need.”
CHKD’s Children’s Pavilion, a 14-story tower on Gresham Drive, opened to outpatient services in April, offering mental health treatment, primary care, sports medicine and laboratory and radiology services. The first of 60 private inpatient beds for psychiatric treatment will open in the fall.
Once fully operational, the hospital will employ more than 400 doctors, nurses, therapists and other mental health professionals who will treat thousands of children from across the state and beyond. To address the national shortage of child and adolescent psychiatrists, CHKD is developing a fellowship program to train mental health providers.
“Mental health is fundamental to children’s well-being,” said Matthew Bean, director of marketing of Mid Atlantic Dairy Queen. “Creating mental health resources builds a better future for them and for the entire community.”
— Staff report
|
https://www.pilotonline.com/inside-business/vp-ib-dairy-queen-chkd-0801-20220728-vmcdk3sumfej5mx64sv47xv7yq-story.html
| 2022-07-28T13:37:36
|
en
| 0.917516
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.